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Thesis Overview 
 
As the HIV epidemic enters into its fourth decade, the epidemiology continues to 
change and the response continues to adapt.  One of the most significant trends in 
HIV in developed countries has been the ageing of the cohort as HIV-positive 
individuals infected while young survive longer with anti-retroviral treatment and due 
to ongoing sexual transmission among those aged 50 years and older.  In the United 
States for example, recent estimates have noted that around 50% of people living with 
HIV will be older than 50 by 2015. 
 
Despite these clear trends and their significant implications for prevention, care and 
treatment – specifically with regard to co-morbidity with various chronic diseases – 
very little analysis has been conducted on the HIV and ageing phenomenon in 
developing countries. 
 
This thesis aims to address the shortage of evidence in this emerging area by focusing 
on HIV infection among older adults in sub-Saharan Africa – the region where the 
HIV burden is greatest – from a number of different quantitative angles.   
 
This thesis contains five published works. The University of Sydney’s Academic 
Board approved submission of published work as a thesis on 14 August 2002.  The 
thesis adheres to the University of Sydney thesis by publication format.   
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Chapter One highlights the high rates of AIDS-related mortality among older adults in 
a rural community in high prevalence western Kenya.  This mortality underscores the 
need to better understand the issue of HIV among older adults in Africa. 
 
Chapter Two estimates the number of people aged 50 years and older living with HIV 
in sub-Saharan Africa using United Nations data.  Chapter Three examines HIV-
related awareness, knowledge and testing behaviour among those aged 50 years and 
older in nine rural sites in seven African countries. 
 
Chapter Four examines HIV infection and treatment outcomes among older adults in 
Zomba District in Malawi.  Chapter Five uses a large population-based survey among 
older adults in South Africa to develop a picture of HIV infection along with an 
examination of rates of diabetes, stroke, arthritis, depression and other conditions. 
 
Together, these papers and chapters explore the multi-faceted aspects of HIV among 
older adults in Africa.  Mortality, epidemiology, awareness, treatment outcomes and 
co-morbidities are all addressed to develop a fuller quantitatively-driven picture of the 
issues and challenges facing older adults and the responses needed for this important 
emerging trend. 
 
Ethical Clearance  
 
Malawi’s National Health Sciences Research Committee provided ethical approval 
for Chapter Four.  The research conducted for Chapters One and Three was approved 
by the ethical review committee at Columbia University, New York, USA, and by all 
governments of host countries – in the case of Chapter One specifically, the Kenya 
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Medical Research Institute ethics board.  Ethical review and clearance for Chapter 
Five was obtained through the World Health Organization and South Africa’s Human 
Sciences Research Council Research Ethics Committee.  Ethical approval was not 
required for Chapter Two.  Prior to receipt and analysis for this thesis, all data sets 
were anonymised. 
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Introduction 
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The Human Immunodeficiency Virus (HIV) is one of the greatest public health 
challenges facing the global community.  Since first being identified in 1981, HIV and 
the Acquired Immunodeficiency Syndrome (AIDS) that it causes have led to an 
estimated 30 million deaths worldwide [1].  As of 2008, AIDS caused 3.1% of total 
global mortality making it the sixth highest cause of death [2]. At the end of 2010, 
UNAIDS estimated that, worldwide, 34 million people [range of 31.6 million to 35.2 
million] were living with HIV [3].  This led Kofi Annan, then Secretary-General of 
the United Nations, to declare in 2006 that HIV and AIDS “has inflicted the single 
greatest reversal in the history of human development… it has become the greatest 
challenge of our generation”[4]. 
 
More than 92% of people living with HIV and AIDS (PLWHA) live in low- and 
middle-income countries (LMIC) with about 68% of the total living in sub-Saharan 
Africa [3].  It is in Africa that the HIV epidemic has had and continues to have its 
greatest impact with 70% of new HIV infections in 2010.  The countries with the 
highest prevalence of HIV among those aged 15-49 years are in the southern part of 
Africa.  Sub-Saharan Africa is also a region of the world beset by high rates of 
poverty with 51% of the population living on less than the United Nations and World 
Bank defined poverty line of $1.25 a day as of 2005 [5]. 
 
Over the past decade and especially over the past five years, there has been a robust 
response to the epidemic in LMICs.  While the total available funds for HIV-related 
activities in LMIC in 2001 was US$1.6 billion, according to UNAIDS, in 2009 
US$15.9 billion was available for HIV-related activities in LMIC from all sources [1].  
Of this, US$7.6 billion was from international donor funding disbursements [6].   
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The response – focusing on prevention, care and treatment – has predominantly 
focused on certain groups.  Much of the early emphasis of the HIV response was on 
children partly due to the view that they were innocent (while their parents suffered 
from the high levels of early stigma) and partly due to the fact that single-dose 
nevirapine was the first preventative treatment seen to be appropriate for use in 
developing countries based on feasibility and costs.  As a result, a great deal of 
attention went into prevention of mother-to-child transmission services and, in order 
to reach pregnant women, the delivery channel widely used was the pre-existing 
provision of ante-natal care services [7, 8].    
 
Additionally, following on from patterns seen in developed countries such as the 
United States and Australia, the early response to the epidemic focused on those 
deemed to be at high-risk of HIV infection such as men who have sex with men, sex 
workers and injecting drug users.  
 
One group that has not received much attention in the LMIC HIV response has been 
adults aged 50 years and older.  Those aged 50 years and older are not even counted 
in the common HIV prevalence reports.  Setel and colleagues assert the importance of 
“making everyone count by counting everyone,”[9] yet in the context of HIV, older 
adults are ignored.  UNAIDS and the World Health Organization (WHO) annual HIV 
epidemic updates report on prevalence for those aged 15-49 and for children aged 0-
14 and has done so for more than a decade [1].  The indicators used by the United 
Nations General Assembly Special Session on HIV/AIDS reporting cycle also focus 
on those aged 15-49 and those aged 15-24 for some indicators [10].  The Millennium 
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Development Goals HIV-related indicators require reporting on those aged 15-24 only 
[11].  Demographic and Health Surveys that serve as the basis for much health-related 
evidence in developing countries generally only interview women aged 15-49 and 
men up to ages 54 or 59 [12].  The lack of attention to those aged 50 years and older is 
not only in terms of statistics but also in terms of prevention messaging and targeted 
programming which predominantly targets youth, pregnant women and the afore-
mentioned high risk groups. 
 
In this thesis, the term “older adults” is used to describe those aged 50 years and 
older.  It is acknowledged that in many developed countries, people in this age group 
would not be considered old or elderly.  In Australia for example, most studies on the 
elderly focus on those aged 65 years and above or even 70 [13].  The reason the 50 
years cut off point is used in this thesis is because of the use mentioned in the 
previous paragraph of the 15-49 bracket for the majority of HIV surveillance over the 
first two decades of the HIV response.  Many individuals aged 50 and above are 
productive members of society and are community, business and political leaders.  
They do not necessarily exhibit characteristics that would generally be associated with 
the elderly.  Therefore, the relative term “older adult” is used to differentiate from the 
commonly used 15-49 category.  Where evidence relates to groups that are not aged 
50 years and older, the specific age bracket is provided. 
 
Some would assume that because HIV is a sexually-transmitted infection that older 
adults are not at risk or should not be considered in the HIV response.  The need to 
pay more attention to older adults and HIV is driven by two realities: a) that people 
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aged 50 years and older remain sexually active; and b) that the roll-out of treatment 
has led to PLWHA surviving longer and ageing with HIV.   
 
Despite ageist attitudes that older adults are not sexually active [14], there is 
substantial evidence that people remain sexually active past the age of 50 and well 
into their 70s.  Data from the United States (US) [15, 16],Europe [17, 18] and Asia 
[19, 20] all highlight that a considerable proportion of the elderly are sexually active – 
especially men.  In a Swiss study, the 46-65 age group showed the highest number of 
occasional sexual contacts per person compared to those aged 19-30 and 31-45 [17].  
At the same time, actions to actively prevent the transmission of sexually transmitted 
infections are less common among older adults than among younger adults [21].  
Rates of condom use in particular are less frequent among older adults in developed 
country settings [22].  
 
The expansion of treatment has also had a considerable impact on the ageing of the 
HIV epidemic.  In the face of the immense challenges posed by HIV and AIDS, the 
global community has, over the past eight years, made substantial progress in the 
provision of treatment.  At the end of 2010, UNAIDS estimated that at least 6.6 
million people in LMICs were receiving life-prolonging anti-retroviral treatment 
(ART) [3].  At the end of 2002, this figure was 300,000 demonstrating the 
considerable achievements made in a relatively short period of time in difficult 
circumstances.  In 2010 alone, 1.35 million people were put on treatment.  In total, as 
of the end of 2010, in low- and middle-income countries, 47% of the 14.2 million 
people eligible for treatment were on ART with some countries including Namibia, 
Rwanda and Zambia achieving coverage rates over 70% [3]. 
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As expected, widespread provision of ART to those living with HIV in developed and 
developing countries has been proven to significantly reduce mortality from AIDS 
with strong evidence from South Africa [23] and Ethiopia [24] among other countries.  
The widespread provision of ART has therefore reduced mortality from AIDS-related 
causes down from a peak of 2.2 million per year in the mid-2000s to 1.8 million in 
2010 [3]. 
 
One of the results of the roll-out of ART more widely in Africa and other parts of the 
world has been that PLWHA have been surviving longer.  HIV and AIDS is no longer 
a death sentence but has been transformed to a large degree into a chronic disease that 
can be managed.  With individuals now surviving for years on ART and with the 
upper limit of survival on ART unknown but certainly surpassing 15 years, those who 
were infected with HIV in their 30s and 40s are now surviving into their 50s and 
beyond.  This is leading to an ageing of the HIV cohort in LMIC. 
 
HIV among older adults in developed countries 
 
Despite being largely ignored in LMIC, the ageing of the epidemic has been widely 
documented in developed countries.  As far back as the early 1990s, clinicians in the 
US were commenting on HIV infection among older adults and lamenting the neglect 
by those providing medical services [25-27].  For example, el-Sadr and Gettler stated 
that healthcare providers were less likely to attribute HIV-related symptoms to the 
disease in older people [28] and another article outlined specific tips for how nurses 
could identify HIV among the aged [29].  At the same time, this led researchers to 
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examine HIV-related risk behaviour among older adults specifically with a view to 
better understanding possible preventative response models [30, 31]. 
 
Epidemiological data on the ageing of the HIV cohort in developed countries is 
abundant.  In the US, in 2005, 25% of those infected with HIV were older than 50 
years of age [32] and recent estimates have noted that around 50% of people living 
with HIV will be older than 50 by 2015 [33].  The number of adults aged 50 years and 
older living with HIV grew by 14% a year between 2004 and 2007 [34].  This is not 
only the results of longer survival due to treatment; older adults accounted for 15% of 
new cases of HIV in the US in 2005 [35].  Western European data reveals that 12.9% 
of newly reported cases of HIV infection in 2007 were among peopled aged 50 and 
older compared to 10.4% in 2003 [36].  The percentage of older adults among new 
infections in Eastern Europe has doubled over the same time frame [36].  In the Swiss 
HIV Cohort, 31% of individuals are aged 50 and older [37].  Articles have highlighted 
the HIV and ageing phenomenon in New York [38], London [39], Italy [40] and 
Australia [41]. 
 
The various developed country studies note that older people are less knowledgeable 
about HIV than younger people [42].  Older adults in the US have also been shown to 
perceive themselves to be at lower risk of HIV infection which has considerable 
implications on risk behaviour [42].  Evidence shows that older adults engage in risky 
sexual behaviour as much as younger adults [43]. One study revealed that among 
those who had more than one partner in the past five years, those aged over 50 were 
one-sixth as likely to use condoms as risk takers in their twenties [43].  Older women 
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in particular have difficulty negotiating safe sex [44].  This situation is driven by the 
lack of sexual health information specifically targeting older adults [45]. 
 
As in LMIC, in developed countries, the ageing of the epidemic has been driven by 
both individuals surviving longer on treatment and sexual transmission among over 
50s.  One UK study estimates that 48% of older adults diagnosed between 2000 and 
2007 acquired their infection at age 50 and over [46]. 
 
Over the past few years, evidence on how older adults respond to infection and 
treatment has been emerging [47-50].  Age, independent of HIV infection, is linked to 
a decline in the production of naïve T cells and diminished T cell functionality; these 
are exacerbated by HIV infection [51].  As a result, older adults have been shown to 
have steeper declines in CD4 count [52] and slower immune system reconstitution 
than younger adults following treatment [53].   
 
Hypotheses attribute some of the poorer outcomes to the low levels of knowledge of 
and services for older adults.  The result of this was that those aged 50 and older are 
more often late presenters with a UK study finding that the proportion of older adults 
who were diagnosed with a CD4 cell count less than 200 was higher than among 
younger individuals [46].  Older adults have been found to progress to an AIDS 
diagnosis faster than younger adults in the absence of treatment and to have higher 
rates of morality [54].  Post-ART studies have mixed outcomes but generally show 
little difference in mortality between older and younger adults [55, 56]. 
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Much of the recent evidence on HIV and ageing coming from developed country 
settings focuses on the issue of co-morbidities between HIV and various non-
communicable diseases.  Whereas the early emphasis was on AIDS-related conditions 
such as Kaposi’s sarcoma, pneumonia and tuberculosis, the majority of the clinical 
events occurring among those on ART in developed countries are classified as “non-
AIDS” events including many chronic non-communicable diseases [57].  Amy Justice 
has called this “the inevitable price of success” as individuals on treatment survive 
longer into older age [34]. 
 
As far back as 1991, a US study found that HIV-infected individuals 55 years old 
have nearly four times more chronic co-morbid conditions than do those 45 years old 
[58].  Since then, the focus on co-morbidities with HIV among older adults has 
intensified identifying high rates of conditions such as hypertension, diabetes, arthritis 
and depression among older adults living with HIV [59].  Older people with HIV 
infection are at an increased risk of asymptomatic ischaemic heart disease [60] and 
evidence has linked both HIV infection [61] and ART [62] to diabetes.  Studies have 
identified increased risk of certain cancers [63], intracranial hemorrhage [64] and 
osteoporosis [65].  
 
A study in Italy confirmed higher rates of liver and renal toxicities in older adults with 
HIV compared to younger controls aged 25-35 [66].  Over the course of the study, 
new cardiovascular, endocrine and neuralgic disorders were diagnosed in older 
individuals (24.5 per 100 person-years) than in the younger controls (3.4 per 100 
person-years).  Hasse and colleagues used data from the Swiss HIV Cohort Study to 
highlight elevated rates of multimorbidity among older adults living with HIV and on 
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ART in Switzerland controlling for factors other than age [37].  An increasing number 
of patients on ART aged 50 and older were taking four or more other medications.  
Additional evidence suggests that older adults living with HIV might be at greater risk 
of cognitive impairment [67] - which may have important implications for medication 
adherence [68]. 
 
Some of the elevated rate of co-morbidities is not due to HIV infection but due to 
ART itself.  One study noted a higher risk of hypertension after five or more years on 
treatment [69]. 
 
The full reasons for the elevated levels of chronic disease among PLWHA are not 
entirely clear.  Some attribute it to residual inflammation and from persistent viral 
replication [34].  Treatment itself might be a cause [70].  The high and early rates of 
chronic diseases among HIV-positive older adults in developed countries – what some 
have characterised as “premature ageing” – might be driven by some nucleoside 
analog anti-retroviral drugs which affect mitochondrial DNA mutations in a way that 
mirrors that of normal ageing [71]. 
 
The emphasis on co-morbidities heralds an important shift in developed countries of 
how HIV care is viewed moving from opportunistic infections and AIDS-defining 
malignancies to chronic co-morbidities.  The emerging evidence led one research 
team to state that: 
“Physiological changes observed with ageing, including increased risk of 
infection, reduced immunocompetence, the appearance of several comorbid 
conditions which can affect the disease process and complicate its management, 
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and interactions among antiretrovirals and drugs used for the treatment of 
other diseases, underline the need for age-related evaluations of treatment and 
management strategies.” [66] 
 
Beyond developed country studies, data from Brazil’s long-standing and well-
resourced HIV epidemic and response reveals that ageing is occurring there as well.  
According to Pardi and colleagues, the percentage of patients aged 50 years and older 
diagnosed with AIDS increased from 7% in 1996 to 13% in 2003 [72].  Further 
Brazilian data from Lacerda and Kitner revealed that older adults aged 60 and older 
had more AIDS-defining diseases at diagnosis and had a mortality rate four times 
higher than younger adults [73].  Once on ART however, mortality rates among the 
two groups were similar. 
 
This preponderance of evidence led Jules Levin, the founder and executive director of 
the New York–based National AIDS Treatment Advocacy Project, to state in 2009 
that “aging is the No. 1 problem in HIV today”[74]. 
 
Neglect of older adults by the international community 
 
Despite the clear trend evidence from developed countries, the main organisations 
involved in the global HIV response have made little or no mention of the ageing of 
the epidemic in their publications and proclamations.  An encouraging start was seen 
in 2006 with the UNAIDS report on the global AIDS epidemic that year stating that 
their new estimates of the number of adults living with HIV would now include all 
adults aged 15 years and older as opposed to just those aged between 15 and 49 [75].  
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They made this change because “it is now evident that a substantial proportion of 
people living with HIV are 50 years and older” and they estimated that there were 
around 2.8 million adults aged 50 years and older living with HIV as of 2005 [75]. 
 
Since then however, reading the HIV reports of UNAIDS and the World Health 
Organization among others reveals almost no mention of HIV among those aged 50 
years and older.  Searching for terms such as “ageing,” “aging,” “mature,” “elderly,” 
“older adult,” and “demographic trends/changes,” comes up with very few matches.  
In the 2011 UNAIDS World AIDS Day report [3], in the  364-page 2010 report on the 
global AIDS epidemic [76], and in the 2008 WHO towards universal coverage 
progress report [77], these terms do not appear once and there is no discussion of the 
future demographic trends that might impact the response. 
 
Both the 2009 epidemic update and the 2011 “AIDS at 30” report by UNAIDS 
acknowledge that while “older adults in heterosexual relationships account for a large 
share of new infections,” there are few programmes that address their specific needs 
[1, 78].  Despite this statement, no further information or data was provided to support 
a change in policy. 
 
Beyond the UN system documents, there have been other opportunities to highlight 
the emerging trend of the ageing of the HIV cohort and its potential impact on the 
HIV response.  In June 2011, the UN held a High Level Meeting on AIDS in New 
York ten years after the historic 2001 United Nations Special Session on HIV/AIDS.  
The purpose of the meeting was to “take stock of the progress and challenges of the 
last 30 years and shape the future AIDS response”[79].  Despite the explicit forward 
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looking goal of the meeting and the presence of many prominent practitioners and 
heads of state, in the meeting resolution document, there is no acknowledgement of 
the ageing of the epidemic and its implications and only one mention of non-
communicable diseases amidst a long list of conditions with programmatic overlaps 
with HIV [80]. 
 
Beyond the major institutions tasked with responding to the HIV epidemic, individual 
researchers and practitioners have also failed to directly address the ageing of the 
epidemic.  In order to chart the long-term actions needed to address the trajectory of 
the HIV epidemic, UNAIDS established a group called “aids2031” with the mandate 
to do so.  This group has emphasised the need for a shift in the response from “crisis 
management to sustained strategic response” [81].  Despite this, their recent 
publication makes no mention of ageing and no mention of the likely demographic 
trends [81]. 
 
These organisations and researchers that are meant to be charting the future course of 
the response to the epidemic have ignored one of the major trends – one that will have 
considerable impacts on prevention, care and treatment.  This led some WHO staff to 
title an article “the unexplored story of HIV and ageing”[82]. 
 
The need for more evidence 
 
It is clear that more evidence is needed regarding HIV among older adults outside of 
developed countries.  This thesis focuses on HIV among older adults in sub-Saharan 
Africa particularly and does not examine the issue in other parts of the developing 
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world such as Asia and Latin America.  I have chosen to focus on sub-Saharan Africa 
due to the high rates of HIV prevalence and number of people living with HIV and 
due to the neglect to date of older adults in Africa. 
 
Furthermore, the prevalence, transmission, treatment and care of HIV among older 
adults in sub-Saharan Africa will be different from that of developed countries and 
likely from that of other developing regions – and therefore warrants particular study 
– for a number of reasons.  Firstly, the continuing high rates of poverty among older 
adults, the higher likelihood of residence in rural areas, and higher rates of illiteracy 
make questions of access particularly important to older adults in Africa.  Secondly, 
high rates of infectious diseases such as tuberculosis [83], malaria [84] and neglected 
tropical diseases [85] that are known to interact with HIV make the possible disease 
burden and co-morbidity issues in Africa distinct from those other settings.  Thirdly, 
the health systems challenges that are pervasive across most African settings – 
including shortages of health workers, unsustainable health financing systems, poor 
health information systems and shortages of required medicines [86] – all limit the 
ability to develop an appropriate response to the challenge of HIV among older adults. 
 
Additionally, a pertinent area of sexual activity that specifically focuses on older 
adults is intergenerational relationships, which is one of the causes of the prevalence 
disparity seen between young women and men of the same age.  Most studies on 
intergenerational sex rightly emphasise the vulnerability of young women [87, 88], 
but fail to examine the age, characteristics, attitudes and behaviours of the older men 
– at least some of whom are likely to be older than 50 – who are exploiting the 
vulnerability.  This represents another example of how older adults have been 
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neglected from the HIV response even in situations where they are directly 
implicated. 
 
The larger contextual background to the lack of exploration of HIV among older 
adults in Africa is that the general situation of older people in Africa and their health 
has been neglected by the global policy and research community.  This despite the 
fact that there is a rapidly increasing number of people aged 50 and older in Africa.  
The United Nations has estimated that the percentage rise of the elderly population in 
Africa will be the greatest of any region in the world with the proportion aged 65 or 
over in Africa projected to rise from 3 per cent in 2009 to 7 per cent in 2050 [89].  
According to Smith and Mensah, in sub-Saharan Africa alone, the number of persons 
aged 65 years and older is expected to increase by 50% from 2000 to 2015, from 19.3 
million to 28.9 million [90].  They estimate that in the 30-year period from 2000 to 
2030, the population of elderly persons is projected to double in the Democratic 
Republic of Congo, Mozambique, Cameroon and Ghana.  
 
Despite this increase in absolute numbers and as a percentage of the population, the 
health of people aged 50 and older in Africa has not been a source of much policy or 
research focus compared to that of women and children.  The little work that has been 
done has highlighted the poor health of older adults.  Two reviews of the nutrition and 
health status of the elderly in sub-Saharan Africa found high rates of poverty and 
undernutrition among older adults [91, 92].  A Ugandan study found 68% of older 
women to be undernourished, 81% of older adults to be illiterate, and noted that 76% 
did not visit health facilities when unwell due to lack of funds and weakness [93].  
The reviews and other work have led the authors of one study to state that “very little 
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is known about the health and well-being of African elders”[94] and another to note 
that the “elderly are not a health policy priority for African countries”[92]. 
 
Most of the evidence on HIV and older adults in Africa to date focuses on caregiving 
by older adults through the lens of the orphanhood crisis.  One estimate stated that up 
to 323,000 older individuals in Africa could be the sole caregivers of young children 
due to high rates of AIDS-related mortality [95].  Various studies have examined 
grandparents providing care for AIDS orphans through the lenses of coping [96], 
carers’ physical health [97] and emotional well-being [98].  
 
With regard to HIV infection itself among older adults in sub-Saharan Africa, this is 
an emerging area on which little had been published prior to commencement of this 
PhD in early 2010.  In 2004, a review paper called “aging and infectious diseases in 
the developing world” contained very little evidence on HIV in Africa [99].  A few 
older studies from African settings examined HIV among older adults specifically in 
medical wards [100, 101]or small communities [102] and other research extracted 
small amounts of data on older adults from amongst larger HIV cohorts [103].  For 
example, an African study using 1990s data examined death rates among those with 
HIV and noted that death rates, in the absence of treatment, are higher among older 
adults than younger counterparts [104].  Other work that emerged prior to 
commencement of the PhD included a South African HIV survey that found high rates 
of HIV infection among older people leading to the inclusion of males older than 50 
in the national list of most-at-risk populations [105]. 
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More recently, since the start of this PhD, the evidence regarding HIV among older 
adults has slowly started to build and the published chapters of this PhD have 
contributed to this momentum.  Firstly, two short reports were published 
acknowledging the phenomenon of HIV and ageing in Africa, its importance and the 
need for more attention to it [106] - including one in the widely-read Lancet that 
refers directly to two of the chapters included in this thesis [107]. 
 
The wider range of research evidence on HIV and ageing in Africa published since 
2010 is outlined in the conclusion but two specific papers that emphatically highlight 
the importance of the topic to the future of the epidemic’s response are noted here.  
Using Ugandan data, Mills and colleagues estimated the life expectancy of patients 
once they initiate ART and found that those who start ART at age 20 are likely to live 
an additional 26.7 years; at age 35, life expectancy was an additional 27.9 years and at 
age 50, an additional 24.0 years [108].  This makes clear that as ART coverage 
expands and as individuals are put on treatment at higher baseline CD4 counts and 
with better regimens, life expectancy among PLWHA in Africa is likely to extend 
well past the age of 50.   
 
The evidence of the long-term success of ART has important implications for the 
demographics of those living with HIV well into the future.  Hontelez and colleagues 
modelled the future trend of HIV over the 30 years from 2010 to 2040 in South Africa 
[109].  They estimate that HIV prevalence in people aged 50 years and older will 
nearly double in that time period from 9% to 17% with the fraction of all HIV 
infected people who are aged 50 and older going up from 1 in 12 now to 1 in 4.  These 
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projections reinforce the importance of understanding HIV among older adults as it 
will be central to the response over the coming years. 
 
Additionally, the importance of this area of research and policy will increase with the 
greater attention given to NCDs by the global community over the last few years and 
in Africa specifically [110-112].  In September 2011, a High Level Meeting on NCDs 
was held at the United Nations to put the challenge onto the global agenda.  Though 
HIV barely warranted a mention at the NCD meetings, some commentators have 
drawn the obvious and explicit links noting that “the burden of chronic NCDs is also 
likely to increase as scaled-up programmes of antiretroviral treatment (ART) of HIV-
infected people lead to reduced mortality from HIV/AIDS and possible metabolic side 
effects resulting from life-long ART medications”[113]. 
 
Outline of the thesis 
 
This thesis aims to address the shortage of evidence in this emerging area by focusing 
on HIV infection among older adults in sub-Saharan Africa from a number of 
different angles.  Each of the chapters presents an analytic perspective on the issue 
using a variety of quantitative sources.  As per University of Sydney guidelines on 
theses by publication, each of the five main chapters – excluding the introduction and 
conclusion – are manuscripts that have been published in peer reviewed academic 
journals.  The chapters have been published in high ranking HIV and global health 
journals including AIDS, the Bulletin of the World Health Organization, JAIDS and 
AIDS and Behavior. 
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The first paper included in the thesis as Chapter One highlights the high rates of 
AIDS-related mortality among older adults in a rural community in high prevalence 
western Kenya.  By revealing that AIDS-related mortality persists at high levels 
among those aged 50 and older, it becomes clear that there are older adults who are 
infected with HIV.  The facts of mortality underscore the need to better understand the 
issue of HIV among older adults in Africa. 
 
The second paper and Chapter aims to fill the large epidemiologic evidence gap by 
estimating the number of people aged 50 years and older living with HIV in sub-
Saharan Africa.  Using UNAIDS data along with United Nations population data, the 
number of people living with HIV and the prevalence rates among those 50 and older 
are estimated.  This provides a critical baseline for future analysis and advocacy in 
line with Setel and colleagues call to make “everyone count by counting 
everyone”[9]. 
 
A critical component of HIV among older adults concerns awareness, knowledge and 
testing behaviour fundamentally asking: what do older adults know of HIV?  Most of 
the focus of the HIV response to date has been on younger adults and it was thus 
hypothesised that older adults would have lower rates of HIV-related knowledge than 
younger adults.  This is critical not only for their own prevention and access to 
treatment but also with regard to providing care to the next generation.  Using data 
from nine rural Millennium Village sites in seven African countries, this hypothesis is 
tested in the third paper (Chapter Three).  Questions around HIV knowledge, 
awareness, testing and treatment availability were all included and analysed 
comparing those aged 25-49 with those aged 50 and older. 
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After developing a better understanding of knowledge and prevention, the fourth 
paper (Chapter Four) examines infection and treatment.  Using ART data from Zomba 
District in Southern Malawi, the characteristics of older adults enrolled in treatment 
are analysed along with their treatment outcomes using survival analysis techniques.  
The central question of if older adults living with HIV are different from their 
younger counterparts and if they respond as well to treatment is critical to the 
development of age-appropriate responses to enrolment in treatment, prevention and 
care. 
 
As highlighted above, the question of co-morbidities has been a focus of the response 
to HIV among older adults in developed country settings.  But very little 
corresponding analysis has been conducted in Africa.  Using a large population based 
survey among older adults in South Africa, the multi-morbidity question is explored 
in the fifth paper (Chapter Five).  The data is nationally representative of South Africa 
so a clear picture of HIV infection among older adults in the country is available 
along with an examination of rates of diabetes, stroke, arthritis and depression among 
other conditions. 
 
Together, these papers and chapters explore the multi-faceted aspects of HIV among 
older adults in Africa.  Issues of mortality, epidemiology, awareness, treatment 
outcomes and co-morbidities are all addressed to develop a fuller quantitatively-
driven picture of the issues and challenges facing older adults and the responses 
needed for this important emerging trend. 
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The research for this thesis was conducted using a variety of quantitative methods 
including primary data collection in collaboration with the Millennium Villages 
Project [114] – a multi-sectoral health and development initiative launched in 2004 
that aims to demonstrate that achievement of Millennium Development Goals in rural 
Africa is possible through the coordinated delivery of science-based interventions at 
the community level [115]. Routinely collected programmatic data from Zomba 
District in Malawi was also used as well as analysis of available United Nations and 
World Health Organization datasets.  The methods range from national surveys to 
community health worker administered surveys in a rural Kenyan village.  The data 
presented here all have the advantage of including comparison groups of those 
younger than 50 years of age so that the older cohort data can be understood in 
relation to younger age brackets.   
 
Four additional manuscripts that I have led are included as appendices as they relate 
directly to the topic of this thesis.  The first uses data from three rural sites in sub-
Saharan Africa and examines risk factors for NCDs among older adults [116].  This 
appendix provides some of the first data on risk factors among rural older adults and 
also contributes to the thesis theme of HIV among older adults by examining rates of 
alcohol use – a known risk factor for HIV transmission [117].   
 
The second appendix is a systematic review of published evidence on HIV 
interventions specifically targeted to older adults.  This review was conducted 
globally and not specifically for sub-Saharan Africa so is therefore not included as a 
core chapter.  The findings from the review and their relevance to sub-Saharan Africa 
are, however, discussed in the thesis’s conclusion. 
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The third appendix is a Perspective piece published in the New England Journal of 
Medicine that I co-wrote and that provides an overview of the importance of the issue 
of HIV and ageing in developing countries [118].  The fourth is a letter published in 
the Lancet critiquing the continued neglect of HIV and ageing at the 2011 United 
Nations High Level Meeting on AIDS. 
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EPIDEMIOLOGY AND PREVENTION
High Rates of AIDS-Related Mortality Among
Older Adults in Rural Kenya
Joel Negin, MIA,*† James Wariero, BPharm,‡ Robert G. Cumming, MBBS, MPH, PhD,*
Patrick Mutuo, PhD,† and Paul M. Pronyk, PhD†
Background: Health challenges faced by older people in de-
veloping countries are often neglected amidst a wide range of
competing priorities. This is evident in the HIV ﬁeld where the upper
age limit for reporting HIV prevalence remains 49 years. However,
the long latency period for HIV infection, and the fact that older
people continue to be sexually active, suggests that HIVand AIDS are
likely to affect older people. To better understand this, we studied
mortality due to AIDS in people aged 50 and older in an area of rural
Kenya with high rates of HIV infection.
Methods: A community health worker–administered verbal autopsy
system was introduced in Nyanza Province, encompassing 63,500
people. Algorithms were used to determine cause of death.
Results: A total of 1228 deaths were recorded during the study
period; 368 deaths occurred in people aged 50 years and older. AIDS
was the single most common cause of death, causing 27% of all
deaths. AIDS continued to be the main cause of death up to age 70
years, causing 34% of deaths in people aged 50–59 years and 23% of
deaths in people aged 60–69 years.
Conclusions: AIDS remains the principle cause of death among
older people in Nyanza Province in western Kenya up until the age of
70 years. Greater efforts are needed to integrate older people into the
HIV response and to better understand the speciﬁc vulnerabilities and
challenges faced by this group.
Key Words: AIDS mortality, older adults, verbal autopsy
(J Acquir Immune Deﬁc Syndr 2010;55:239–244)
INTRODUCTION
Beyond the immediate and acute impacts of HIV
infection, it has been suggested that HIV represents a ‘‘long-
wave event’’ whose full effects emerge gradually over a period of
decades.1 As HIV survival in sub-Saharan Africa increases with
more individuals on antiretroviral therapy2,3 and as populations
age, the long-wave elements of the epidemic in Africa cannot be
ignored. Despite this, the global HIV community has largely
focused its attention on the 15–49 age bracket in surveillance
and in prevention and treatment programming.
To date, very few studies on HIV have focused on
people 50 and older, and these few studies have focused on
developed countries.4–10 With Joint United Nations Pro-
gramme on HIV/AIDS and other prominent HIV data focusing
on prevalence of those aged 15–49, the burden of disease
among those older than 50 is often ignored and represents
a signiﬁcant blind spot in the response to the epidemic.
One component of understanding disease impact is
through examining the patterns and determinants of mortality.
However, in many developing countries, where high numbers
of deaths take place outside of health facilities, vital events
often go unregistered and unreported,11 and the data that do
exist are often of poor quality or derived from uncertain
estimates.12 Monitoring adult deaths, particularly among those
older than 50 years, has received little attention despite the fact
that the proportion of older people in developing countries is
expected to rise dramatically over the coming decades.13
A number of sources including Demographic and Health
Surveys do not include mortality assessments among those
aged 50 years or older and do not interview women older than
49 years of age.14–16 Several other adult mortality studies also
stop recording at either 49 or 59 years old.17,18
To contribute to a better understanding of HIV among
older adults in Africa, this article examines patterns of mortality
among older adults in rural western Kenya. We employed data
from a novel real-time vital events and verbal autopsy (VA)
monitoring platform to track numbers of deaths and their causes,
with an emphasis on HIV and AIDS, and note the implications
for more effective prevention, care, and support services.
SETTINGS AND METHODS
The project was conducted in a cluster of villages in
rural Nyanza Province, Kenya—the site of a multisectoral
health and development initiative launched in 2004. The
Millennium Villages Project (MVP) aims to accelerate
progress toward the Millennium Development Goals in rural
Africa through the coordinated delivery of science-based
interventions at the village scale in agriculture, health,
education, and infrastructure.19–21 The project operates in 14
sites in 10 sub-Saharan African countries with project sites
drawn from a diversity of agro-ecological zones in ‘‘hunger
hot-spots,’’ where rates of child undernutrition exceed 20%.
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The villages in the Nyanza Province site encompass
63,500 people of whom 90% lived on less than $2 a day at project
commencement in 2004. A baseline survey in 2004 revealed
children younger than 5 mortality rate of 149 per 1000 live births
and infant mortality rate of 95 per 1000 live births.21 The area is
holoendemic for malaria, and 63% of children younger than 5
tested positive for malaria. The majority of residents are engaged
in subsistence agriculture and animal husbandry. Ethical approval
for the MVP was provided by both Columbia University and
Kenya Medical Research Institute ethics boards.
As of 2008, 12.1% of the study population were aged
50 years or older and 6.6% were 60 years or older.
In the MVP project site, mortality information was
routinely collected through a community health worker (CHW)–
administered vital events and VA system. VAs have evolved over
the past several decades as tools to supplement deﬁciencies in
vital information.22–24 Operating at the juncture of demography
and public health, VAs are structured interviews administered by
nonhealth workers to the care givers of the deceased. They pose
standardized questions about the main symptoms and signs
experienced by the deceased in the time leading up to death and
the circumstances preceding death. The information obtained
from these ﬁeld interviews are used to make a determination of
the probable cause of death.22 Numerous studies have
documented the reliability of the VA technique and its validity
(when compared with medical records), with reasonable
sensitivity and speciﬁcity for selected causes of death among
adults and children in Africa and Asia.25–31
The VA administered for this project included the
following components:
1. CHW administration: CHWs have been introduced to
maximize the delivery of health information and services to
households in the project site. There are currently 83 CHWs
in the project site—a ratio of 1 CHW to every 130–180
households, with household visits taking place every 1–2
months. Part of the portfolio of these CHWs is the tracking
of vital events.
2. Verbal autopsy specialist: The VA specialist is a community
health worker specially trained in the VA methodology.
When a death is recorded, a VA is triggered immediately. In
practice, VAs are conducted within 2–4 weeks after a death
has taken place.
3. VA tools: A standardized VA tool has been developed with
separate forms for adult/maternal deaths and for children. The
cause of death form has been derived from previously validated
VA tools that are tailored to assess signs and symptoms
experienced by the deceased in the time preceding death.
4. Algorithmic assessment of cause of death diagnosis: To
facilitate a rapid turn-around time for generating critical
information for targeting interventions, ‘‘expert algo-
rithms’’ have been employed. These are established valid
techniques for determining the probable cause of death,32–34
which have been expanded to facilitate an assessment of the
social circumstances leading up to death. This innovation
eliminates the need for standard dual physician-based
assessments, which can be both expensive and create
a long-time delay in generating ‘‘real-time’’ information for
program managers that can contribute to operational
adaptations to rapidly improve service delivery.
Mortality data were routinely collected as part of
programatic interventions for the period January 2008 through
May 2009 and were anonymized before analysis. Analysis was
conducted in SPSS (SPSS Inc, Chicago, IL.) and Excel
(Microsoft, Seattle, WA). The age and sex distribution of the
population in the survey area was estimated from detailed
population demographic information that was previously collected
through a household survey of a subsample of the population.
This methodology has been presented in detail elsewhere.21
Deaths were categorized according to Global Burden of Disease
designations with anemia and ‘‘old age’’ categories being added.35
RESULTS
Information on a total of 1228 deaths from January 2008
to May 2009 was collected. The annualized mortality rate was
13.65 per 1000. Males accounted for 56.2% of all deaths, with
mortality rates of 15.44 per 1000 per year for males and 11.87
per 1000 per year for females. Figure 1 shows number of
deaths and mortality rates per year by 5-year age band.
FIGURE 1. Number of deaths and
mortality rate per 1000 per year by
5-year age groups.
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Overall, communicable, maternal, perinatal, and nutri-
tional conditions plus anemia accounted for 71.9% of deaths,
with noncommunicable diseases accounting for 16.4% and
injuries 7.8%. The 5 leading causes of death—AIDS, malaria,
respiratory infections, diarrheal diseases, and cardiovascular
diseases—accounted for two-thirds of total deaths (Table 1).
For 1.7% of deaths, no speciﬁc cause of death could be
attributed, and these cases were classiﬁed as ‘‘other.’’ The
deaths attributed to old age were those for which no speciﬁc
underlying cause of death could reliably be assigned based on
the verbal autopsy tool. The average age of those whose death
was characterized as old age was 85.7 years.
AIDS accounted for 39.2% of deaths among men aged
15–49 and 50.0% of deaths among women in the same age
group. Together, intentional and unintentional injuries
accounted for 15.8% of deaths among men aged 15–49.
Among people aged 50 and older, there were 368 deaths.
AIDS was the most frequent cause of death, causing 18.3% of
male deaths and 15.8% of female deaths (Table 2). Other
communicable diseases such as respiratory infections and
malaria were also common causes of death, whereas non-
communicable disease mortality rates were, as expected, higher
than in those aged younger than 50. Analysis of mortality in
5-year age bands showed that AIDS remained the main cause of
death among those aged in their 50s and 60s, with non-
communicable diseases such as cardiovascular disease and
diabetes only overtaking AIDS as the major cause of death past
the age of 70 years (Fig. 2).
DISCUSSION
This study employed a vital events and verbal autopsy
system to examine patterns of mortality in rural western
Kenya, with a particular focus on older adults. Communicable
diseases were the most frequent cause of death with AIDS,
malaria, respiratory infections, and diarrheal diseases causing
the largest number of deaths. Among those aged 50 and older,
AIDS remained the most signiﬁcant cause of death up to the
age of 70. It was only among those aged older than 70 that
noncommunicable diseases surpassed AIDS as the most
common cause of death.
Total annual mortality rates in this study were slightly
lower than that seen across demographic surveillance systems
sites in Tanzania, Ethiopia, Ghana, Burkina Faso, and
Mozambique.36 In a study conducted in another area in
Western Kenya in 2003, rates of cardiovascular disease,
diarrheal disease, and respiratory infections rates were
relatively similar to the rates found in our study, but rates of
AIDS and tuberculosis mortality were higher and number of
deaths through injuries was lower.37 Other studies have
conﬁrmed high rates of malaria mortality among older adults
even in highly endemic areas where acquired immunity has
been assumed.38–40
The high level of mortality found in this study suggests
that AIDS is a very important cause of death among people
older than 50 in rural Kenya. The HIV epidemic in Kenya is
generalized and mature. Women are generally infected
younger than men41 perhaps contributing to the higher rates
of AIDS-related mortality among males older than 50 given
the median 10-year period between infection and death.42
Recent studies in Kenya have estimated that, nationally, 5% of
those infected with HIV are aged 50 years and older and that
HIV prevalence is 7.8% among 50-year to 54-year olds, 3.6%
among 55–59, and 2.7% among 60-year to 64-year olds.43 A
home-based voluntary counseling and testing program in the
project site revealed HIV prevalence of 6.8% among those
TABLE 1. Total Deaths and Percentage by Cause and by Sex
Cause of Death Male Deaths Female Deaths Total Deaths
HIV/AIDS 179 (25.9%) 154 (28.6%) 333 (27.1%)
Malaria 110 (15.9%) 67 (12.5%) 177 (14.4%)
Respiratory infections 67 (9.7%) 54 (10.0%) 121 (9.9%)
Diarrheal diseases 49 (7.1%) 39 (7.2%) 88 (7.2%)
Cardiovascular diseases 28 (4.1%) 24 (4.5%) 52 (4.2%)
Intentional injuries 40 (5.8%) 11 (2.0%) 51 (4.2%)
Malignant neoplasms 19 (2.8%) 28 (5.2%) 47 (3.8%)
Tuberculosis 30 (4.3%) 17 (3.2%) 47 (3.8%)
Unintentional injuries 28 (4.1%) 17 (3.2%) 45 (3.7%)
Perinatal conditions 14 (2.0%) 14 (2.6%) 28 (2.3%)
Diabetes mellitus 18 (2.6%) 9 (1.7%) 27 (2.2%)
Digestive diseases 17 (2.5%) 10 (1.9%) 27 (2.2%)
Old age 9 (1.3%) 17 (3.2%) 26 (2.1%)
Respiratory diseases 11 (1.6%) 13 (2.4%) 24 (2.0%)
Meningitis 15 (2.2%) 6 (1.1%) 21 (1.7%)
Other 10 (1.4%) 11 (2.0%) 21 (1.7%)
Infectious diseases other 8 (1.2%) 12 (2.2%) 20 (1.6%)
Anemia 10 (1.4%) 9 (1.7%) 19 (1.5%)
Genitourinary diseases 14 (2.0%) 3 (0.6%) 17 (1.4%)
Nutritional deﬁciencies 6 (0.9%) 7 (1.3%) 13 (1.1%)
Maternal conditions 0 (0.0%) 10 (1.9%) 10 (0.8%)
Childhood cluster diseases 2 (0.3%) 4 (0.7%) 6 (0.5%)
Neuropsychiatric conditions 5 (0.7%) 0 (0.0%) 5 (0.4%)
Congenital anomalies 1 (0.1%) 1 (0.2%) 2 (0.2%)
Endocrine disorders 0 (0.0%) 1 (0.2%) 1 (0.1%)
Total 690 538 1228
TABLE 2. Total Deaths and Percentage by Cause and by Sex
Among Those 50 and Older
Cause of Death Male Deaths Female Deaths Total Deaths
HIV/AIDS 36 (18.3%) 27 (15.8%) 63 (17.1%)
Respiratory infections 27 (13.7%) 17 (9.9%) 44 (12.0%)
Cardiovascular diseases 23 (11.7%) 20 (11.7%) 43 (11.7%)
Malignant neoplasms 12 (6.1%) 22 (12.9%) 34 (9.2%)
Malaria 19 (9.6%) 10 (5.8%) 29 (7.9%)
Old age 9 (4.6%) 17 (9.9%) 26 (7.1%)
Diabetes mellitus 16 (8.1%) 6 (3.5%) 22 (6.0%)
Diarrheal diseases 7 (3.6%) 14 (8.2%) 21 (5.7%)
Digestive diseases 5 (2.5%) 7 (4.1%) 12 (3.3%)
Genitourinary diseases 9 (4.6%) 2 (1.2%) 11 (3.0%)
Tuberculosis 7 (3.6%) 4 (2.3%) 11 (3.0%)
Unintentional injuries 6 (3.0%) 5 (2.9%) 11 (3.0%)
Infectious diseases other 6 (3.0%) 4 (2.3%) 10 (2.7%)
Intentional injuries 4 (2.0%) 4 (2.3%) 8 (2.2%)
Respiratory diseases 3 (1.5%) 5 (2.9%) 8 (2.2%)
Other 8 (4.1%) 7 (4.1%) 15 (4.1%)
Total 197 171 368
q 2010 Lippincott Williams & Wilkins www.jaids.com | 241
J Acquir Immune Deﬁc Syndr  Volume 55, Number 2, October 1, 2010 AIDS in Older Adults in Rural Kenya
41
aged 50 and older (8.5% in males, 5.8% in females).44
Prevalence among 50-year to 59-year olds was 10.0% (11.1%
in males, 9.5% in females) and for those 60 and older, it was
4.8% (7.2% in males, 3.1% in females).
In one of the few sub-Saharan African studies to look
carefully at causes of death in people 50 years and older,
Adjuik et al38 found that, in Southern Africa, the AIDS
mortality rate was higher in 45-year to 59-year olds than
among 15-year to 44-year olds. Zaba et al,45 using cohort study
data from 6 African sites, also show that mortality of HIV-
infected persons increases steadily with age though their data
stops at age 55 for some sites and 65 for others. This suggests
that the results of this study are generalizable to locations
beyond rural Kenya that share similar HIV prevalence rates.
Most studies on HIV and older adults in developing
countries focus on the impact of HIV on economic and social
roles—and in particular on the role of grandparents in caring
for HIVorphans—with little regard to the prevalence of HIV in
older people or the direct impact of HIV infection on their
health.9,46,47 Misconceptions remain common regarding older
people and HIV. The authors of a study in Nigeria assert that
‘‘older people are no longer sexually active, and it is believed
that HIV/AIDS is not a major problem in that segment of the
population.’’48 This low sense of risk can potentially lead to
older people not being tested as part of routine testing and low
uptake of HIV counseling, testing, and other services.
Kyobutungi et al10 lament the lack of HIV programs targeting
older people in sub-Saharan Africa.
Reasons have been posited for the high rates of AIDS
mortality among older people. The Collaborative Group on
AIDS Incubation and HIV Survival has noted that the older the
individual, the faster the progression from HIV infection to
AIDS with life expectancy of only 4 years for those infected at
age 65 or older.49 The high levels of HIV prevalence among
older people might be related to remarriage after widowhood
or divorce and the risk of forming HIV discordant partner-
ships.50 In general, however, the sexual activity of older
individuals in the developing world is barely researched.9
Older populations also experience high rates of
mortality due to noncommunicable diseases such as cardio-
vascular disease and diabetes. As has been reported elsewhere,
such diseases are common even in rural areas of developing
countries.51,52 However, the mortality rates from cardiovascu-
lar disease and diabetes in rural Kenya appear to be much
lower than in rural India.53
CHW-administered VAs could potentially overlook
a proportion of deaths, thus underrepresenting mortality. To
assess this systematically, a 3-month retrospective review of all
households was conducted. It revealed only one missing death
during the assessment period suggesting information on the
vast majority of deaths in the cluster are routinely captured
using the CHW-based approach.
Over the past several decades, VAs have been
increasingly accepted as a tool to assess mortality, and have
undergone substantial methodological reﬁnement. Although
VAs have been validated in numerous studies,25–31 limitations
include recall bias, alongside errors in classiﬁcation, and
veriﬁcation.54,55 Additionally, many deaths are multifactorial
with signiﬁcant overlap between causes of death such as AIDS
and tuberculosis. Multiple studies have, however, demon-
strated a high correlation between VA cause of death and HIV
status56,57 though the validity of VA in identifying child HIV
deaths58 and older adult HIV death59 has been questioned.
Another potential limitation is that, in rural populations in
resource-poor countries, age reporting may be inaccurate
especially among older age groups.18
IMPLICATIONS
With HIV and noncommunicable diseases together
contributing to more than half of the deaths among older
people in western Kenya, greater efforts are needed to address
premature deaths arising from these conditions. Although
responses have traditionally been implemented separately, there
is increasing realization that there are signiﬁcant synergies
available. In particular, the shared ‘‘chronicity’’ of therapies for
HIV, diabetes, and cardiovascular disease suggest that a uniﬁed
response might be appropriate.60 HIV, cardiovascular disease,
and diabetes are largely asymptomatic and require long-term
treatments to prolong life, and therefore require similar systems
of protocol-based decentralized delivery, with well-coordinated
care and support to optimize adherence. Furthermore, the
FIGURE 2. HIV/AIDS and major non-
communicable disease as percent-
age of total deaths by age.
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diseases themselves are biologically linked, as antiretroviral
therapy has been associated with increased risk of diabetes61,62
and heart disease.63,64
The HIV treatment systems that have been developed in
many African countries—adherence support, ongoing treat-
ment delivery mechanisms, drug procurement procedures—
could be leveraged to deliver noncommunicable disease
programs. Already systems that had been developed for other
diseases are shifting to respond to noncommunicable diseases;
in Cambodia, for example, those trained to provide leprosy
care are being retrained to support diabetes patients with foot
care (Sally Duke, MBBS, MIPH, personal communication,
August 2009).
The high rate of AIDS mortality among older adults
highlights the need for targeted prevention and treatment
efforts and research to develop a better understanding of the
speciﬁc vulnerabilities facing this age group. As more
individuals with HIV survive and as population aging
continues, the challenge of HIV and older adults will only
become more pressing.
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Chapter One  
Supplementary Information 
 
 
 
 
The community health worker administered verbal autopsy form used in 
Sauri, Kenya is provided as supplementary information.  The layout of the 
actual form used by the community health workers differs from the one 
presented here. 
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Ministry of Health/ Sauri Millennium Villages Project 
Record of Death 
- to be filled by trained community health worker at the earliest appropriate opportunity after a report of death, for 
persons resident within the cluster area for a period of at least 4 months before the death 
 
1. Identity of Deceased Person 
  
Name of Deceased Person  
Village, Sub-village  
Homestead Number  
Household Number  
Personal Identification Number  
  
 
2. Identity of Respondent 
-should be a close relative of the deceased e.g. parent, grown up child, spouse, etc.  
 
Name of Respondent  
Village, Sub-village  
Homestead Number  
Household Number  
Personal Identification Number  
Relation to the deceased  
 
3. Date of death:   …….(dd)/……….(mm)/…………..(yyyy) 
    Date of birth:    …….(dd)/……….(mm)/…………..(yyyy) 
     Age of Deceased: ………….(yy)……………..(mm) 
    Gender:  o  Male           o   Female 
 
4. Place of Death: (where did the deceased die?) 
 o At home             o  At Health Facility  (Name…………………………………………..) 
 o At traditional healer’s 
 o Outside home …………………………………………………………………………… 
 
5. Cause of death: (what caused the death of the deceased?) 
 o Illness     o Road accident   o Assault/murder       o  Suicide  o  Other accident/injury 
 o  Childbirth 
 
6. Details of Illness: 
(i) If the deceased died of illness in a hospital, what was the respondent told is the cause 
of death? 
o Malaria                         o HIV related complication (ayaki)             o Tuberculosis  
(TB/kahera)          o Other chest infection (Tuo kor)             o Asthma (athma, tuo mar 
thung’)                  o Diabetes (tuo mar sukari)                    o Epilepsy (hunwa/ndulume) o 
High blood pressure (remo maringo matek)         o Other Heart disease  (tuo adundo)         
o Cancer   o Diarrhoeal infection (tuo diep) o Other-specify-……………………………... 
46
 
(ii) If the patient died of illness at home, what does the respondent think was the cause of 
death? 
o Malaria                         o HIV related complication (ayaki)             o Tuberculosis  
(TB/kahera)          o Other chest infection (Tuo kor)             o Asthma (athma, tuo mar 
thung’)                  o Diabetes (tuo mar sukari)                    o Epilepsy (hunwa/ndulume) o 
High blood pressure (remo maringo matek)         o Other Heart disease  (tuo adundo)         
o Cancer   o Diarrhoeal infection (tuo diep) o Other-specify-……………………………... 
 
(iii) If the respondent does not know what the deceased died from but knows it was 
illness, ask about the symptoms the deceased had (Use this verbal autopsy format 
specifying symptom and duration- 
o Fever  o Diarrhea  
o Rash  o Vomiting  
o Bleeding  o Headache  
o Weight loss  o Fits/Convulsions  
o Jaundice  o Paralysis  
o Swelling  o Urine Output  
o Ulcers  o Recent Surgery  
o Cough  o Pregnancy  
o Chest pain   o Alcohol Use  
o Other pain  o Other (specify)  
 
Health Facilitator’s Final Conclusion on Most Probable Cause of Death: 
…………………………………………………………………………………………….. 
 
SUMMARY OF FINDINGS 
Age   
Gender   
Date of Death  
Place of Death  
Probable Cause of Death  
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Chapter Two  
 
Negin J, Cumming R. Quantifying HIV prevalence in older 
adults in sub-Saharan Africa: extrapolating from existing 
data. Bulletin of the World Health Organization 
2010;88:847-853. 
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Introduction
Despite the global attention being paid to the epidemic of 
infection with the human immunodeficiency virus (HIV), 
HIV infection rates among older adults in sub-Saharan Africa 
have been a neglected area of study. The Joint United Nations 
Programme on HIV/AIDS (UNAIDS) and other prominent 
sources of data report prevalence rates only for those aged 15–49 
years, and the indicators used by the United Nations General 
Assembly Special Session focus predominantly on the same 
age group. The burden of disease among those aged ≥ 50 years 
is almost always ignored and this represents a significant blind 
spot in the global response to the epidemic of HIV infection and 
acquired immunodeficiency syndrome (AIDS).
As a result of the situation described above, there is a paucity 
of data on HIV infection in people aged ≥ 50 years. In 2006, UN-
AIDS shifted to reporting the number of HIV-positive (HIV+) 
people aged ≥ 15 years, but it provides limited data specifically 
on those aged > 49. The 2006 report on the epidemic revealed 
some of the only existing data for this age group and stated that 
globally “around 2.8 million adults aged 50 years and older were 
living with HIV in 2005”.1 Other estimates have been based on 
limited data.2 While individuals > 49 years of age account for 
approximately 10% of the cumulative HIV infection case-load 
in the United States of America,3 the corresponding proportion 
for Africa is not known.
The few existing studies on HIV infection among older 
adults have focused mainly on developed countries.4–9 Studies 
in developing countries emphasize the social and economic im-
pact of HIV infection – mainly its effect on older grandparents 
in their role as caretakers of children orphaned as a result of 
parental HIV infection – and have ignored the prevalence of 
HIV infection in older people and its impact on their lives.10,11
As more people in sub-Saharan Africa have begun taking 
antiretroviral treatment, mortality rates have dropped12,13 and 
HIV+ individuals are surviving longer. At the same time, older 
people remain at risk for infection. In the light of the ageing of 
the general population, there is a need to better understand the 
prevalence and characteristics of HIV infection among older 
adults in sub-Saharan Africa. To begin to address this informa-
tion gap, we have used existing data and information to estimate 
the prevalence of HIV infection among people > 49 years of age 
in sub-Saharan Africa.
Methods
The data in this analysis came from a variety of sources. The 
main source was data on the prevalence of HIV infection re-
leased by UNAIDS in conjunction with its 2008 report on the 
global AIDS epidemic.14 The UNAIDS web site provides data, 
by country and by year, on the estimated number of people 
living with HIV as well as on the prevalence of HIV infection 
among adults aged 15–49 years.14 It does not, however, provide 
the number of HIV+ people aged ≥ 50 years or the prevalence 
of HIV infection in this age group. To derive those data, we 
needed to know the total population of each country in sub-
Saharan Africa and its age distribution. We obtained the total 
population of each country from the 2007 world population data 
sheet15 and extracted the percentage of the total population aged 
15–49 years and ≥ 50 years, by country, from World population 
prospects: the 2008 revision, using data from 2005, the most 
recent year for which data were available.16 Using population 
data from 2007 and the percentage of the total population aged 
15–49 years, we calculated the number of people aged 15–49 
years in each country. The use of UNAIDS data on the prevalence 
of HIV infection in this age group allowed us to calculate the 
Une traduction en français de ce résumé ﬁgure à la ﬁn de l’article. Al ﬁnal del artículo se facilita una traducción al español. .ﺔﻟﺎﻘﳌا ﻩﺬﻬﻟ ﻞﻣﺎﻜﻟا ﺺﻨﻟا ﺔﻳﺎﻬﻧ ﰲ ﺔﺻﻼﺨﻟا ﻩﺬﻬﻟ ﺔﻴﺑﺮﻌﻟا ﺔﻤﺟﱰﻟا
Objective To quantify the number of cases and prevalence of human immunodeﬁciency virus (HIV) infection among older adults in 
sub-Saharan Africa.
Methods We reviewed data from Demographic and Health Surveys (DHS). Although in these surveys all female respondents are < 50 
years of age, 18 of the surveys contained data on HIV infection among men aged ≥ 50 years. To estimate the percentage of older adults 
(i.e. people ≥ 50 years of age) who were positive for HIV (HIV+), we extrapolated from data from the Joint United Nations Programme 
on HIV/AIDS on the estimated number of people living with HIV and on HIV infection prevalence among adults aged 15–49 years.
Findings In 2007, approximately 3 million people aged ≥ 50 years were living with HIV in sub-Saharan Africa. The prevalence of HIV 
infection in this group was 4.0%, compared with 5.0% among those aged 15–49 years. Of the approximately 21 million people in 
sub-Saharan Africa aged ≥ 15 years that were HIV+, 14.3% were ≥ 50 years old.
Conclusion To better reﬂect the longer survival of people living with HIV and the ageing of the HIV+ population, indicators of the 
prevalence of HIV infection should be expanded to include people > 49 years of age. Little is known about comorbidity and sexual 
behaviour among HIV+ older adults or about the biological and cultural factors that increase the risk of transmission. HIV services need 
to be better targeted to respond to the growing needs of older adults living with HIV.
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number of people that had HIV infection. 
By subtracting this number from the total 
number of HIV+ people who were aged 
≥ 15 years, as calculated by UNAIDS, we 
estimated the number of HIV+ people 
aged ≥ 50 years. We then divided this 
number by the total number of people 
aged ≥ 50 in a country (as derived from 
World population prospects: the 2008 revi-
sion) to estimate the prevalence of HIV 
infection among people aged ≥ 50 years.
For this analysis we used sub-Saharan 
African countries as classified by UN-
AIDS. Data were not available for Cape 
Verde, the Comoros or Sao Tome and 
Principe. For the Democratic Republic 
of the Congo UNAIDS only provides 
high and low estimates of the number 
of people living with HIV. We used the 
midpoint between the two. UNAIDS 
data for Kenya for 2007 were awaiting 
finalization of the Kenya AIDS Indicator 
Survey, so we used those results, released 
in 2009, for analysis.17
Population-based surveys, predomi-
nantly the Demographic and Health 
Surveys (DHS) web site,18 were a second 
source of data for this study. We accessed 
the DHS reports and AIDS Indicator 
Survey reports on the site. To focus on the 
most recent data, we reviewed all surveys 
conducted after 2000 that contained 
information on HIV testing in countries 
in sub-Saharan Africa, and we extracted 
relevant data. Of the 43 DHS reports 
conducted after 2000 in countries in 
sub-Saharan Africa, 39 (91%) included 
interviewees aged ≥ 50, but only if they 
were men, and the upper age limit for 
these interviewees ranged from 54 to 
64 years. Because the surveys are designed 
primarily to collect data on maternal and 
child health, the age ceiling for women 
interviewees is 49 years.
Of the 39 reports that included 
interviewees aged ≥ 50, 18 provided data 
on the prevalence of HIV infection based 
on population-based HIV testing of inter-
viewees in this age group. The others con-
tained information only on HIV-related 
awareness and behaviour. Of the four 
AIDS Indicator Surveys for which data 
were available, only the Ugandan survey 
included interviewees aged > 49 years: in 
that country, both men and women aged 
< 60 years were interviewed.
In addition, we searched the Internet 
and the grey literature to identify other 
sources of data on population-based HIV 
testing in sub-Saharan Africa. South Af-
rican data sources and the Kenyan AIDS 
Indicator Survey were identified through 
this process.
Results
Based on the analysis of data obtained from 
UNAIDS and World population prospects: 
the 2008 revision, we estimated that in 
2007 approximately 3 million people aged 
≥ 50 years were living with HIV in sub-
Saharan Africa. This represents 14.3% of 
the approximately 21 million people aged 
≥ 15 years who are infected with HIV 
(Table 1). The five countries with the high-
est number of older adults living with HIV 
in sub-Saharan Africa were Mozambique, 
Nigeria, South Africa, Zambia and Zim-
babwe; together these countries accounted 
for 54% of the total number of older adults 
living with HIV. The estimated prevalence 
of HIV infection among the 74 million 
people aged ≥ 50 years in sub-Saharan 
Africa is 4.0%, compared with 5.0% among 
those aged 15–49 years.
Table 2 presents information on 
the prevalence of HIV infection among 
those aged ≥ 50 years in several countries 
in sub-Saharan Africa from DHS, AIDS 
Indicator Surveys and other population-
based surveys. The highest prevalence of 
HIV infection among those aged ≥ 50 
years was found in Zimbabwe during 
2005–2006: 20% of all men aged 50–54 
years were living with HIV.22
The 39 DHS reports that include 
male interviewees aged ≥ 50 also contain 
data on HIV-related awareness, behaviour 
and attitudes. The questions asked during 
the course of the decade included in our 
study differ and this makes direct com-
parisons difficult, but for each country the 
responses of those aged ≥ 50 years can be 
compared with those of people < 50. In 
general, older men are less aware of and 
knowledgeable about HIV-prevention 
measures than men aged 15–49. Inter-
viewees in eight countries (Benin, Cape 
Verde, Ghana, Lesotho, Mali, Nigeria, 
Uganda and Zambia) were asked the same 
question about whether using a condom 
and having only one sexual partner are 
effective prevention measures, and in 
seven of the countries (all but Ghana) 
men aged ≥ 50 years knew less than men 
< 50. For example, in Nigeria 68.6% 
(2612/3808) of men aged 15–49 knew 
that using condoms and having only one 
partner are effective prevention measures, 
as opposed to only 58.3% (978/1678) of 
men aged 50–59.23
In four of the seven countries where 
interviewees were asked about the num-
ber of sexual partners they had had dur-
ing the past 12 months, namely Benin, 
the Democratic Republic of the Congo, 
Ghana and Nigeria, men aged ≥ 50 years 
were more likely to have had two or more 
sexual partners than those aged 15–49. In 
each of these four countries, the percent-
age of men aged ≥ 50 years who had had 
two or more sexual partners during the 
previous 12 months and who had used 
condoms the last time they had engaged 
in sexual intercourse was much lower than 
among men aged 15–49. For example, in 
Ghana only 7.9% (5/64) of the men aged 
50–59 years who had engaged in sex with 
at least two partners over the previous 12 
months had used a condom during their 
last sexual intercourse, compared with 
26.2% (120/459) of men aged 15–49.
Discussion
An analysis of UNAIDS and World popu-
lation prospects data suggests that approxi-
mately 3 million adults aged ≥ 50 years are 
living with HIV in sub-Saharan Africa. 
People in this age group account for 14.3% 
of all HIV+ people ≥ 15 years of age. This 
study confirms that HIV infection does 
not affect younger people exclusively.
Comparisons between the two types 
of data sources used in this study reveal an 
occasional match between the prevalence 
of HIV infection estimated from UN-
AIDS data and the prevalence obtained 
from population-based HIV testing. For 
example, in Benin calculations made from 
UNAIDS data suggest that in 2007 the 
prevalence of HIV infection among those 
aged ≥ 50 years was 1.0%; similarly, DHS 
data for 2006 suggest a prevalence of 1.0% 
among men aged 50–64.24 However, 
in other countries there are significant 
discrepancies. For Lesotho, data derived 
from UNAIDS statistics suggest a preva-
lence of 27.8% in 2007 among those aged 
≥ 50 years, whereas according to data from 
the 2004 DHS, prevalence among men 
aged 50–59 is around 16%.25 These sur-
veys do not measure the same indicator: 
most DHS data cover men in a limited 
age range, as previously indicated, while 
UNAIDS data are for all adults aged 
≥ 50 years.
The main results presented in this 
paper depend on the quality of the data 
obtained from UNAIDS. These data are 
derived from mathematical and demo-
graphic projection models based primar-
ily on prevalence data from population-
based surveys, time–trend prevalence 
data from antenatal clinics, estimates of 
the need for antiretroviral treatment and 
its coverage, mortality rates and total 
population;26–28 they are not designed 
specifically to quantify the prevalence 
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of HIV infection among older adults. 
Consequently, prevalence and case-load 
calculations from UNAIDS reports 
represent the best available, but they do 
not allow derivation of exact population 
numbers. Population-based surveys of 
HIV infection prevalence among older 
adults would provide more reliable and 
robust data.
Table 1. Infection with the human immunodeﬁciency virus (HIV) among adults aged ≥ 50 years (older adults) and people aged 
15–49 years in sub-Saharan Africa, by country, 2007
Countrya Older adults who are 
HIV+
People aged 15–49 
who are HIV+
People aged ≥ 15 
who are HIV+
HIV+ older adults as a 
percentage of all HIV+ 
people aged ≥ 15No.b % No. % No.
Angola 24 600 1.8 155 400 2.1 180 000 13.7
Benin 8 900 1.0 50 100 1.2 59 000 15.1
Botswana 49 700 24.4 230 300 23.9 280 000 17.8
Burkina Faso 9 400 0.8 110 600 1.6 120 000 7.8
Burundi 6 500 0.8 83 500 2.0 90 000 7.2
Cameroon 59 900 3.1 440 100 5.1 500 000 12.0
Central African Republic 12 200 2.5 127 800 6.3 140 000 8.7
Chad 11 700 1.1 168 300 3.5 180 000 6.5
Congo 9 200 2.2 63 800 3.5 73 000 12.6
Côte d’Ivoire 48 500 2.1 371 500 3.9 420 000 11.6
Democratic Republic of the Congo 81 600 1.5 368 400 1.4 450 000 18.1
Djibouti 2 400 2.8 12 600 3.1 15 000 15.9
Equatorial Guinea 1 600 3.3 8 200 3.4 9 800 16.4
Eritrea 3 400 0.8 31 600 1.3 35 000 9.9
Ethiopia 157 700 2.1 732 300 2.1 890 000 17.7
Gabon 8 200 5.2 37 800 5.9 46 000 17.9
Gambia 1 200 0.8 6 300 0.9 7 500 16.2
Ghana 33 900 1.4 216 100 1.9 250 000 13.6
Guinea 6 300 0.6 74 700 1.6 81 000 7.8
Guinea-Bissau 1 100 0.5 13 900 1.8 15 000 7.1
Kenya 169 100 5.6 1 430 900 7.8 1 600 000 10.6
Lesotho 61 900 27.8 198 100 23.2 260 000 23.8
Liberia 1 700 0.5 30 300 1.7 32 000 5.4
Madagascar 4 500 0.3 8 500 0.1 13 000 34.9
Malawi 156 200 12.7 683 800 11.9 840 000 18.6
Mali 6 200 0.6 86 800 1.5 93 000 6.7
Mauritania 1 600 0.6 12 400 0.8 14 000 11.4
Mauritius 800 0.3 12 200 1.7 13 000 5.9
Mozambique 228 500 11.2 1 171 500 12.5 1 400 000 16.3
Namibia 18 100 8.1 161 900 15.3 180 000 10.0
Niger 7 200 0.6 48 800 0.1 56 000 12.9
Nigeria 300 300 2.1 2 099 700 3.1 2 400 000 12.5
Rwanda 1 500 0.2 128 500 2.8 130 000 1.2
Senegal 5 600 0.5 58 400 0.1 64 000 8.7
Sierra Leone 7 400 1.6 43 600 1.7 51 000 14.5
Somalia 3 100 0.4 20 900 0.5 24 000 12.8
South Africa 679 700 10.2 4 720 300 18.1 5 400 000 12.6
Swaziland 31 400 29.2 138 600 26.1 170 000 18.5
Togo 14 800 2.2 105 200 3.3 120 000 12.3
Uganda 150 100 6.8 659 900 5.4 810 000 18.5
United Republic of Tanzania 199 200 5.4 110 0 800 6.2 1 300 000 15.3
Zambia 200 000 18.6 780 000 15.2 980 000 20.4
Zimbabwe 206 600 15.2 993 400 15.3 1 200 000 17.2
Sub-Saharan Africa 2 993 500 4.0 17 997 800 5.0 20 991 300 14.3
HIV+, HIV-positive.
a This table reﬂects sub-Saharan African countries as classiﬁed by the Joint United Nations Programme on HIV/AIDS; the data do not include Cape Verde, Comoros 
and Sao Tome and Principe.
b Numbers have been rounded to the nearest hundred.
Sources: data derived from references 15 and 16.
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Table 2. Prevalence of infection with the human immunodeﬁciency virus (HIV) among older adults (i.e. people aged ≥ 50 years) in 
sub-Saharan Africa, by country, from population-based surveys conducted after 2000
Country Study
Year(s) Sex of respondents Age range 
(years)
Prevalence of HIV in-
fection (%)
Source
Benin 2006 Male 50–64 1.0 DHS18
Burkina Faso 2003 Male 50–54 2.8 DHS18
2003 Male 55–59 2.6 DHS18
Cameroon 2004 Male 50–54 2.5 DHS18
2004 Male 55–59 1.0 DHS18
Cape Verde 2005 Male 50–54 0.3 DHS18
2005 Male 55–59 0.0 DHS18
Democratic Republic of the Congo 2007 Male 50–59 0.6 DHS18
Ethiopia 2005 Male 50–54 0.9 DHS18
2005 Male 55–59 0.3 DHS18
Ghana 2003 Male 50–54 3.6 DHS18
2003 Male 55–59 2.8 DHS18
Guinea 2005 Male 50–54 1.6 DHS18
2005 Male 55–59 2.5 DHS18
Kenya 2003 Male 50–54 5.7 DHS18
2007 Male 50–54 8.3 KAIS17
2007 Male 55–59 2.3
2007 Male 60–64 3.4
2007 Female 50–54 7.5
2007 Female 55–59 4.7
2007 Female 60–64 1.7
Lesotho 2004 Male 50–54 16.2 DHS18
2004 Male 55–59 16.6 DHS18
Mali 2006 Male 50–59 1.7 DHS18
2001 Male 50–59 1.4 DHS18
Niger 2006 Male 50–54 0.1 DHS18
2006 Male 55–59 0.5 DHS18
Rwanda 2005 Male 50–54 1.7 DHS18
2005 Male 55–59 0.8 DHS18
Senegal 2005 Male 50–54 0.3 DHS18
2005 Male 55–59 0.3 DHS18
South Africa 2005 Male 50–54 14.2 NHPIBCS19
2005 Male 55–59 6.4 NHPIBCS19
2005 Female 50–54 7.5 NHPIBCS19
2005 Female 55–59 3.0 NHPIBCS19
2005 Male ≥ 60 4.0 NHPIBCS19
2005 Female ≥ 60 3.7 NHPIBCS19
2008 Male 50–54 10.4 NHPIBCS20
2008 Female 50–54 10.2 NHPIBCS20
2008 Male 55–59 6.2 NHPIBCS20
2008 Female 55–59 7.7 NHPIBCS20
2008 Male ≥ 60 3.5 NHPIBCS20
2008 Female ≥ 60 1.9 NHPIBCS20
Uganda 2004–2005 Male 50–54 6.9 UHSS21
2004–2005 Female 50–54 5.4
2004–2005 Male 55–59 5.8
2004–2005 Female 55–59 4.9
Zambia 2001–2002 Male 50–54 13.5 DHS18
2001–2002 Male 55–59 11.6 DHS18
Zimbabwe 2005–2006 Male 50–54 20.0 DHS18
DHS, Demographic and Health Survey; KAIS, Kenya AIDS Indicator Survey; NHPIBCS, South African National HIV Prevalence, Incidence, Behaviour and Communication 
Survey; UHSS, Uganda HIV/AIDS Sero-behavioural Survey 2004–2005.
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A few studies have documented HIV 
infection among older adults: a study in 
rural Cameroon showed a prevalence of 
2.6% among men and women aged 55–70 
years,29 and a study among people admit-
ted to hospital in Dar es Salaam, United 
Republic of Tanzania, reported a prevalence 
of 15% among those aged ≥ 55.30 A study in 
the Congo described 175 cases of HIV in-
fection among people aged ≥ 55 years from 
1990 to 1996.31 An 81-year-old male who 
was HIV+ was identified in an Ethiopian 
study.32 In general, however, data on HIV in-
fection in older adults in Africa are limited.
Two facets to the issue of HIV positiv-
ity among older adults generate particular 
challenges. One is the occurrence of new 
cases of HIV infection among older adults 
and the other is the ageing of the popula-
tion infected with HIV.33
Previous studies have shown that 
those who become infected with HIV later 
in life progress more rapidly towards AIDS 
and death than those who are infected at 
a younger age. Justice and Weissman have 
noted evidence that being older at the time 
of seroconversion is strongly associated 
with faster disease progression and shorter 
survival.34 A study in the United Kingdom 
of Great Britain and Northern Ireland 
revealed that those who became infected 
between the ages of 15 and 34 years had 
a 10-year survival rate of 72%, compared 
with 12% of those who seroconverted after 
the age of 55.35 In 2001, the Collaborative 
Group on AIDS Incubation and HIV 
Survival predicted a life expectancy of 
only four years for people who become 
infected at age ≥ 65 years.36 A 2001 study 
in the United States demonstrated that 
reconstitution of the immune system after 
initiating antiretroviral treatment was 
slower in older patients.37
As more people survive longer with 
HIV, the overall case-load will age and 
new challenges will arise in sub-Saharan 
Africa. Older adults have greater comor-
bidity, experience more side-effects from 
antiretroviral treatment and hence may 
be less likely to adhere to treatment.34 The 
toxicity of antiretroviral therapy, combined 
with decreased kidney and liver function 
in older individuals, may lead to treatment 
difficulties such as drug interactions.38 
Studies are needed to better understand 
the pharmacokinetics of antiretroviral 
agents in elderly people.39
Common misconceptions about 
sexual activity among older people re-
main. A study in Nigeria dismissed older 
people as no longer being sexually active,40 
confirming what Ory et al. called “ageist 
assumptions about sexual behaviour”.33 
These attitudes limit the development of 
appropriate responses tailored specifically 
to older adults.
Several factors put older people at 
a higher risk of becoming infected with 
HIV. The thinning of the vaginal wall 
after menopause increases the risk of HIV 
transmission during sex.41 Practices such 
as wife inheritance and ritual cleansing, in 
which a widow is expected to either marry 
or have sex with relatives of the deceased 
husband, can increase older women’s ex-
posure to the virus.42 Additionally, many 
older people are poor and may not be able 
to afford health services.
Older adults’ access to HIV-related 
services and information is limited: the 
UNAIDS update for 2009 stated that 
“even though the largest share of new 
infections in many African countries oc-
curs among older heterosexual couples, 
relatively few prevention programmes 
have specifically focused on older adults”.43 
DHS data suggest that levels of condom 
use and knowledge about condoms are low 
among older adults. In the United States, 
Ory and Mack noted that people aged ≥ 50 
years who had known risk factors for HIV 
infection were one-sixth as likely to report 
using condoms as people in their twenties 
with comparable risk factors.3 The lack of 
targeted prevention services becomes even 
more important considering that many 
older people care for younger ones, since 
a lack of knowledge may prevent older 
people from effectively teaching the next 
generation about HIV.
The delivery of services to older 
adults with HIV infection needs to be im-
proved. In the United States, el-Sadr and 
Gettler have indicated that health-care 
providers are less likely to attribute signs 
and symptoms of disease in older people 
to HIV infection.44 Data from Brazil sug-
gest that older people are diagnosed later 
in the course of HIV infection, with more 
AIDS-defining diseases present at diagno-
sis.45 This may be true for Africa as well.
South Africa has added men aged 
≥ 50 years to its list of populations con-
sidered to be at greatest risk for HIV 
infection, according to a 2008 survey.20 
The 6.0% prevalence among these men, 
together with the limited reach of nation-
al communication programmes, low levels 
of knowledge and poor adoption of pre-
ventive behaviours, has highlighted the 
need to focus prevention on this group.
The need to better understand the 
various HIV-related challenges faced by 
older adults will increase as the HIV+ 
population ages. Research should be 
aimed at understanding the specific vul-
nerabilities and challenges faced by this 
group. It should focus on understanding 
the impact of highly active antiretroviral 
therapy on older people in Africa and on 
understanding the sexual behaviour and 
practices of older people.
Barnett views HIV infection and 
AIDS as posing a new type of challenge for 
the global community: a “long-wave event” 
whose “troubling and large-scale effects 
emerge gradually over decades”.46 For the 
past few decades, the global HIV community 
has focused on people aged 15–49 years, 
often ignoring the long-wave elements of 
the epidemic. A significant percentage of 
the population – those aged ≥ 50 years – has 
been largely excluded from HIV prevention 
and testing services. The high prevalence of 
HIV infection and the high rates of death 
from AIDS-related causes among older 
people in developing countries call for greater 
efforts to integrate the needs of older people 
into responses to the HIV epidemic and to 
strengthen targeted prevention, care and 
support programmes. ■
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ﺺﺨﻠﳌا
ﺔﻴﻟﺎﺤﻟا تﺎﻴﻄﻌﳌا ﻦﻣ ﻰﻘﺘﺴﳌا رﺎﺸﺘﻧﻻا ءاﺮﻘﺘﺳا :ﺎﻴﻘﻳﺮﻓﺄﺑ ىﱪﻜﻟا ءاﺮﺤﺼﻟا بﻮﻨﺟ ﰲ ينﻨﺴﳌا ﰲ زﺪﻳﻷا سويرﻔﺑ ىوﺪﻌﻟا
 ﺎﻫرﺎﺸﺘﻧا ىﺪﻣو زﺪﻳﻷا سويرﻔﺑ ﺔﺑﺎﺻﻹا تﻻﺎﺣ داﺪﻋﻷ ﻲﻤﻜﻟا ﺪﻳﺪﺤﺘﻟا فﺪﻬﻟا
ﺎﻴﻘﻳﺮﻓﺄﺑ ىﱪﻜﻟا ءاﺮﺤﺼﻟا بﻮﻨﺟ ﰲ ينﻨﺴﳌا ينﺑ
 ﺔﻴﻓاﺮﻏﻮيمﺪﻟا  تﺎﺣﻮﺴﳌا  ﻦﻣ  تﺎﻴﻄﻌﻣ  ضاﺮﻌﺘﺳﺎﺑ  نﻮﺜﺣﺎﺒﻟا  مﺎﻗ  ﺔﻘﻳﺮﻄﻟا
 هﺬﻫ  ﻦﻬﻴﻠﻋ  ﺖﻠﻤﺘﺷا  ئيﻼﻟا  تﺎﺒﻴﺠﺘﺴُﳌا  نأ  ﻦﻣ  ﻢﻏﺮﻟا  ﲆﻋو  .ﺔﻴﺤﺼﻟاو
 18 ﰲ لﺎﺟﺮﻟا  نﺈﻓ ،ًﺎﻣﺎﻋ 50 ﺮﻤﻋ نود ﺔﻳﺮﻤﻌﻟا  تﺎﺌﻔﻟا  ﻦﻣ ﻦﻛ تﺎﺣﻮﺴﳌا
 سويرﻓ  ىوﺪﻌﺑ  ﺔﺻﺎﺧ  تﺎﻴﻄﻌﻣ  ﲆﻋ  ﺖﻠﻤﺘﺷا  ﻲﺘﻟا  تﺎﺣﻮﺴﳌا  هﺬﻫ  ﻦﻣ
 ﺔﻳﻮﺌﳌا ﺔﺒﺴﻨﻟا ﺮﻳﺪﻘﺘﻟو .ًﺎﻣﺎﻋ 50 يوﺎﺴﻳ وأ ﻦﻣ ﱪﻛأ ﺮﻤﻋ ﰲ اﻮﻧﺎﻛ ،زﺪﻳﻷا
 ينﻴﺑﺎﺠﻳﻹاو  (ًﺎﻣﺎﻋ  50  يوﺎﺴﻳ  وأ  ﻦﻣ  ﱪﻛأ  ﺮﻤﻋ  ﰲ  ﻢﻫ  ﻦﻤﻣ)  ينﻨﺴﻤﻠﻟ
 ﺞﻣﺎﻧﺮﺑ  ﻦﻣ  تﺎﻴﻄﻌﳌا  ءاﺮﻘﺘﺳﺎﺑ  نﻮﺜﺣﺎﺒﻟا  مﺎﻗ  ﺪﻘﻓ  ،زﺪـﻳﻷا  سويرﻔﻟ
 يﺮﻳﺪﻘﺘﻟا  دﺪﻌﻟا  لﻮﺣ  ،ﻪﺳويرﻓو  زﺪﻳﻷا  ﺔﺤﻓﺎﻜﳌ  كﱰﺸﳌا  ةﺪﺤﺘﳌا  ﻢﻣﻷا
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Resumé
Infection à VIH chez les adultes âgés en Afrique subsaharienne: extrapolation de la prévalence à partir de 
données existantes
Objectif Quantiﬁer le nombre de cas et la prévalence de l’infection par 
le virus de l’immunodéﬁcience humaine (VIH) chez les adultes âgés en 
Afrique subsaharienne.
Méthodes Nous avons étudié les données des enquêtes démographiques 
et sanitaires. Même si, dans ces enquêtes, toutes les femmes interrogées 
sont âgées de moins de 50 ans, 18 des enquêtes contenaient des données 
sur l’infection à VIH chez les hommes âgés de 50 ans et plus. Pour évaluer 
le pourcentage d’adultes âgés (c.-à-d. de personnes âgées de 50 ans et 
plus) qui étaient séropositives (VIH+), nous avons extrapolé à partir des 
données du Programme commun des Nations Unies sur le VIH et le Sida 
(ONUSIDA) sur le nombre estimé de personnes vivant avec le VIH et sur 
la prévalence de l’infection à VIH chez les adultes âgés de 15 à 49 ans.
Résultats En 2007, approximativement 3 millions de personnes âgées 
de 50 ans et plus vivaient avec le VIH en Afrique subsaharienne. La 
prévalence de l’infection par le VIH dans ce groupe était de 4%. Elle était 
en comparaison de 5% chez les 15–49 ans. Sur les quelques 21 millions 
d’habitants de l’Afrique subsaharienne âgés de 15 ans et plus qui étaient 
porteurs du virus HIV, 14,3% d’entre eux étaient âgés de 50 ans et plus.
Conclusion Pour mieux reﬂéter la survie plus longue des personnes 
vivant avec le VIH et le vieillissement de la population séropositive, les 
indicateurs de prévalence de l’infection à VIH doivent être étendus aﬁn 
d’inclure les personnes âgées de plus de 49 ans. On sait peu de choses 
sur la comorbidité et le comportement sexuel des adultes âgés séropositifs 
ou sur les facteurs biologiques et culturels qui augmentent le risque de 
transmission. Les services relatifs au VIH doivent être mieux ciblés pour 
répondre aux besoins croissants des adultes âgés qui vivent avec le virus.
Resumen
Infección por el VIH entre los adultos de mayor edad en el África subsahariana: extrapolación de la 
prevalencia a partir de los datos existentes
Objetivo Cuantiﬁcar el número de casos y la prevalencia de la infección 
por el virus de la inmunodeﬁciencia humana (VIH) entre los adultos de 
mayor edad en el África subsahariana.
Métodos Se han analizado los datos procedentes de las Encuestas 
demográﬁcas y de salud (EDS). Aunque en estos estudios todas las 
mujeres entrevistadas son menores de 50 años, 18 de estas encuestas 
contenían datos sobre la infección por VIH en hombres con una edad igual 
o superior a los 50 años. Para calcular el porcentaje de adultos de mayor 
edad (es decir, personas de 50 o más años de edad) con positividad al 
VIH (VIH+), se extrapolaron los datos procedentes del Programa Conjunto 
de las Naciones Unidas sobre el VIH/SIDA sobre la cantidad estimada de 
personas con el VIH y sobre la prevalencia de la infección por este virus 
entre los adultos con edades comprendidas entre 15 y 49 años.
Resultados En 2007, en el África subsahariana había unos 3 millones de 
personas de 50 años o mayores con el VIH. La prevalencia de la infección 
por el VIH en este grupo fue del 4,0%, en comparación con el 5,0% 
correspondiente al grupo con edades comprendidas entre 15 y 49 años. 
De la cantidad aproximada de 21 millones de personas ≥ 15 años con 
VIH en el África subsahariana, el 14,3% tenía 50 años de edad o más.
Conclusión Para poder reﬂejar mejor la mayor supervivencia de las 
personas con VIH y el envejecimiento de la población VIH+, se deben 
ampliar los indicadores de la prevalencia de la infección por el VIH, de 
manera que incluyan a las personas mayores de 49 años. Se sabe poco 
sobre la morbilidad asociada y el comportamiento sexual de los adultos 
VIH+ de mayor edad o acerca de los factores biológicos y culturales que 
aumentan el riesgo de transmisión. Los servicios relacionados con el VIH 
deben orientarse mejor para responder a las necesidades crecientes de los 
adultos de edad más avanzada que se ven afectados por esta enfermedad.
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.ًﺎﻣﺎﻋ 49 و 15 ينﺑ ﺎﻣ ﺔﻳﺮﻤﻌﻟا
 ﱪﻛأ ﺮﻤﻋ ﰲ ﺺﺨﺷ ينﻳﻼﻣ ﺔﺛﻼﺛ ﱄاﻮﺣ كﺎﻨﻫ نﺎﻛ ،2007 مﺎﻋ ﰲ تادﻮﺟﻮﳌا
 ﰲ ىﱪﻜﻟا ءاﺮﺤﺼﻟا بﻮﻨﺟ ﰲ زﺪﻳﻷا سويرﻔﺑ ينﺑﺎﺼﻣ ًﺎﻣﺎﻋ 50 يوﺎﺴﻳ وأ ﻦﻣ
 ،4.0% ﺔﻋﻮﻤﺠﳌا  هﺬﻫ  ﰲ  سويرﻔﻟﺎﺑ  ىوﺪﻌﻟا  رﺎﺸﺘﻧا  ﺔﺒﺴﻧ  ﺖﻐﻠﺑو  .ﺎﻴﻘﻳﺮﻓأ
 49 و 15 ينﺑ ﺖﺣواﺮﺗ ﻲﺘﻟا ﺔﻳﺮﻤﻌﻟا ﺔﻋﻮﻤﺠﳌا ينﺑ 5.0% ﺖﻐﻠﺑ ﺔﺒﺴﻨﺑ ﺔﻧرﺎﻘﻣ
 يوﺎﺴﻳ وأ ﻦﻣ ﱪﻛأ ﺮﻤﻋ ﰲ نﺎﻜﺴﻟا ﻦﻣ ﺔﻤﺴﻧ نﻮﻴﻠﻣ 21 ﱄاﻮﺣ ينﺑ ﻦﻣو .ًﺎﻣﺎﻋ
 14.3% نﺎﻛ ،سويرﻔﻠﻟ ينﻴﺑﺎﺠﻳﻹا ىﱪﻜﻟا ءاﺮﺤﺼﻟا بﻮﻨﺟ نﺎﻜﺳ ﻦﻣ ﺎﻣﺎﻋ 15
.ًﺎﻣﺎﻋ 50 يوﺎﺴﻳ وأ ﻦﻣ ﱪﻛأ ﺮﻤﻋ ﰲ
 سويرﻔﻟ  ينﺸﻳﺎﻌﳌا  ﺎﻴﻘﺑ  لﻮﺣ ﻞﻀﻓأ  ةرﻮﺼﺑ ءﻮﻀﻟا  ءﺎﻘﻟإ  ﻞﺟأ  ﻦﻣ جﺎﺘﻨﺘﺳﻻا
 ﺐﺠﻳ ،ﺔﺧﻮﺨﻴﺸﻟا  ﺔﻠﺣﺮﻣ سويرﻔﻠﻟ  ينﻴﺑﺎﺠﻳﻹا  غﻮﻠﺑو ةﺎﻴﺤﻟا  ﺪﻴﻗ ﲆﻋ زﺪﻳﻷا
 ﺮﻤﻋ ﻦﻣ ﱪﻛأ ﻢﻫ ﻦﻣ ﻞﻤﺸﺘﻟ سويرﻔﻟﺎﺑ ىوﺪﻌﻟا رﺎﺸﺘﻧا تاﴍﺆﻣ قﺎﻄﻧ ﻊﻴﺳﻮﺗ
 ﺔﻴﺴﻨﺠﻟا تﺎﻴﻛﻮﻠﺴﻟاو كﱰﺸﳌا لﻼﺘﻋﻻا لﻮﺣ ًﺎﻀﻣﺎﻏ لاﺰﻳ ﻻ يرﺜﻜﻟﺎﻓ .ًﺎﻣﺎﻋ 49
 و  ﺔﻴﺟﻮﻟﻮﻴﺒﻟا  ﻞﻣاﻮﻌﻟا  لﻮﺣ  وأ  ينﻨﺴﳌا  ﻦﻣ  زﺪﻳﻷا  سويرﻔﻟ  ينﻴﺑﺎﺠﻳﻹا  ينﺑ
 تﺎﻣﺪﺨﻟا فﺪﻬﺘﺴﺗ نأ ﻲﻐﺒﻨﻳو .سويرﻔﻟا لﺎﻘﺘﻧا ﺮﻄﺧ ﻦﻣ ﺪﻳﺰﺗ ﻲﺘﻟا ﺔﻴﻓﺎﻘﺜﻟا
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Abstract In Africa, older adults aged 50 and older are
still sexually active and play a critical role as caregivers,
yet little is known about their attitudes towards HIV and
awareness of services. In this study, surveys were con-
ducted in nine African sites. A multilevel model was ﬁtted
to evaluate the relationship between age and outcome
variables. The study reveals that people aged 50 years and
older have lower levels of HIV-related knowledge and
awareness than those aged 25–49. Older adults were less
likely to have been tested for HIV and women aged 50 and
older showed particularly low levels of awareness.
Keywords HIV testing  HIV awareness  Older adults 
Africa
Introduction
In sub-Saharan Africa (SSA), HIV among older adults has
largely been ignored, though there has been some emerging
interest in this topic [1]. A recent study estimated that there
are three million HIV positive people in SSA aged 50 and
older representing more than 14% of those over the age of
15 infected [2]—suggesting that increased attention is
warranted for older age groups.
Despite this, most HIV prevention efforts largely target
younger people and little is known about the attitudes
towards HIV and awareness of prevention, testing and
treatment among older adults. Examining HIV-related
knowledge and attitudes among people over 50 in SSA is
important for a number of reasons. Older adults remain
sexually active and therefore remain at risk of HIV infec-
tion. As anti-retroviral therapy (ART) is rolled out, more
HIV positive individuals are living longer thus furthering
the ageing of the epidemic. Older adults in SSA also play a
critical role as educators and caregivers and older people
remain inﬂuential community members and leaders. Many
older people are involved in taking care of young adults
and children and act as gatekeepers of information, playing
a major role in reinforcing attitudes and normative
behaviour. Recent work has noted that caregivers perceive
a lack of skills to provide information to and care for
dependents [3].
Very little research has been done on HIV-related
knowledge and attitudes among older adults in SSA. A
recent study on ART knowledge in Africa found only one
relevant study on this topic [4]. Some research has been
conducted in other parts of the world—particularly in
developed countries. A review of HIV attitudes among
older adults in the US showed that inadequate HIV trans-
mission education and poor awareness contributed to
increased HIV risk [5]. A study from Thailand directly
compared HIV knowledge and attitudinal data for Thais
50 years of age and older against that of young adults
(20–39) revealed lower levels of correct knowledge among
those aged 50 and older as well as lower levels of HIV
testing and less awareness of treatment availability [6].
In Africa, most work on HIV attitudes and stigma has
ignored older adults and has also provided less focus on
rural areas speciﬁcally. Demographic and Health Surveys
(DHS) include questions on HIV awareness and attitudes
but question female interviewees only up to the age of 49
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and only up to 54 or 59 for men [7]. In order to address
these gaps, we examined HIV awareness, attitudes,
behaviour and testing among older adults across a number
of rural sites in Africa.
Setting and Methods
The study was conducted in nine clusters of villages across
eight countries in sub-Saharan Africa as part of the Mil-
lennium Villages Project (MVP). The MVP is a multi-
sectoral health and development initiative launched in 2004
that aims to demonstrate that achievement of Millennium
Development Goals in rural Africa is possible through the
coordinated delivery of science-based interventions at the
community level in agriculture, health, education and
infrastructure [8]. The project sites are all rural and are
drawn from a diversity of agro-ecological zones in ‘hunger
hot-spots,’ where rates of child under-nutrition exceeded
20% at baseline and where the majority of residents were
engaged in subsistence agriculture and animal husbandry.
The sites extend across a broad geographic range
including West Africa, East Africa and Southern Africa
locations that had different levels of HIV prevalence at the
time of the study surveys from 2005 to 2007. District-level
prevalence among those aged 15–49 where project sites are
located ranged from 0.5% in Louga district in Senegal to
17.8% in Zomba district in Malawi. Prevalence data for
those aged 50 and older is not available as older adults are
not included in UNAIDS data and most DHS studies [2].
Before project commencement, baseline surveys were
conducted. Within each MVP community, a detailed
household mapping was conducted including a population
census and a household wealth score. Proportional sam-
pling was carried out to randomly select 300 households
stratiﬁed by geographic area, gender of household head,
and wealth. Consenting households were then included in
baseline data collection. Within each participating house-
hold, individuals were recruited for study inclusion based
on eligible age range.
The information in this paper comes from the HIV and
sexually transmitted infection baseline survey which was
developed based on validated DHS tools [7]. Questions
focus on HIV-related knowledge, attitudes, and behaviour;
however, seroprevalence was not determined during base-
line survey activities. The same questionnaire was utilised
across all sites. Sites were excluded from analysis if the
sample size of the 50 years and older age group was below
30.
Respondents who had not heard of HIV or AIDS were
not asked subsequent questions but have been included in
the denominator for relevant questions based on the
assumption that they would not have correct knowledge or
have awareness of other elements of HIV and AIDS. This
adheres to DHS guidelines [9].
A multilevel model was ﬁtted to evaluate the relation-
ship between age group (25–49 years versus 50 ? years)
and the respective outcome variables. The research evalu-
ated multiple outcome variables related to HIV knowledge,
stigma, and behaviour. Six knowledge questions [continu-
ous variable, range 0–6] and two stigma-related questions
[binary variable: 1 = at least one stigmatic response] were
used (Table 2). Multilevel models were ﬁtted considering
the hierarchical structure of data where MVP site locations
is the Level 2 (higher level) classiﬁcation unit. This was
done to account for sources of variation between sites.
Independent covariates, such as gender, that were statisti-
cally signiﬁcantly associated with HIV-related outcomes in
unadjusted models (using P\ 0.1 as the cut-off) were
included in further multivariable modelling. Additionally,
multiplicative interaction terms were tested between age
group and gender.
To examine the scope for multilevel modeling, the
magnitude of between site variation in HIV related out-
comes was examined in a two level random intercepts
model. The variance partitioning coefﬁcient (VPC) was
computed, which is the ratio of the random site variance to
the total variance. For binary variables, residuals were
assumed to have a standard logistic variance structure at
the Level 1 and normally distributed variance structure at
Level 2.
Statistical modelling was conducted using Stata Soft-
ware (Stata Corp, 4905 Lakeway Drive, College Station,
TX 77845 USA).
Additionally, a secondary analysis was conducted to
evaluate site-speciﬁc variation by age group for each
respective question. Chi square test of independence was
used to assess this site-speciﬁc variation. These site-spe-
ciﬁc analyses were conducted in Microsoft Excel (Micro-
soft Corporation, One Microsoft Way, Redmond, WA
98052).
Results
Across the nine sites, there were a total of 1,534 respon-
dents aged 25–49 and 722 aged 50 and older. Of those aged
50 and older, 45.2% (n = 326) were aged 50–59, 32.1%
(n = 232) aged 60–69 and 22.7% (n = 164) aged 70 and
older. The male/female ratio among those aged 25–49 was
0.90 and among those aged 50 and older 1.19.
Multilevel models for all four outcomes variables were
evaluated using three explanatory variables: age group,
gender, and interaction between age group and gender. In
the unadjusted model, knowledge score was signiﬁcantly
lower for adults older than 50 years as compared to adults
64 AIDS Behav (2012) 16:63–68
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aged 25–49 years (Table 1). The average male participant
correctly answered 3.47 questions, while females correctly
answered 0.63 fewer questions. In the ﬁnal model, con-
trolling for other covariates, knowledge score was signiﬁ-
cantly lower for adults older than 50 years and for females.
Older adults had correct knowledge of 0.50 fewer questions
and females answered 0.35 fewer questions correctly than
the average male respondent aged 25–49. Moreover, there
was a signiﬁcant multiplicative effect for older females,
who had signiﬁcantly lower knowledge scores (0.35 fewer
correctly answered questions) after controlling for the
overarching age and gender effects. As for the variance
partition coefﬁcient in the ﬁnal model, 26.8% of the total
variance in knowledge score was due to between-site
differences.
For the two questions comprising the stigma score,
stigma was not signiﬁcantly different by age group. In the
ﬁnal model, stigma was signiﬁcantly lower among females
as compared to males and the difference between those
older than 50 and those 25–49 was not signiﬁcant.
For the ﬁnal model of HIV testing, age group and gender
were statistically signiﬁcant. The odds of ever having an
HIV test were 0.56 smaller for older adults (50?) and 0.32
smaller for females compared to males aged 25–49.
However, the interaction between age group and gender
was not signiﬁcant. HIV testing had the highest between-
site VPC of the four ﬁnal models.
After controlling for other covariates, the odds of talking
to a partner about HIV was signiﬁcantly lower for older
adults (50?) and for females. The interaction term between
age group and gender was signiﬁcant (P value\0.1) while
controlling for the overall affects of age group and gender.
For the secondary analysis of site-speciﬁc variation,
Table 2 presents selected data from ﬁve sites on knowl-
edge, stigma, testing and whether or not respondents had
talked to their partner about HIV. In eight of the nine sites,
older adults were signiﬁcantly (P\ 0.05) less likely to
have heard of voluntary counselling and testing than those
aged 25–49. Levels of awareness of prevention of mother-
to-child transmission (PMTCT) and anti-retroviral treat-
ment (ART) were also lower among older adults. In all of
the West African sites, more than 84% of older women had
not heard of ART. In eight of the nine sites (six signiﬁ-
cantly), older adults were less likely to know that one could
reduce their chances of getting HIV by using a condom
every time they had sex when compared to respondents
aged 25–49.
HIV testing levels among older adults were signiﬁcantly
lower than among those aged 25–49 in three of four West
Africa sites, but in only one East African site. Levels of
ever tested among older men ranged from 23% in Rwanda
to 0% in Senegal and among older women from 17% in
Rwanda to 0% in Senegal. Across all sites, a minimum of
50% of respondents aged 50 and older expressed a will-
ingness to be tested for HIV.
Discussion
Information on HIV awareness and knowledge among
younger adults is widely available. Our study is one of the
ﬁrst among older people and it reveals that people aged
50 years and older in rural Africa have lower levels of
HIV-related knowledge and awareness than those aged
25–49. Older adults are also less likely to have been tested
for HIV and are less likely to have spoken to their partners
about HIV. Women aged 50 and older show particularly
low levels of awareness and knowledge compared to both
younger women and to men aged 50 and older. Despite
this, older adults demonstrated a high level of willingness
to care for family members who are HIV-positive.
The few DHS studies that included men aged 50 and
older reveal similar ﬁndings to our study. In the 2008
Nigerian DHS, men aged 50–59 were less likely than men
aged 15–49 to know that condoms were an effective pre-
vention measure when used during every sexual encounter
and had less knowledge of PMTCT [10]. Conﬁrming our
results, DHS reports conducted since 2005, which do not
include data on older women, reveal that testing rates
among men aged 50 and older (with the upper age range
varying from 54–64 depending on site) are lower than
among men aged 15–49 in Nigeria, Benin, Democratic
Republic of Congo, Lesotho, Uganda and Cape Verde [7].
The Kenya AIDS Indicator Survey also revealed lower
testing rates among older adults and among older women in
particular [11]. While 18.9% of men aged 60–64 had been
tested for HIV, only 6.0% of women of the same age had.
Additionally, the highest syphilis prevalence rates in Kenya
were among those aged 60–64. A study in Uganda revealed
that participants over 50 years of age were less ART
knowledgeable than younger interviewees [4].
The ﬁndings of this study have important implications
for HIV services in Africa. Low levels of knowledge
among sexually active older adults will impact HIV
transmission. Higher general knowledge of HIV and
treatment knowledge are associated with better adherence
to ARVs [12] suggesting that, without information, treat-
ment outcomes among older adults might be compromised.
The persistence of high levels of stigma among older
adults and among older women in particular can reduce the
possible uptake of HIV testing programs and can lead to
reduced care seeking behaviour. Stigma is particularly
important among older adults who are often expected to
take on caregiving roles for their children or grandchildren
affected by HIV. A South African study showed that pro-
viding HIV education workshops to older people led to a
AIDS Behav (2012) 16:63–68 65
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more positive attitude towards people living with HIV and
led them to perceive themselves as more able to provide
care to HIV-positive family members [3].
The role of grandparents and the older generation on the
attitudes and health-seeking behaviour of the wider popu-
lation is important. Bezner Kerr and colleagues note that
health education efforts rarely involve grandmothers and
that hospital personnel often have disparaging attitudes
towards the role that grandmothers can and do play in the
community and that few health education programs have
addressed the role that grandmothers play in decision-
making [13]. The older generation’s attitudes and knowl-
edge has resonance and impact beyond their own behaviour
and therefore cannot be ignored. The low levels of
awareness of service availability suggest that more needs to
be done to increase the responsiveness of the health system
to older individuals’ needs.
The development of a better understanding of the sexual
behaviour and attitudes of older adults will not only have
impact on their own risk proﬁle but also possibly on that of
the younger generations. Intergenerational relationships—
sexual relationships predominantly between younger
women and older men—are one of the drivers of the epi-
demic in sub-Saharan Africa.
The strength of this study is the cross-country compa-
rability using the same survey tool as well as its focus on
rural populations. Limitations include the small sample
size in some sites which precluded analysis of narrower age
groupings as well as the fact that some of the data is now a
few years old. Given the amount of activity and funding for
HIV activities in many of these countries over the past few
years (albeit starting in urban areas and not focused on
older populations), attitudes and awareness might have
improved slightly. The HIV status of the respondents was
not available and could not be associated with knowledge
responses. Lastly, the data is not nationally representative
and provides a snapshot of a number of speciﬁc rural areas.
There is a need for targeted prevention messaging and
the building of treatment awareness among older adults in
SSA. Healthcare organisations, governments, and local
communities should view older adults as sexually active, as
caretakers and educators. Recognising this, South Africa
has added males older than 50 to their list of most-at-risk
populations [14]. Workshops have been conducted among
older adults, such as caregiver workshops in South Africa,
which have led to more positive attitudes and improved
knowledge [3]. Such initiatives are needed so older Afri-
cans can more effectively provide leadership towards an
AIDS-free generation.
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Additional tables with supplementary information are provided here that 
were not included in the final published version of the manuscript. 
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Supplementary Table 1. Survey Sites and Adult HIV Prevalence by Site during 
Survey Year 
 
Country – Village Year of 
Survey 
National HIV 
Prevalence (15-
49) in that Year 
(26) 
District/Province/State/Region 
HIV Prevalence in Nearest Year 
for Which Data is Available 
Ghana – Bonsaaso  2006-07 2.0 (2006) 2.3% in Ashanti region (2003) (27) 
Kenya – Sauri  2005 6.9 14.9% in Nyanza province (2007) 
(28) 
Malawi – Mwandama  2006 12.1 17.8% in Zomba district (2004) (29) 
Mali – Tiby  2007 1.5 1.3% in Segou region (2006) (30) 
Nigeria – Ikaram  2007 3.1 3.2% in Ondo State (2005) (31) 
Nigeria – Pampaida  2006 3.1 6.8% in Kaduna State (2005) (32) 
Rwanda – Mayange  2006 2.9 2.5% in East province (2005) (33) 
Senegal – Potou  2007 1.0 0.5% in Louga district (2005) (34) 
Tanzania – Mbola  2007 6.2 6.1% in Tabora region (2007-8) (35) 
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Supplementary Table 2. Outcome and exposure variables  
 
Knowledge Score: 
number of correct 
responses to six (6) 
HIV knowledge 
questions [continuous 
variable, range 0-6] 
[“don’t know” 
responses were 
regarded as lack of 
knowledge] 
a.  Is there anything a person can do to avoid getting 
HIV/ AIDS, or the virus that causes AIDS?  
b. Can a person get the AIDS virus from mosquito or 
other insect bites?  
c. Can people reduce their chances of getting the AIDS 
virus by using a condom every time they have sex?,  
d. Can a mother who is infected with the AIDS virus 
reduce the risk of giving the virus to the baby by taking 
certain drugs during pregnancy?; and  
e. Have you ever heard of VCT, Voluntary Counseling 
and Testing for the virus that causes HIV/AIDS?  
f. Is there any medicine that a person with AIDS can take 
to stay alive? 
Stigma: stigmatic 
response to at least one 
of two stigma questions 
[binary variable: 1 = at 
least 1 stigmatic 
response)] [“don’t 
know” responses were 
excluded from 
analysis] 
a. If a member of your family got infected with the virus 
that causes AIDS, would you want it to remain a secret 
or not?; or  
b. If a relative of yours became sick with the virus that 
causes AIDS, would you be willing to care for her or 
him in your own household? 
Behaviour – Ever 
Tested for HIV [binary 
variable: 1 = ever 
tested for HIV] 
a. Have you ever been tested to see if you have the AIDS 
virus? 
Behaviour – Ever 
Talked to Partner about 
HIV [binary variable: 1 
= talked to partner] 
a. Have you ever talked with your husband/wife/partner 
about ways to prevent getting the virus that causes 
AIDS? 
Exposure Variables Age Group: binary variable (1=50+ years) 
Sex: binary variable (1=Female) 
Age and Sex Interaction: binary variable (1=Female 
50+ years) 
 
65
Supplementary Table 3. Characteristics of Study Participants 
Location 
N (Male/Female Ratio) 
25-49 Years 50+ Years 
Total:  
25+ Years 
Ghana - Bonsaaso 214 (0.86) 44 (1.20) 258 (0.91) 
Kenya – Sauri 131 (1.02) 94 (0.96) 225 (0.99) 
Malawi - Mwandama 150 (0.92) 75 (0.67) 225 (0.83) 
Mali – Tiby 164 (0.94) 87 (1.69) 251 (1.15) 
Nigeria - Ikaram 150 (0.74) 152 (0.99) 302 (0.86) 
Nigeria - Pampaida 224 (0.99) 62 (3.36) 286 (1.25) 
Rwanda - Mayange 182 (0.81) 75 (0.91) 257 (0.84) 
Senegal - Potou 161 (0.81) 48 (0.66) 209 (0.77) 
Tanzania - Mbola 158 (1.03) 85 (2.23) 243 (1.33) 
Total 1534 (0.90) 722 (1.19) 2256 (0.98) 
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Supplementary Table 4. 
Responses to knowledge, stigma, testing and talking to partner questions by age by West African site 
 Bonsaaso, Ghana Tiby, Mali Ikaram, Nigeria Pampaida, Nigeria Potou, Senegal 
  25-49 yrs 
50+ 
yrs  p-value   
25-49 
yrs 
50+ 
yrs  p-value   
25-49  
yrs 
50+ 
yrs  p-value   
25-49 
yrs 
50+ 
yrs  p-value   
25-49 
yrs 
50+ 
yrs  p-value    
 Overall Sample Size  214 44   164 87   150 152   224 62   161 48     
 KNOWLEDGE                                         
Is there anything a person can do to avoid getting 
HIV/ AIDS, or the virus that causes AIDS? 93% 84% 0.074  * 81% 80% 0.887   72% 54% 0.002  *** 71% 63% 0.231   86% 60% 0.000  *** 
Can a person get the AIDS virus from mosquito or 
other insect bites? 36% 32% 0.639   16% 22% 0.239   30% 20% 0.054  * 37% 34% 0.645   32% 21% 0.147   
Can people reduce their chances of getting the AIDS 
virus by using a condom every time they have sex? 58% 48% 0.193    66% 53% 0.044  ** 53% 37% 0.005  *** 44% 51% 0.322   54% 25% 0.000  *** 
Can a mother who is infected with the AIDS virus 
reduce the risk of giving the virus to the baby by 
taking certain drugs during pregnancy? 
17% 9% 0.197    25% 30% 0.405    23% 17% 0.141    25% 31% 0.412   28% 6% 0.002  *** 
Is there any medicine that a person with AIDS can 
take to stay alive? 24% 9% 0.030  ** 37% 25% 0.069  * 19% 14% 0.197   17% 23% 0.354   33% 8% 0.001  *** 
Have you ever heard of VCT, Voluntary Counseling 
and Testing for the virus that causes HIV/AIDS? 55% 80% 0.003  *** 65% 51% 0.031  ** 40% 28% 0.032  ** 3% 2% 0.631   55% 17% 0.000  *** 
 STIGMA                                         
If a member of your family got infected with the virus 
that causes AIDS, would you want it to remain a 
secret or not? 
41% 33% 0.375   53% 44% 0.189   28% 25% 0.692   42% 47% 0.584   40% 42% 0.844   
If a relative of yours became sick with the virus that 
causes AIDS, would you be willing to care for her or 
him in your own household? 
79% 90% 0.092  * 88% 89% 0.846   84% 78% 0.283   70% 68% 0.758   91% 78% 0.051  * 
 TESTING                                         
Have you ever been tested to see if you have the 
AIDS virus? 5% 7% 0.554   10% 6% 0.275   5% 5% 0.822   0% 2% 0.329   7% 0% 0.063  * 
 TALKING TO PARTNER                                         
Have you ever talked with (your husband/ 
wife/partner you are living with) about ways to 63% 50% 0.105    33% 26% 0.305    41% 26% 0.009  *** 26% 26% 0.969   30% 8% 0.003  *** 
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prevent getting the virus that causes AIDS? 
Statistical Testing: * for p<0.1; ** p<0.05; *** p<0.01  
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Supplementary Table 5.  
Responses to knowledge, stigma, testing and talking to partner questions by age by East and Southern African site 
 Sauri, Kenya Mwandama, Malawi Mayange, Rwanda Mbola, Tanzania 
  25-49 yrs 
50+ 
yrs 
p-
value   
25-49 
yrs 
50+ 
yrs 
 p-
value    
25-49 
yrs 
50+ 
yrs 
p-
value   
25-49 
yrs 
50+ 
yrs 
p-
value   
 Overall Sample Size: 131 94   150 75   182 75   158 85     
 KNOWLEDGE   
Is there anything a person can do to avoid getting HIV/ 
AIDS, or the virus that causes AIDS? 94% 79% 0.001 *** 98% 97% 0.755   100% 97% 0.026 ** 89% 76% 0.009 *** 
Can a person get the AIDS virus from mosquito or other 
insect bites? 55% 45% 0.128  53% 51% 0.777   66% 53% 0.044 ** 61% 49% 0.089 * 
Can people reduce their chances of getting the AIDS virus 
by using a condom every time they have sex? 84% 66% 0.002 *** 60% 56% 0.593    82% 63% 0.002 *** 66% 52% 0.025 ** 
Can a mother who is infected with the AIDS virus reduce the 
risk of giving the virus to the baby by taking certain drugs 
during pregnancy? 
68% 66% 0.713   55% 40% 0.036  ** 87% 68% 0.000 *** 47% 34% 0.045 ** 
Is there any medicine that a person with AIDS can take to 
stay alive? 86% 77% 0.086 * 91% 72% 0.000  *** 81% 65% 0.006 *** 61% 44% 0.008 *** 
Have you ever heard of VCT, Voluntary Counseling and 
Testing for the virus that causes HIV/AIDS? 97% 81% 0.000 *** 97% 84% 0.001  *** 77% 65% 0.049 ** 82% 65% 0.003 *** 
 STIGMA                                 
If a member of your family got infected with the virus that 
causes AIDS, would you want it to remain a secret or not? 43% 36% 0.330  62% 56% 0.379   28% 33% 0.442  31% 32% 0.927   
If a relative of yours became sick with the virus that causes 
AIDS, would you be willing to care for her or him in your own 
household? 
92% 87% 0.201  94% 96% 0.646   96% 97% 0.548  95% 96% 0.599   
 TESTING                                 
Have you ever been tested to see if you have the AIDS 
virus? 22% 16% 0.249  31% 9% 0.000  *** 44% 19% 0.000 *** 24% 9% 0.005 *** 
 TALKING TO PARTNER                                 
Have you ever talked with (your husband/ wife/partner you 
are living with) about ways to prevent getting the virus that 
causes AIDS? 
69% 52% 0.017 ** 68% 52% 0.025  ** 80% 55% 0.000 *** 64% 66% 0.761   
Statistical Testing: * for p<0.1; ** p<0.05; *** p<0.01 
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Chapter Three  
Supplementary Information 
 
 
 
 
The Millennium Village Project AIDS and other Sexually Transmitted 
Diseases Module Survey used in this study is provided as supplementary 
information.  Surveys were adapted slightly for use in each site based on 
local context and therefore surveys for each site have slight differences. 
The survey provided here is the one that was used in the Ruhiira, Uganda 
site.   
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MILLENNIUM VILLAGE PROJECT
EARTH INSTITUTE, COLUMBIA UNIVERSITY 
HEALTH AND NUTRITION QUESTIONNAIRE
AIDS AND OTHER SEXUALLY-TRANSMITTED DISEASES MODULE-MV1
DATE OF INTERVIEW DATE MONTH YEAR
STARTING TIME ENDING TIME
INTERVIEWER'S NAME
DATA
ENTERED BY
CHECKED BY DATE CHECKED / / DATE ENTERED / /
RELATION TO HOUSEHOLD HEAD
HEAD . . . . . . . . . . . . . . . . . . . . . . . . 01
SPOUSE . . . . . . . . . . . . . . . . . . . . . . 02
PARENT . . . . . . . . . . . . . . . . . . . . . . 03
CHILD . . . . . . . . . . . . . . . . . . . . . . . . 04
GRAND CHILD . . . . . . . . . . . . . . . . . . 05
NEPHEW/NIECE . . . . . . . . . . . . . . . . 06
SON/DAUGHTER IN LAW . . . . . . . 07
BROTHER/SISTER . . . . . . . . . . . . . . 08
WIFE 2 . . . . . . . . . . . . . . . . . . . . . . . . 09
WIFE 3 . . . . . . . . . . . . . . . . . . . . . . . . 10
OTHER RELATIVE . . . . . . . . . . . . . . 96
OTHER NON-RELATIVE . . . . . . . . . . 97
UNIQUE HOUSEHOLD ID
UNIQUE HOUSEHOLD 
NAME OF HOUSEHOLD HEAD HEAD ID . . . . . . . . . . . . 
NAME OF MAIN RESPONDENT UNIQUE RESPONDENT'S
(IF NOT HH HEAD) ID . . . . . . . . . . . . . . . . . . 
The following questions are designed to collect information on sexually transmitted infections (STI) and HIV AIDS 
in men and women within a household . The information is needed to estimate the scope and scale of these 
infections and the effectiveness of mitigating interventions promoted under the Millennium Development Village 
Project. Your co-operation and patience in answering these questions ACCURATELY will be highly appreciated. 
These questions should be answered by both  the Household head and/or their spouse(s) as well as any adult
males and females aged 13 years and above . 
1 Now I would like to talk about something else. YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Have you ever heard of a disease called HIV/AIDS? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 27
2 Is there anything a person can do to avoid getting HIV/ AIDS, YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
or the virus that causes AIDS? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
DON’T KNOW . . . . . . . . . . . . . . . . . . 90 4
3 What can a person do? ABSTAIN FROM SEX . . . . . . . . . . . . . . 01
Any thing else? USE CONDOMS . . . . . . . . . . . . . . . . . . 02
LIMIT SEX TO ONE PARTNER/STAY
FAITHFUL TO ONE PARTNER . . . . . 03
CIRCLE ALL MENTIONED. LIMIT NUMBER OF SEX PARTNERS. . . 04
AVOID SEX WITH PROSTITUTES. . . . . 05
AVOID SEX WITH PERSONS WHO 
HAVE MANY PARTNERS . . . . . . . . . . 06
AVOID BLOOD TRANSFUSIONS . . . . . 07
AVOID INJECTIONS . . . . . . . . . . . . . . . . 08
AVOID SHARING RAZORS/BLADES . 09
AVOID KISSING . . . . . . . . . . . . . . . . . . 10
AVOID MOSQUITO BITES . . . . . . . . . . 11
SEEK PROTECTION FROM 
TRADITIONAL HEALER . . . . . . . . . . 12
OTHER ____________________ 96
(SPECIFY)
OTHER ____________________ 97
(SPECIFY)
DON’T KNOW . . . . . . . . . . . . . . . . . . 90
10-Feb-06
RUHIIRA
1…………………………. Ruhiira
3…………………………. Karundi
CELL NO 
9 ………………………….Town cell
10…………………………..Kishenyi
11 …………………………  Kahurwa 
5…………………………. Nyakimiri I
6…………………………. Nyakimiri II
7………………………….Rwakyiebezi
8 ………………………….Omwicwamba
: 
: : 
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4 Can a person get the AIDS virus from mosquito or other insect YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
bites? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
DON’T KNOW . . . . . . . . . . . . . . . . . . 90
5 Can people reduce their chances of getting the AIDS virus by YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
using a condom every time they have sex? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
DON’T KNOW . . . . . . . . . . . . . . . . . . 90
6 Do you know someone personally who has the virus that YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
causes AIDS or someone who died of AIDS? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
7 Can the virus that causes AIDS be During pregnancy YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
transmitted from a mother to NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
UR3
a child?
During delivery YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
UR3
by breastfeeding YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
UR3
8 Can a mother who is infected with the AIDS virus reduce the YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
risk of giving the virus to the baby by taking certain drugs NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
during pregnancy? DON’T KNOW . . . . . . . . . . . . . . . . . . 90
9 Have you ever talked with (your husband/ wife/partner you are YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
living with) about ways to prevent getting the virus that causes NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
AIDS? IF MORE THAN ONE WIFE/PARTNER, ASK ABOUT ALL. 
10 If a member of your family got infected with the virus that YES, KEEP IT SECRET. . . . . . . . . . . . . . 1
causes AIDS, would you want it to remain a secret or not? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
DON’T KNOW/ NOT SURE . . . . . . . . . . 90
11 If a relative of yours became sick with the virus that causes YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
AIDS, would you be willing to care for her or him in your own NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
household? DON’T KNOW/ NOT SURE/ DEPENDS. 90
12 If a female teacher has the AIDS virus, should she be allowed CAN CONTINUE . . . . . . . . . . . . . . . . . . 1
to continue teaching in school? SHOULD NOT CONTINUE. . . . . . . . . . . . 2
DON’T KNOW/ NOT SURE/ DEPENDS. 90
13 Do you think your chances of getting AIDS are small, moderate, NO RISK AT ALL . . . . . . . . . . . . . . . . . . 1
SMALL . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
great, or no risk at all? MODERATE . . . . . . . . . . . . . . . . . . . . . . 3
GREAT . . . . . . . . . . . . . . . . . . . . . . . . 4 15
HAS AIDS . . . . . . . . . . . . . . . . . . . . . . 5 16
14 Why do you think that you have (no risk/a small chance) of IS NOT HAVING SEX . . . . . . . . . . . . . . 1
getting AIDS? Any other reason? USES CONDOMS. . . . . . . . . . . . . . . . . . 2
HAS ONLY ONE PARTNER . . . . . . . . . . 3
CIRCLE ALL MENTIONED. LIMITS THE NUMBER OF PARTNERS . 4
PARTNER HAS NO OTHER PARTNERS. .5
PARTNERS TESTED NEGATIVE………..UR6
OTHER ____________________ 96 16
(SPECIFY)
15 Why do you think that you have a (moderate, great) chance of DOES NOT USE CONDOMS. . . . . . . . . . 1
getting AIDS? Any other reason? HAS MORE THAN 1 SEX PARTNER. . . 2
PARTNER HAS OTHER PARTNERS. . . 3
CIRCLE ALL MENTIONED. HOMOSEXUAL CONTACTS . . . . . . . . . . 4
HAD BLOOD TRANSFUSION/INJECTION.5
MOSQUITO BITES……………………….UR6
OTHER ____________________ 96
(SPECIFY)
16 Is there any medicine that a person with AIDS can take to YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
stay alive? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
DON’T KNOW . . . . . . . . . . . . . . . . . . 90
17 Should children aged 12-14 be taught about using condom YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
to avoid AIDS? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
DON’T KNOW . . . . . . . . . . . . . . . . . . 90
DON’T KNOW……………………………
DON’T KNOW……………………………
DON’T KNOW……………………………
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18 Have you ever heard of VCT, Voluntary Counseling and Testing YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
for the virus that causes HIV/AIDS? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 27
19 I do not want to know the results, but have you ever been YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
tested to see if you have the AIDS virus? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 24
20 I don't want to know the results of the test, but did you ever YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
get the results of the test? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
21 When was the last time you were tested? LESS THAN 12 MONTHS AGO . . . . . 1
12-23 MONTHS AGO . . . . . . . . . . . . . . 2
2 YEARS OR MORE AGO . . . . . . . . . . 3
22 The last time you were tested, did you ask for the test, was it ASKED FOR THE TEST . . . . . . . . . . . . 1
offered to you and you accepted, or was it required? OFFERED AND ACCEPTED. . . . . . . . . . 2
REQUIRED . . . . . . . . . . . . . . . . . . . . . . 3
23 Where did you go for the test? PUBLIC SECTOR
GOVERNMENT HOSPITAL . . . . . . . 11
IF PLACE IS HOSPITAL, HEALTH CENTRE, OR CLINIC, GOVT. HEALTH CENTRE/CLINIC. . . 12
WRITE THE NAME OF THE PLACE.  PROBE TO IDENTIFY GOVERNMENT DISPENSARY . . . . . 13
THE TYPE OF SOURCE AND CIRCLE THE APPROPRIATE OTHER PUBLIC________________ 16
CODE. (SPECIFY)
PRIVATE MEDICAL SECTOR
(NAME OF PLACE) MISSION/CHURCH HOSP. CLINIC. . . 21
FPAU HEALTH CENTRE/CLINIC . . . 22
PRIVATE HOSPITAL/CLINIC. . . . . . . 23
PHARMACY/CHEMIST . . . . . . . . . . . . 24
PRIVATE DOCTOR . . . . . . . . . . . . . . 25
NURSING/MATERNITY HOME . . . . . 26
BLOOD TRANSFUSION SERVICE . . . 31
OTHER ______________________ 96 27
(SPECIFY)
24 Would you want to be tested for the AIDS virus? YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
DON’T KNOW/ NOT SURE/ DEPENDS. 90
25 Do you know a place where you could go to get an AIDS test? YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 27
26 Where can you go for the AIDS  test? PUBLIC SECTOR
GOVERNMENT HOSPITAL . . . . . . . 11
IF PLACE IS HOSPITAL, HEALTH CENTRE, OR CLINIC, GOVT. HEALTH CENTRE/CLINIC. . . 12
WRITE THE NAME OF THE PLACE.  PROBE TO IDENTIFY GOVERNMENT DISPENSARY . . . . . 13
THE TYPE OF SOURCE AND CIRCLE THE APPROPRIATE OTHER PUBLIC________________ 16
CODE. (SPECIFY)
PRIVATE MEDICAL SECTOR
MISSION/CHURCH HOSP. CLINIC. . . 21
FPAU HEALTH CENTRE/CLINIC . . . 22
PRIVATE HOSPITAL/CLINIC. . . . . . . 23
PHARMACY/CHEMIST . . . . . . . . . . . . 24
PRIVATE DOCTOR . . . . . . . . . . . . . . 25
NURSING/MATERNITY HOME . . . . . 26
BLOOD TRANSFUSION SERVICE . . . 31
NGO BASED CLINIC …………………….UR32
OTHER ______________________ 96
(SPECIFY)
27 (Apart from AIDS), have you heard about (other) infections that YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
can be transmitted through sexual contact? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2 31
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28 If a man has a sexually transmitted disease, what symptoms ABDOMINAL PAIN . . . . . . . . . . . . . . . . 01
might he have? Any other? GENITAL DISCHARGE/DRIPPING. . . . . 02
FOUL SMELLING DISCHARGE. . . . . . . 03
BURNING PAIN ON URINATION . . . . . 04
CIRCLE ALL MENTIONED. REDNESS/INFLAMMATION IN 
GENITAL AREA . . . . . . . . . . . . . . . . 05
SWELLING IN GENITAL AREA . . . . . . . 06
GENITAL SORES/ULCERS . . . . . . . . . . 07
GENITAL WARTS . . . . . . . . . . . . . . . . 08
GENITAL ITCHING . . . . . . . . . . . . . . . . 09
BLOOD IN URINE . . . . . . . . . . . . . . . . . . 10
LOSS OF WEIGHT . . . . . . . . . . . . . . . . 11
IMPOTENCE/NO ERECTION. . . . . . . . . . 12
OTHER ____________________ 96
(SPECIFY)
OTHER ____________________ 97
(SPECIFY)
NO SYMPTOM . . . . . . . . . . . . . . . . . . . . 13
DON’T KNOW . . . . . . . . . . . . . . . . . . . . 90
29 If a woman has a sexually transmitted disease, what symptoms ABDOMINAL PAIN . . . . . . . . . . . . . . . . 01
might she have? Any other? GENITAL DISCHARGE/DRIPPING. . . . . 02
FOUL SMELLING DISCHARGE. . . . . . . 03
BURNING PAIN ON URINATION . . . . . 04
CIRCLE ALL MENTIONED. REDNESS/INFLAMMATION IN 
GENITAL AREA . . . . . . . . . . . . . . . . 05
SWELLING IN GENITAL AREA . . . . . . . 06
GENITAL SORES/ULCERS . . . . . . . . . . 07
GENITAL WARTS . . . . . . . . . . . . . . . . 08
GENITAL ITCHING . . . . . . . . . . . . . . . . 09
BLOOD IN URINE . . . . . . . . . . . . . . . . . . 10
LOSS OF WEIGHT . . . . . . . . . . . . . . . . 11
HARD TO GET PREGNANT/HAVE
A CHILD . . . . . . . . . . . . . . . . . . . . . . 12
OTHER ____________________ 96
(SPECIFY)
OTHER ____________________ 97
(SPECIFY)
NO SYMPTOM . . . . . . . . . . . . . . . . . . . . 13
DON’T KNOW . . . . . . . . . . . . . . . . . . . . 90
30 Now I would like to ask you some questions about your health YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
in the last 12 months.  During the last 12 months, have you had NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
a sexually-transmitted disease? DON’T KNOW . . . . . . . . . . . . . . . . . . . . 90
31 IS RESPONDENT A MAN? IF A WOMAN 34
32 Sometimes, men experience an abnormal discharge from their YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
penis. During the last 12 months, have you had an abnormal NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
discharge from your penis? DON’T KNOW . . . . . . . . . . . . . . . . . . . . 90
33 Sometimes men have a sore or ulcer on or near their penis. YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
During the last 12 months, have you had a sore or ulcer on or NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
near your penis? DON’T KNOW . . . . . . . . . . . . . . . . . . . . 90 36
34 Sometimes, women experience an abnormal vaginal discharge. YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
During the last 12 months, have you had a bad-smelling unusual NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
discharge from your vagina? DON’T KNOW . . . . . . . . . . . . . . . . . . . . 90
35 Sometimes women have a genital sore or ulcer. During the last YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
12 months, have you had a genital sore or ulcer? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
DON’T KNOW . . . . . . . . . . . . . . . . . . . . 90
36 CHECK Q30, Q32, Q33, Q34, Q35:
IF ONE OF THEM HAS '1' CIRCLED OTHERWISE 42
37 The last time you had (PROBLEM(S) FROM Q30, Q32/33, YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Q34/35), did you seek any kind of advice or treatment? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
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38 The last time you had (PROBLEM(S) did you do any of the 
following?  
A. Did you go to a clinic, hospital or YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
private doctor? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
B. Did you consult a traditional YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
healer? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
C. Did you seek advice or buy YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
medicines in a shop or pharmacy? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
D. Did you ask for advice from YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
friends or relatives? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
39 When you had (PROBLEM(S)  FROM Q30, Q32/33, Q34/35), YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
did you tell the person(s) with whom you were having sex? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
SOME/NOT AT ALL . . . . . . . . . . . . . . . . 3
DID NOT HAVE A PARTNER . . . . . . . 4
40 When you had (PROBLEM(S)  FROM Q30, Q32/33, Q34/35), YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
did you do anything to avoid infecting your sexual partner(s)? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
PARTNER(S) ALREADY INFECTED . . . 3 42
41 What did you do to avoid infecting your partner(s)?
A. Did you use medicine? YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
B. Did you stop having sex? YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
C. Did you use a condom when YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
having sex? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
42 How old were you when you first started being sexually NOT YET SEXUAL ACTIVE……………UR1
active?
SEXUALY ACTIVE………..UR2 YRS       
43 How many sexual partners have you ever had in your life time? 0 PARTNER . . . . . . . . . . . . . . . . 1
1 PARTNER . . . . . . . . . . . . . . . . 2 EXIT
2-5 PARTNERS . . . . . . . . . . . . . . . . 3
6-10 PARTNERS . . . . . . . . . . . . . . . . 4
11-20 PARTNERS . . . . . . . . . . . . . . . . 5
21-50 PARTNERS . . . . . . . . . . . . . . . . 6
MORE THAN 50 PARTNERS . . . . . . . 7
44 In the past 12 months, have you had sex with anyone else, YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
other than the one who is your main partner? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
REFUSED TO ANSWER . . . . . . . . . . 7 EXIT
45 The last time you had sexual intercourse with someone YES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
who is not your main partner, did you use a condom? NO . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
REFUSED TO ANSWER . . . . . . . . . . 7
Thank you very much for sparing time to answer these questions. Your services are highly appreciated.
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Abstract
Background: There are approximately 3 million people aged 50 and older in sub-Saharan Africa who are HIV-positive.
Despite this, little is known about the characteristics of older adults who are on treatment and their treatment outcomes.
Methods: A retrospective cohort analysis was performed using routinely collected data with Malawi Ministry of Health
monitoring tools from facilities providing antiretroviral therapy services in Zomba district. Patients aged 25 years and older
initiated on treatment from July 2005 to June 2010 were included. Differences in survival, by age group, were determined
using Kaplan–Meier survival plots and Cox proportional hazards regression models.
Results: There were 10,888 patients aged 25 and older. Patients aged 50 and older (N = 1419) were more likely to be male
(P,0.0001) and located in rural areas (P = 0.003) than those aged 25–49. Crude survival estimates among those aged 50–59
were not statistically different from those aged 25–49 (P = 0.925). However, survival among those aged 60 and older
(N = 345) was worse (P = 0.019) than among those 25–59. In the proportional hazards model, after controlling for sex and
stage at initiation, survival in those aged 50–59 did not differ significantly from those aged 25–49 (hazard ratio 1.00 (95% CI:
0.79 to 1.27; P = 0.998) but the hazard ratio was 1.46 (95% CI: 1.03 to 2.06; P = 0.032) for those aged 60 and older compared
to those aged 25–49.
Conclusions: Treatment outcomes of those aged 50–59 are similar to those aged 25–49. A better understanding of how
older adults present for and respond to treatment is critical to improving HIV services.
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Introduction
There are approximately 3 million people aged 50 and older in
sub-Saharan Africa who are HIV-positive, representing more than
13% of all HIV cases in the region [1]. These figures are likely to
increase as the number of people on life-prolonging anti-retroviral
treatment (ART) grows. Despite this, older people have been
neglected in the global and regional HIV response. UNAIDS and
other prominent data sources report prevalence rates of those aged
15–49 [2] and few services directly target those aged 50 and older
[3,4].
The evidence base on ART presentation, initiation and
outcomes for older adults from developed countries has been
growing over the past few years [5,6]. There is evidence that older
adults are more likely to be late presenters with more AIDS-
defining diseases and are more likely to die before treatment
initiation [7–10]. After initiation of ART, studies have also shown
higher mortality [11] and slower immune system reconstitution
[12] leading some to suggest that older adults should initiate
treatment earlier than younger counterparts [13].
There has not however been much analysis conducted on older
adults in sub-Saharan Africa [14,15]. Recently, one Ugandan and
one South African study provided some of the first evidence
reporting on treatment outcomes revealing elderly age status (50
and older) associated with higher mortality [16,17].
A recent study revealed that older Africans are less likely to have
a good understanding of HIV, are less likely to have been tested
and are less likely to be aware of treatment availability [18]. Along
with this, for older adults in sub-Saharan Africa, issues of stigma,
lack of access to health services, poor overall health [19] and ageist
views on sexual behavior might negatively impact on the
effectiveness of ART scale-up efforts.
In Malawi, a country with a 2009 HIV prevalence of 11%
among those aged 15–49, analysis of 2007 UNAIDS data
suggested that there are approximately 156,000 people over 50
who are living with HIV in Malawi or 16.8% of the total [1].
Furthermore, people over 50 make up 9.3% of Malawi’s
population [20]. ART coverage has expanded dramatically over
the past few years and, as of 2009, 72% of those who needed treatment
were receiving it based on 2006 World Health Organization ART
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guidelines [2] suggesting that the numbers ageing with HIV will
increase. Despite this, no published work exists for Malawi
specifically examining HIV among older adults.
Using data from Zomba District in Malawi, this study examines
the characteristics of older adults on ART, their condition at
initiation and their treatment outcomes compared against younger
adults.
Methods
Subjects were adults aged 25 and older at time of ART
initiation residing in Zomba District in southern Malawi who
accessed ART services in the district’s 23 health facilities between
1 July 2005 and 30 June 2010.
The methods used in this study have been described in detail
elsewhere (Chan et al 2010) [21]. In brief, a retrospective cohort
analysis was performed using data collected with standard Malawi
Ministry of Health (MOH) ART monitoring tools. ART provision
was implemented as per MOH guidelines based on WHO clinical
staging or CD4 count ,250 cells ?mm3 where measurement of
CD4 is available. The first line ART regimen in Malawi is
stavudine, lamivudine and nevirapine in fixed-dosed combination.
After initiation, follow-up was monthly and then, after approxi-
mately 6 months, patients were followed less often depending on
assessment of adherence. In the project district, mortality was
documented by trained health workers in health facilities and by
reports from trained patient guardians where deaths occurred at
home. Defaulter tracing was also conducted which revealed
additional deaths.
Analyses in this paper only included those aged 25 and older to
exclude those regarded by MDG [22] and UNGASS [23]
indicators as adolescents. Age was defined as age at treatment
initiation. The 23 health facilities where MOH ART provision is
supported by Dignitas International were classified as urban, semi-
urban or rural based on location and catchment area of facility.
Analysis of conditions at initiation was based on examination at
baseline of 52 HIV-related conditions detailed in WHO clinical
staging including: acute ulcerative mouth infections, Kaposi’s
sarcoma, various types of pneumonia and weight loss to name a
few. As per Malawi MOH guidelines, individuals were initiated
based on characterization as being in WHO clinical stage 3 or 4
or, if characterized as Stage 1 or 2, based on low CD4 count if
available. As a result, baseline CD4 counts were collected for only
47% of patients. Additionally, CD4 testing capacity was only
available in urban settings with blood samples from rural patients
being sent to urban facilities as needed.
Statistical analyses included Chi-square tests for categorical
variables and t-tests for continuous variables to compare differences
between groups. Logistic regression analyses were used for
categorical outcomes including WHO clinical stage and number
of conditions at initiation. Interactions between age and sex and
between age and location of initiation were tested in the logistic
regression analyses. Cox proportional hazard regression models
were used to evaluate relationships between age, sex and status at
initiation and treatment outcomes (death). CD4 count was not used
for these analyses due to high number of missing values. Differences
in survival time between groups of subjects by age categories and by
sex were investigated using Kaplan–Meier survival plots. Data
analysis was performed using SAS v.9.2.
For the Cox proportional hazards model and Kaplan-Meier
survival curves, analyses excluded those whose follow-up status
was characterized in the dataset as ‘‘missing’’ or suspected of
having ‘‘defaulted.’’ This represented 22.7% (N=2475) of all
those aged 25 and older who had initiated in the five year period
from 1 July 2005 to 30 June 2010. Based on a systematic review
[24] and data from two studies in Malawi, [25,26] we estimate that
approximately 41–50% of those lost to follow-up would have died
within approximately two years. Analyses were run to identify
differences in characteristics between those in the analyzed cohort
versus those excluded.
Ethics Statement
The study analysis received approval from the National Health
Sciences Research Committee of Malawi in April 2011.
Results
There were 10888 patients aged 25 and older who had initiated
ART between 1 July 2005 and 30 June 2010 in the database. Of
those, 6789 (62.4%) were female; 9469 (87.0%) were aged 25–49,
1074 (9.9%) were 50–59 and 345 (3.2%) were aged 60 and older.
The older age groups had significantly (P,0.0001) higher per-
centages of male patients than the younger age groups: 44.9% of
those 50 years and older were male compared to 36.6% of those
aged under 50 years (table 1). Older adults were also more likely to
be living in a rural location compared to younger adults (P= 0.003).
There were no significant differences between age groups for year of
initiation or TB status at baseline.
After adjusting for location and sex, age group was not
associated with WHO clinical stage at initiation of ART or with
the number of HIV-related conditions at initiation. Females were
slightly more likely than males to have two or more HIV-related
conditions at initiation (odds ratio (OR): 1.17 (95% confidence
interval (CI): 1.05 to 1.32)). Those who initiated in semi-urban and
rural areas were less likely (OR: 0.61 (95% CI: 0.53 to 0.69)) to
have two or more conditions compared to urban patients.
Interactions between age and location and between age and sex
were tested and were not significant.
Data were available for 8412 individuals for the analysis of
treatment outcomes. Of these, 765 (9.1%) died within 5 years of
initiation of treatment. Survival rates among those aged 50–59
were not statistically different from those aged 25–49 (P= 0.92)
(figure 1). Survival among those aged 60 and older was
significantly worse (P= 0.02) than among those 25–59. Those
aged 60 and older also had significantly worse survival (P = 0.04)
than those aged 50–59. Further analysis revealed that sex was a
significant predictor of survival (P,0.0001), with males having
worse survival than females (figure 2).
After controlling for sex and WHO clinical stage at initiation,
the hazard ratio (HR) for those aged 50–59 compared to those
aged 25–49 was 1.00 (95% CI: 0.79 to 1.27; P= 0.99) (table 2).
Compared to those aged 25–49 years, those aged 60 and older
were at significant increased risk of dying (HR=1.46 (95% CI:
1.03 to 2.06; P= 0.03)). Controlling for stage and age group, being
female reduced the risk of death with a hazard ratio of 0.58 (95%
CI: 0.50 to 0.67; P,0.0001). As expected, WHO clinical stage was
strongly associated with mortality. After controlling for sex and age
group, compared to Stage 1, the hazard ratio for Stage 3 was 5.4
(95% CI: 1.74 to 16.94) and the hazard ratio for Stage 4 was 12.3
(95% CI: 3.93 to 38.32).
Of the 765 who died, 629 (82.2%) died within the first year of
ART initiation. The pattern of mortality between the age groups
was unchanged with those 50–59 have similar mortality to those
aged 25–49 with those 60 and older having higher mortality.
Due to missing outcome data, 2475 (22.7%) of subjects were
excluded from survival analyses. The mean age and baseline CD4
of those included in analysis were not meaningfully different from
the mean age of those excluded but those excluded were more
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likely to be male and were more likely to have been characterized
as WHO Stage 4 on initiation of treatment (table 3). Importantly,
the relative differences in sex and WHO Stage between those
included and those excluded from survival analyses were largely
consistent among those over 50 and among those under 50.
If the excluded patients are included in the survival analysis up
to the point when they were classified as missing, the results and
significance noted above remained in the same direction and
changed only slightly in magnitude. The hazard ratio for those
aged 60 and older became 1.52 (95% CI: 1.08 to 2.15; P= 0.0168)
while the hazard ratio for those aged 50–59 remained 1.00
compared to those aged 25–49. Using the Kaplan-Meier survival
curves, when including those with incomplete outcome data, those
60 and older had significantly worse survival than those 50–59
(P = 0.03).
Discussion
Adults aged 50 and older in Zomba District, Malawi, who
initiated ART were more likely than younger adults to be male
and be receiving treatment at a rural health facility. However,
based on WHO clinical stage and number of HIV-related
conditions at ART initiation, older adults in this population were
no sicker at presentation than younger adults.
We found no difference in mortality on treatment among those
aged 50 to 59 years compared to those aged 25 to 49, indicating
that people in their fifties respond just as well to treatment as
younger people. Survival among those aged 60 and older was
reduced; however, this is to be expected due to higher rates of all-
cause mortality among older adults. In this study, sex was a much
better predictor of survival than age in the Zomba District ART
cohort. This study suggests that females are more likely to survive
than men.
In our study, 9% of those initiated on treatment died over the
course of the five years. This level of mortality was higher than was
found in Uganda [16] but comparable to data seen in South
Africa, Cote d’Ivoire and elsewhere in Malawi [15].
The lack of significant differences in the clinical condition of
older adults at initiation of ART is contrary to what has been
hypothesized. In Brazil, those aged 60 and older had more AIDS-
Table 1. Characteristics of patients at initiation of antiretroviral therapy.
25–49 50–59 60+
N % N % N %
P Value
(25–49 vs 50+)
Sex
Female 6007 63.4% 613 57.1% 169 49.0% ,0.0001
Male 3462 36.6% 461 42.9% 176 51.0%
WHO Stage / Reason for ART Initiation
Stage 1 341 3.6% 29 2.7% 10 2.9% 0.188
Stage 2 3300 34.9% 363 33.9% 121 35.4%
Stage 3 4281 45.3% 511 47.8% 177 51.8%
Stage 4 1530 16.2% 167 15.6% 34 9.9%
Missinga 17 0.2% 3 0.3% 3 0.9%
ART Location
Urban 4971 52.5% 525 48.9% 154 44.6% 0.003
Semi Urban 1600 16.9% 177 16.5% 71 20.6%
Rural 2898 30.6% 372 34.6% 120 34.8%
CD4 cell counts at baseline (cells/ml)
less than or equal to 50 608 13.7% 39 7.7% 10 5.9% 0.001
between 50 and 99 748 16.8% 87 17.2% 28 16.6%
between 100 and 199 1515 34.0% 179 35.4% 55 32.5%
between 200 and 299 1388 31.2% 184 36.4% 68 40.2%
300 or over 192 4.3% 17 3.4% 8 4.7%
Missinga 5018 53.0% 569 52.9% 176 51.0%
Median baseline CD4 157 171 185
Tuberculosis status at baseline
TB past or present 1406 14.8% 155 14.4% 52 15.1% 0.797
No TB 8063 85.2% 919 85.6% 293 84.9%
Year of ART Initiation
2009–2010 3827 40.4% 415 38.6% 150 43.5% 0.287
2007–2008 4354 46.0% 525 48.9% 154 44.6%
2005–2006 1287 13.6% 134 12.5% 41 11.9%
aMissing values not included in percentages in categories above.
Zomba District by age category 25–49,50–59 and 60 and older who initiated treatment from July 2005 to June 2010.
doi:10.1371/journal.pone.0026546.t001
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Figure 1. Survival estimates by age. Kaplan-Meier survival estimates by age group for those aged 25 and older who initiated treatment in Zomba
District between 1 July 2005 and 30 June 2010. Blue is 25–49 (N= 7297); Red is 50–59 (N= 839); Green is 60+ (N = 276).
doi:10.1371/journal.pone.0026546.g001
Figure 2. Survival estimates by sex. Kaplan-Meier survival estimates by sex for those aged 25 and older who initiated treatment in Zomba District
between 1 July 2005 and 30 June 2010. Blue is Male (N= 3057); Red is Female (N= 5355).
doi:10.1371/journal.pone.0026546.g002
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defining diseases at diagnosis than those aged 20–39 [8] and a
review of developed country studies found that older adults
presented later and sicker [6]. However, the recent South African
ART among older adults study found that they did not present
with more advanced disease than younger individuals [17]. Similar
to our findings, the Ugandan study by Bakanda and colleagues
also found that older adults were more likely to be male and did
not differ in WHO clinical stage at treatment initiation [16].
With regard to treatment outcomes, the Ugandan study found
that being aged 50 and older was associated with mortality
compared to those 18 to 49 after controlling for other variables
[16]. The South African study found that older adults had 32%
excess mortality compared to those 25 to 49 [17]. A four site cross-
Africa study found that treatment outcomes for over 50s were
worse than for younger age groups [15]. Ours is the first study that
breaks down the over 50 group into additional age categories for
analysis.
Especially for the 50–59 age group, our data confirms what has
been seen in non-African studies where older HIV-infected
patients responded as well to ART as younger age groups [27–
30]. A Brazilian study that compared those aged 20–39 against
those aged 60 and older found that, once on ART, mortality
between the two groups was similar [8]. A recent case-control
study, in which the outcome in patients aged 55 years or older was
compared with patients aged 35 years or younger, all treated with
ART, concluded that the virological outcome did not differ
between groups [31]. The picture is complex however as a number
of other studies have found that there is slower recovery of CD4
levels among older adults [12,32]. The eventual higher mortality
among older adults in the study was expected and has been seen in
other studies [33,34].
Our finding that women on ART are more likely to survive than
men has been observed in other studies in Malawi [35] and across
Africa [36]. Potential reasons for this sex difference could be that
men seek care at a more advanced stage of illness and have poorer
levels of adherence.
The strength of the study is its inclusion of program data from
an entire district’s ART population including urban and rural
sites. However, study limitations include concerns regarding
accuracy and consistency that are associated with use of
operational data. Because data were extracted from routine
monitoring and evaluation indicators, information that might be
included in a prospective study is not available, as it is not a part of
routine clinical care for ART provision under the Malawi MOH
Table 2. Cox proportional hazards models for mortality.
Model with age, sex and WHO Stage at initiation (N=8390) Model with Age and Sex (N=8412)
Variable Hazard ratio 95% confidence limits P Value Hazard ratio 95% confidence limits P Value
Age group 0.098 0.216
25–49 1.00 1.00
50–59 1.00 0.79–1.27 0.998 0.97 0.77–1.23 0.826
60+ 1.46 1.03–2.06 0.032 1.35 0.96–1.91 0.086
Sex 0.58 0.50–0.67 ,0.0001 0.52 0.46–0.60 ,0.0001
WHO Stage ,0.0001
Stage 1 1.00
Stage 2 2.38 0.76–7.49 0.139
Stage 3 5.43 1.74–16.94 0.004
Stage 4 12.27 3.93–38.32 ,0.0001
doi:10.1371/journal.pone.0026546.t002
Table 3. Comparison of those included in survival analysis and those excluded.
Included in Analysis (N) Excluded from Analysis (N)
Total population Age (mean) 38.3 (8412) 38.0 (2475)
Sex (% male) 36.3% (3057) 42.1% (1042)
WHO Stage 3 and 4 (%) 61.1% (5122) 63.8 (1578)
Baseline CD4 (mean) 162.6 (4055) 154.6 (1070)
25 to 49 Age (mean) 35.5 (7297) 35.5 (2171)
Sex (% male) 35.2% (2569) 41.1% (893)
WHO Stage 3 and 4 (%) 60.8% (4425) 63.9% (1386)
50 and older Age (mean) 56.1 (1115) 56.0 (304)
Sex (% male) 43.8% (488) 49.0% (149)
WHO Stage 3 and 4 (%) 62.9% (697) 63.2% (192)
doi:10.1371/journal.pone.0026546.t003
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public health model and is reflective of resource limitations in that
setting. Specifically, high levels of missing baseline CD4 data made
usage of that variable difficult.
A further limitation was the approximately 20% loss to follow
up in the dataset. However, the levels of loss to follow-up in this
study are comparable to those seen in a review of loss to follow-up
across Africa [24]. The exclusion of those lost to follow-up from
analysis is likely to have led to underestimation of the absolute
number of deaths and mortality rates. However, because the
magnitude of differences in characteristics of those included and
excluded was similar in the different age groups, the relative risk of
death (or hazard ratio) comparing those aged 50 years and over
with those aged under 50 was unlikely to be biased.
While some studies have also excluded those lost to follow-up,
[15] other studies have used randomization techniques to impute
outcome status [16,37]. These imputation techniques make
assumptions about which variables are correlated with mortality.
For example, Bakanda and colleagues [16] assumed that those
with lower CD4 count and those who were older were more likely
to die. We did not conduct outcome imputation for those lost to
follow-up. Given that age and its relation to mortality was the
primary outcome of this study, it was felt that including age in the
imputation method would be inappropriate as the method of
imputation would be directly related to the primary outcome of
interest. Baseline CD4 was also not ideal for use as an imputation
variable due to the large number of non-random missing values in
our dataset. In the future, greater efforts will be needed to trace
those lost to follow-up and examine specific characteristics and
determinants of mortality [38,39].
That older adults respond well to ART despite a lack of
specifically targeted services is an encouraging sign for ART scale-
up. This evidence can be used to combat ageist stigma [40] and to
encourage promotion of services among this age group. There
have been suggestions there might be higher adherence rates
among the elderly – which has been found in developed countries
[27,41] – which may be driving the positive treatment response.
With the ageing of the epidemic, HIV has become a complex
chronic disease characterised by increasing rates of co-morbid
conditions including liver and renal disease, cancers, osteoporosis,
neurocognitive and cardiovascular diseases [5]. It is well known
that older people’s immune systems weaken with age regardless of
HIV status leaving older people at greater susceptibility to a range
of conditions [42,43] – but this has not been specifically studied in
Africa among those on ART. The ageing of the epidemic has
implications on service delivery with a growing need for integrated
diagnostic and treatment services for HIV and non-communicable
diseases.
Older adults have been largely neglected by the global HIV
response but there are encouraging signs that those aged 50 and
older are starting to be seen by the HIV community as productive,
fully active contributors, care givers, and educators, whose
susceptibility to HIV needs to be integrated into the core of the
response to the epidemic.
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Chapter Four  
Supplementary Information 
 
 
 
 
The Zomba District anti-retroviral treatment initiation patient card is 
provided as supplementary information.  This card is filled out for each 
new patient commencing treatment. 
 
 
84
 Patient Master Card – ART Initiation Version 3 (circle options) Transfer-In Date  ARV no  Year  
   
P a t i e n t  D e t a i l s  S t a t u s  a t  A R T  i n i t i a t i o n  F i r s t  p o s i t i v e  H I V  t e s t  
 Rapid Patient Name  WHO Stage 1 2 3 4 TB status None Past Curr Date, Place   PCR 
Sex, Birth date M F DOB Patient Phone CD4 count  % KS N Y A R T  R e g i m e n s  Start date 
Phys. Address  CD4 Date  Pregnant N Y 1st Line d4T 3TC NVP  
Guardian Name  Relation Height, Wt. cm kg Ever taken ARVs N Y 1st Line Alt   
Agrees to FUP N Y  Guardian Phone Age at init.  Last ARVs (drug, date)  2
nd Line   
 
Date Hgt Wt Outcome Outc Date  ART Regimen Side Effects TB status ARVs given CPT Comments / Lab  
Suspected Confirmed  
cm kg 
     1st L 1st Line Alt. 2nd L 
Non
Stan
dard
     
No Yes no Rx Rx 
Pill 
count 
Doses 
missed No. of 
tablets To 
No. of 
tablets 
 
Next 
appointment 
Jan   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Feb   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Mar   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Apr   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
May   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Jun   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Jul   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Aug   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Sep   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Oct   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Nov   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
Dec   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
                                
   D Def Stop TO  Start AZT EFV AZT EFV 2Ad 2Ch NS Non PN HP SK Oth N Y C Rx    P G    
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 WHO Clinical Staging Circle all conditions found in the patient 
 Adults and Children Adults only (15 years or older) Children only (14 years or younger) 
1 • Asymptomatic 
• Persistent generalized lymphadenopathy 
  
2 • Respiratory tract infections, recurrent (sinusitis, tonsillitis, otitis 
media, pharyngitis 
• Herpes zoster 
• Angular cheilitis 
• Oral ulcerations, recurrent 
• Papular pruritic eruptions / Fungal nail infections 
• Moderate weightloss <10%, unexplained 
• Seborrhoeic dermatitis 
• Hepatosplenomegaly, persistent unexplained 
• Lineal gingival erythema 
• Wart virus infection, extensive 
• Molluscum contagiosum, extensive 
• Parotid enlargement, persistent unexplained 
3 • Fever, persistent unexplained (intermittent or constant, >1 
month) 
• Oral hairy leukoplakia 
• Pulmonary tuberculosis (current) 
• Pulmonary tuberculosis within the last 2 years 
• Anaemia, unexplained  < 8 g/dl 
• Neutropaenia, unexplained  < 50 /mm3 
• Thrombocytopaenia, chronic  < 50,000 /mm3 
• Severe weightloss >10% and/or BMI <18.5kg/m2, unexplained 
• Diarrhoea, chronic (>1 month) unexplained  
• Oral candidiasis 
• Severe bacterial infections (pneumonia, empyema, 
pyomyositis, bone/joint, meningitis, bacteraemia) 
• Acute necrotizing ulcerative stomatitis, gingivitis or periodontitis 
• Moderate unexplained wasting / malnutrition not responding to 
treatment (weight-for-height 70-79% or MUAC 11-12cm) 
• Diarrhoea, persistent unexplained (14 days or more) 
• Oral candidiasis (from age 2 months) 
• Acute necrotizing ulcerative gingivitis or periodontitis 
• Lymph node tuberculosis 
• Bacterial pneumonia, severe recurrent 
• Symptomatic lymphoid interstitial pneumonitis 
• Chronic HIV-associated lung disease including brochiectasis 
4 • Pneumocystis pneumonia 
• Candidiasis of oesophagus, trachea, bronchi or lungs 
• Extrapulmonary tuberculosis 
• Kaposi’s sarcoma 
• HIV encephalopathy 
• Cryptococcal meningitis or other Extrapulmonary cryptococcosis 
• Disseminated non-tuberculous mycobacterial infection 
• Cryptosporidiosis, chronic with diarrhoea 
• Isosporiasis >1 month 
• Disseminated mycosis (coccidiomycosis or histoplasmosis) 
• Symptomatic HIV-associated nephropathy or cardiomyopathy 
• HIV wasting syndrome 
• Bacterial pneumonia, recurrent severe 
• Chronic herpes simplex infection (orolabial, genital / anorectal 
>1 month or visceral at any site) 
• Cytomegalovirus infection (retinitis or infection of other organs) 
• Toxoplasmosis of the brain 
• Progressive multifocal leukoencephalopathy 
• Non-typhoidal Salmonella bacteraemia, recurrent 
• Lymphoma (cerebral or B-cell non-Hodgkin) 
• Invasive cancer of cervix 
• Leishmaniasis, atypical disseminated 
• Severe unexplained wasting / malnutrition not responding to 
treatment (weight-for-height <70% or MUAC <11cm or oedema) 
• Bacterial infections, severe recurrent (empyema, pyomyositis, bone/ 
joint, meningitis, but excluding pneumonia) 
• Chronic herpes simplex infection (orolabial or cutaneous >1 month or 
visceral at any site) 
• Cytomegalovirus infection: retinitis or cytomegalovirus infection 
affecting another organ (from age 1 month) 
• Toxoplasmosis of the brain (from age 1 month) 
• Cerebral or B-cell non-Hodgkin lymphoma 
• Progressive multifocal leukoencephalopathy 
Ever taken ARVs Has the patient ever taken any ARVs? (e.g. single dose nevirapine for PMTCT, or triple therapy) If yes, specify drug and approximate date when last taken 
    
Outcome (circle only one option, leave blank if patient alive on ART) ART Regimen (circle only one option) Side Effects (circle at least one option) ARVs given 
D Died Start d4T 3TC NVP Non No side effects P ARVs given to patient 
Def AZT AZT 3TC NVP PN Peripheral neuropathy G ARVs given to guardian 
 
Defaulted: More than 2 months overdue after expected to have 
run out of tables, unknown survival and ART status EFV d4T 3TC EFV HP Hepatitis TB Status (any form of TB) 
Stop Patient stopped taking ARVs (clinician’s or patient’s own decision) AZTEFV AZT 3TC EFV SK Skin rash N TB Not suspected 
TO Transferred to other ARV clinic (including ‘unofficial’ transfers) SwAd Switch Adult: AZT 3TC TDF LPV/r Oth Other ARV drug side effect Y TB Suspected 
  SwCh Switch Child: ddI ABC LPV/r CPT  C TB Confirmed not (yet) on TB treatment 
  NS Non-Standard regimen (specify in comments) Indicate of CPT given in months RX TB Confirmed & currently taking TB treatment 
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Abstract 
 
Objectives: Limited evidence is available on HIV, aging and comorbidities in sub-
Saharan Africa. This article describes the prevalence of HIV and chronic comorbidities 
among those aged 50 years and older in South Africa using nationally representative data. 
 
Design: The WHO’s Study of global AGEing and adult health (SAGE) was conducted in 
South Africa in 2007–2008. SAGE includes nationally representative cohorts of persons 
aged 50 years and older, with comparison samples of those aged 18–49 years, which aims 
to study health and its determinants. 
 
Methods: Logistic and linear regression models were applied to data from respondents 
aged 50 years and older to determine associations between age, sex and HIV status and 
various outcome variables including prevalence of seven chronic conditions. 
 
Results: HIV prevalence among adults aged 50 and older in South Africa was 6.4% and 
was particularly elevated among Africans, women aged 50–59 and those living in rural 
areas. Rates of chronic disease were higher among all older adults compared with those 
aged 18–49. Of those aged 50 years and older, 29.6% had two or more of the seven 
chronic conditions compared with 8.8% of those aged 18–49 years (P<0.0001). When 
controlling for age and sex among those aged 50 and older, BMI was lower among HIV-
positive older adults aged 50 and older (27.5) than in HIV-negative individuals of the 
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same age (30.6) (P<0.0001). Grip strength among HIV-positive older adults was 
significantly (P=0.004) weaker than among similarly-aged HIV-negative individuals. 
 
Conclusion: HIV-positive older adults in South Africa have high rates of chronic disease 
and weakness. Studies are required to examine HIV diagnostics and treatment instigation 
rates among older adults to ensure equity of access to quality care, as the number and 
percentage of older adults living with HIV is likely to increase. 
 
Keywords: aging; chronic disease; comorbidity; HIV; older adults; South Africa 
 
 
90
 
 
Introduction 
 
As of 2007, almost one in eight people living with HIV in sub-Saharan Africa was aged 
50 years and older [1]. With life expectancy increasing for individuals on antiretroviral 
(ARV) treatment (ART) [2], the number of older people with HIV will continue to 
increase and will have considerable impacts on the future course of the epidemic. 
Overall, South Africa is aging despite the impacts of HIV mortality on the total 
population, with the highest percentage (15.9%) of persons aged 50 years and above  in 
sub-Saharan Africa in 2012 [3]. 
 
The aging of the HIV epidemic in South Africa has received more attention than other 
parts of Africa over the past few years [4–6]. Recent estimates for South Africa predict 
that HIV prevalence in patients aged 50 and older will nearly double in the next 30 years 
from 9% in 2010 to 17% in 2040, whereas the fraction of HIV-infected patients aged 50 
and over will triple in the same period. The increase will be particularly pronounced 
among men: less than one in 12 HIV-infected people is aged over 50 in 2010 but in 2040 
this will be one in four [7]. 
 
Despite this emerging evidence, there are still substantial knowledge gaps about HIV-
positive individuals aged 50 and older in South Africa. Previous studies on older adults in 
South Africa have been conducted with subpopulations in which HIV is highly prevalent 
[4]. One of the key issues that has not yet received much attention in sub-Saharan Africa 
is noncommunicable diseases (NCDs) and comorbidities among people living with HIV. 
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Traditionally, HIV and AIDS-associated conditions have focused on opportunistic, 
primarily infectious diseases such as tuberculosis, pneumonia and Kaposi’s sarcoma. 
However, newer evidence from developed countries demonstrates that there is also an 
additional burden of HIV-related and ART-related chronic comorbidities, especially 
among those aged 50 and older [8]. Patients aging with HIV are more likely to develop 
NCDs and at an earlier age than those who are HIV-negative, threatening the long-term 
survival of people living with HIV. These conditions include coronary artery disease, 
dyslipidemia, some cancers, metabolic syndrome, diabetes, osteoporosis and dementia 
[9–11]. This has led to calls for greater attention to multimorbidity in the care of people 
living with HIV [12,13]. 
 
However, not much evidence on comorbidities occurring in HIV-infected individuals is 
available from African settings. Although chronic comorbidities in the context of HIV 
have been acknowledged as likely [14,15], the situation has not been well quantified. A 
small number of African studies have measured prevalence of specific conditions among 
HIV-positive individuals. For instance, one study reports that cardiac abnormalities are 
more common in people with HIV compared with controls [16]. 
 
The topic of HIV, aging and comorbidities remains neglected by the international 
community [17]. Examining the realities and complexities of HIV and aging in South 
Africa is critical to improving quality of care and treatment options. The co-existence of 
communicable and NCD burdens pose complex challenges for an already taxed 
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healthcare system: evidence is needed to better inform the South African health system 
and build its capacity to respond to multiple comorbidities [18–20]. In order to start to 
address the knowledge gaps, this article aims to describe HIV prevalence and 
associations between HIV and chronic comorbidities – among those aged 50 years and 
older in South Africa using nationally representative data. 
 
Methods 
 
The WHO implemented Wave 1 of the Study of global AGEing and adult health (SAGE) 
in six low-income and middle-income countries, including South Africa, in 2007–2008. 
Cross-sectional data was used from SAGE: a study with nationally representative cohorts 
of persons aged 50 years and older, with comparison samples of younger adults aged 18–
49 years in each country, which aims to study health, health-related outcomes and their 
determinants. The survey instrument included multiple modules devised to measure 
health status, risk factors and chronic diseases, health systems coverage and 
responsiveness and healthcare expenditures. Biomarkers, including a blood sample, were 
collected. More information on SAGE survey methods and materials is available 
elsewhere [21–23]. 
 
Data for the South African SAGE survey were collected from March 2007 to September 
2008. A population-based representative sample of the population aged 50 years or older 
was interviewed, with a smaller cohort of adults aged 18–49 years included for 
comparison purposes. The survey includes information on respondents’ health, physical 
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functioning, risk factors and perceptions of well being. Anthropometric measures were 
collected, including BMI and waist and hip circumferences. Dried blood spot samples 
were collected through finger prick and used to determine HIV status through laboratory 
testing. Grip strength was measured as a proxy for mobility and functioning. Interviewers 
were retired or unemployed nurses. Respondent consent was obtained for the interview 
and the blood sample. In South Africa, SAGE was carried out in partnership with the 
WHO, the Human Sciences Research Council (HSRC) and the National Department of 
Health (NDOH). Blood samples were stored and analyzed at Global Clinical and Viral 
Laboratories, Durban, South Africa. Ethical review and clearance was obtained through 
WHO and the HSRC Research Ethics Committee. Financial support was provided by the 
NDOH, the United States National Institute on Aging's Division of Behavioral and Social 
Research, HSRC and WHO. 
 
Respondents were asked whether they had been diagnosed with a number of NCDs, using 
the following question format: `have you ever been told by a health professional that you 
have…?', or `have you ever been diagnosed with…?', for each health condition. Given 
the limitations of self-reported chronic conditions [24], a validated set of symptom 
questions and a related diagnostic algorithm were used to ascertain prevalence of angina, 
arthritis, asthma and depression [25]. The set of symptoms for each condition was 
derived from standard instruments, such as the World Mental Health Survey version of 
the Composite International Diagnostic Interview for the diagnosis of depression [26] or 
the Rose questionnaire for angina [27]. A validated set of symptom questions is not 
available for diabetes or stroke prevalence, which was, therefore, based on a self-report of 
the condition. Hypertension prevalence was based on mean blood pressure readings of 
equal to or greater than 140░mmHg for SBP and 90░mmHg for DBP. 
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The validated WHO Disability Assessment Schedule (WHODAS) 12-item instrument 
was used to assess functioning and disability [28]. The total score was transformed to an 
index between 0 and 100, with 0 representing extreme problems or complete disability 
and 100 representing a total absence of disability. Grip strength was calculated as mean 
maximum hand grip strength of both hands in kilograms. 
 
Data was weighted using poststratified individual probability weights based on the 
selection probability at each stage of selection. Individual weights were poststratified by 
province, sex and age groups according to the 2009 medium mid-year population 
estimates from Statistics South Africa [29]. Weights were not normalized. Weights sum 
to the total population aged 18 years and older. 
 
Regression models were applied to data from respondents aged 50 years and older to 
determine associations between explanatory variables age, sex and HIV status and 
various outcome variables. Logistic regression was applied with prevalence of various 
chronic conditions and linear regression analysis was conducted for continuous variables 
including WHODAS, BMI, grip strength and waist-to-hip ratio. Models were weighted 
using the aforementioned population weights. All analyses were conducted using SAS 
statistical software version 9.2 (SAS Institute Inc., Cary, North Carolina, USA). 
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Results 
 
In total, 4227 individuals responded to the questionnaire of whom 385 (9.1%) were aged 
18–49, 1695 (40.1%) were aged 50–59, 1232 (29.1%) were aged 60–69 and 912 (21.6%) 
were 70 years and older. The overall response rate for those aged 50 and older was 76%. 
Of the total respondents, HIV status results were available for 3161 (74.8%) individuals 
due to some respondents not consenting as well as a small number of inconclusive 
results. Response rates for HIV testing ranged from 72.2% among those aged 50–59 to 
76.9% for those aged 70 years and older. 
 
 
Focusing on those aged 50 years and older and using sample weights so that the data is 
nationally representative, 6.4% of older adults in South Africa were HIV-positive at the 
time of the survey. This ranges from 8.6% among those aged 50–59 to 3.3% among those 
aged 70 and older (Table 1). The HIV prevalence estimate for those aged 18–49 years in 
South Africa in 2008 was 16.9% [6]. HIV prevalence was higher among women, those 
living in rural areas, Africans and those with less education. Prevalence was highest in 
the Free State (12.2%) and lowest in the Western Cape (2.1%). HIV prevalence among 
women aged 50–59 years was considerably higher than among men of the same age 
(Figure 1). 
 
Table 2a provides data on the prevalence of chronic comorbidities by HIV status across 
three age groups (18–49, 50–59, >60 years). First analysis compares prevalence of 
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comorbidities between HIV-positive older adults and HIV-negative older adults. Rates of 
arthritis were significantly (P<0.0001) lower among HIV-positive individuals over the 
age of 50 (6.5%) as compared with HIV-negative people of the same ages (18.8%). 
 
Whereas 53.4% of all (both HIV-positive and negative) those aged 18–49 did not have 
any chronic condition, only 22.0% of those aged 50 and older did not. Only 8.8% of those 
aged 18–49 years had two or more conditions compared with 29.6% of those aged 50 and 
older (P<0.0001). 
 
BMI was lower among HIV-positive older adults aged 50 and older (27.5 kg/m2) than 
HIV-negative individuals of the same age (30.6 kg/m2) (P<0.0001) (Table 2b). Grip 
strength among HIV-positive older adults (33.5 kg) was significantly (P=0.004) weaker 
than among similarly-aged HIV-negative individuals (38.3 kg). 
 
Second analysis compares comorbidities among HIV-positive individuals aged 50 and 
older against HIV-positive individuals aged 18–49. Rates of hypertension among HIV-
positive individuals were significantly higher (P=0.0003) among those above the age of 
50. WHODAS was higher among HIV-positive older adults (23.0) than among those 
HIV-positive individuals aged 18–49 (6.2) (P0.0001). 
 
After adjusting for age and sex using logistic regression, arthritis was the only chronic 
condition that was statistically significantly associated with HIV status among people 
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aged 50 years and over (Table 3). Among individuals aged 50 years and older, living with 
HIV was associated with a lower prevalence of arthritis [odds ratio 0.30 (95% confidence 
intervals 0.14–0.65); P=0.002]. Among those aged 50 and older, age and sex were not 
associated with the presence of chronic conditions. When including those aged 18–49 as 
well as older individuals, as expected, there was a significant positive association 
between older age and presence chronic conditions. 
 
In linear regression models in those 50 years and older (Table 4), when controlling for 
age and sex, HIV status was statistically significantly associated with BMI and grip 
strength. The grip strength of those living with HIV was on average 4.73 kg weaker than 
among those who were HIV-negative (95% confidence intervals 0.77–8.70; P=0.019). 
Those living with HIV also had on average a BMI 3.86 points lower (95% confidence 
intervals 2.17–5.55; P<0.0001). Age and sex also had significant associations with 
WHODAS, BMI and grip strength. 
 
Among those 50 years of age and older, levels of happiness and life satisfaction were 
lower among those who were HIV-positive. When asked how satisfied they were with 
life as a whole, 51.8% of HIV-positive individuals responding `satisfied' or `very 
satisfied' compared with 60.6% of those HIV-negative (P=0.039). When ask about their 
level of happiness, 34.6% of the HIV-positive respondents replied `happy' or `very happy' 
compared with 55.5% of those HIV-negative (P<0.0001). 
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Discussion 
 
HIV prevalence among adults aged 50 and older in South Africa remains high and is 
particularly elevated among Africans, women aged 50–59 years, those living in rural 
areas and in some provinces such as Free State and KwaZulu-Natal. Rates of chronic 
disease were higher among all older adults compared with those aged 18–49 years. HIV 
status, however, was only statistically significantly associated with arthritis and not with 
any of the other conditions that we studied. When controlling for age and sex among 
those aged 50 and older, HIV status was significantly associated with lower BMI and 
weaker grip strength. 
 
Our finding of 6.4% prevalence among all individuals aged 50 years and older is similar 
to that found by Peltzer et al. [5] in the 2005 South African HIV prevalence and 
behavioral survey (5.8%) and in the 2008 South African national HIV prevalence, 
incidence, behavior and communication survey (6.0%) [6]. The higher rate of HIV 
prevalence among women aged 50–59 relative to men of the same age found in this study 
was not seen in those two studies. The 3.3% HIV prevalence rate among those aged 70 
and older could cautiously be taken as evidence of old age incidence. 
 
A Ugandan study using the same survey methodology also found significantly lower BMI 
among HIV-infected older people compared with HIV-negative counterparts as well as 
lower rates of hypertension [30]. Overall, the Ugandan study found that older adults 
living with HIV had a similar health and functional status as other older people. 
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Despite significant evidence from developed country settings of associations between 
HIV and various chronic conditions, these were generally not found in this study among 
those aged 50 and older. Evidence of links between HIV and diabetes [31], 
cardiovascular disease [32], cerebrovascular and ischemic heart diseases [11], 
hypertension [33] and stroke [34] have been found in various studies in developed 
countries. HIV-associated arthritis has been observed in high-income countries linked to 
both HIV infection [35] and some ARV medications [36] and emerging evidence from 
Uganda shows high rates of rheumatic manifestations among HIV-positive individuals 
[37], although the Ugandan study did not have a HIV-negative comparison group. 
Despite this, our findings reveal lower rates of arthritis among those living with HIV 
aged 50 and older. There are many types of arthritis with differing causes and there is 
evidence that some types of ART might reduce the frequency of some types of arthritis 
[38,39]. Further research is needed on the interaction between HIV, ARVs and immune 
function in the occurrence and severity of various forms of arthritis. 
 
The study is enhanced by the oversampling of older adults in SAGE providing a 
nationally representative perspective on the health of older adults. The approximately 
25% missing HIV status values, however, may introduce bias, which could be leading to 
the lack of relationships observed between HIV status and various comorbidities in this 
study. Those with missing data were more likely to be female, African and slightly 
younger than those who responded. This might explain the high prevalence of HIV found 
in women aged 50–59 years in this study. 
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For a number of chronic conditions, prevalence was determined based on responses to a 
set of self-reported symptom questions rather than clinical diagnosis. This can lead to 
imprecision based on each individual’s interpretation of the question – especially in cases 
of neurological or cognitive deficit. For measures such as hypertension based on blood 
pressure, the reporting of prevalence based on established cut-off points ignores the 
continuous association between blood pressure and hypertension [40]. 
 
A further limitation of this study is the lack of data on ART. Valcour et al. [31] noted that 
it was ART especially that was associated with increased metabolic risk factors. Given 
that a number of comorbidities discussed in this article are more prevalent among those 
on certain ART regimens, the lack of such information limits the conclusions that can be 
drawn. As of December 2009, 971,556 South Africans were on ART, representing 56% 
of those who need treatment based on WHO 2006 guidelines and 37% of those who need 
it based on WHO 2010 guidelines [41]. According to 2008 data, ART coverage varied 
between provinces, from 25.8% in the Free State to 71.7% in the Western Cape [42]. In 
these 2008 data, there are no figures on ART by age group or among those over 50 years 
of age specifically. Whether or not people aged 50 and older are over-represented or 
under-represented in ART programs is unknown and this would have an impact on 
associations with some chronic comorbidities. 
 
The question of multimorbidity is critical to the future care and treatment models of HIV. 
There is a shift in care from a focus on opportunistic infections and AIDS-defining 
malignancies to a new set of chronic comorbidities, which may be due to chronic 
inflammation from long-term HIV infection as well as ART toxicities exacerbated by 
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aging [13,17,43,44]. Evidence from developed countries shows high levels of 
multimorbidity among older adults [45,46]. A multimorbidity perspective has been 
recommended when considering optimal healthcare for older people, as it is more patient-
centered and captures potentially interacting conditions [47]. 
 
This has important implications for integration of chronic care models in already strained 
developing country health systems. There is an opportunity to leverage the investment in 
HIV systems to develop an integrated response to a range of chronic diseases [48]. 
Chronic disease clinics that provide continuity of care, long-term adherence support and 
can prevent and monitor drug interactions and reactions is needed to ensure a high level 
of care [49]. 
 
In addition to the chronic conditions, the weaker grip strength, lower BMI and higher 
disability score highlights poorer overall health among older adults living with HIV 
compared with older adults who do not have HIV. More attention is needed to poverty, 
nutrition and access to disability and health services among older adults with HIV. 
 
South Africa has added men over 50 to its list of most at-risk populations, meriting extra 
attention in the national HIV response [6]. Despite misperceptions to the contrary, older 
adults aged 50 and older in South Africa remain sexually active with 63% of men and 
30% of women having had sex in the past month [5]. The most recent sexual partner of 
more than 11% of men aged 50–59 was aged 31–40 years, suggesting that 
intergenerational relationships remain of concern to HIV transmission [5]. National 
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communication programs have failed to sufficiently target older adults leading to lower 
rates of HIV knowledge among those aged 50 and older [6,50]. 
 
Future research among older adults living with HIV in sub-Saharan Africa, including 
upcoming SAGE surveys, will need to take into account access to ART, time on ART 
and the amount of time that an individual has been HIV-positive in order to better assess 
prevalence and incidence of comorbidities. Further diagnostic tests for chronic conditions 
– in addition to self-reported symptomatic algorithms – would enhance precision. Cancer 
and dementia are additional important health challenges among older adults and among 
people living with HIV that should be included in future studies. Furthermore, efforts to 
integrate care should be evaluated for their impact on quality of care, outcomes and 
avoidance of adverse drug reactions. As the HIV epidemic in Africa ages, more evidence 
will be needed to end the neglect of older adults and develop models of care that meet the 
needs of this vulnerable group. 
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Figure. 1. HIV prevalence among people aged 50 years and older by age and sex, 
2007–08. 
Weighted to be representative of South Africa. Note: weights were poststratified by 
province, sex and age groups according to 2009 data from Statistics South Africa. 
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Table 1. HIV prevalence among people aged 50 years and older by group, 2007–08. 
Variable Group Unweighted N 
with HIV/total 
N 
Weighted 
HIV 
prevalence 
Weighted 95% 
confidence limits 
Age 50+ 147/2869 6.4% 4.9–7.9% 
 50-59 96/1224 8.6% 6.2–11.0% 
 60-69 35/944 5.0% 2.4–7.6% 
 70+ 16/701 3.3% 1.4–5.1% 
Sex Male 56/1188 4.9% 3.0–6.8% 
 Female 91/1681 7.5% 5.4–9.7% 
Ethnicity African/black 113/1540 8.2% 6.2–10.2% 
 White 0/188 0.0% 0.0–0.0% 
 Colored 19/593 2.1% 0.8–3.5% 
 Indian/Asian 2/229 0.7% 0.0–2.0% 
Education Less than primary 78/1354 7.7% 5.3–10.0% 
 Primary completed 30/571 6.1% 3.3–8.8% 
 Secondary completed 22/465 4.2% 1.4–7.0% 
 Postgraduate completed 2/104 1.4% 0.0–4.0% 
Province 
(selected) 
Free State 11/176 12.2% 2.7–21.8% 
Gauteng 14/242 6.1% 1.9–10.3% 
 KwaZulu-Natal 29/399 8.8% 4.3–13.6% 
 Western Cape 4/199 2.1% 0.0–4.8% 
Urban/rural Urban 85/1816 5.5% 3.8–7.2% 
 Rural 62/1052 7.9% 5.2–10.6% 
Marital 
status 
Currently 
married/cohabitating 
61/1469 4.6% 3.0–6.2% 
Never 
married/separated/widowed
82/1356 8.4% 5.8–11.1% 
Weighted to be representative of South Africa. Note: weights were poststratified by 
province, sex and age groups according to 2009 data from Statistics South Africa. 
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Table 2. Measurement of conditions by HIV status and by age group  
(a) Prevalence of conditions by HIV status by age group, 2007–08 (weighted to be representative of South Africa) 
Condition Unweighted 
N with 
condition 
HIV status Ages 
18–49 
years 
Unweighted 
N 
Ages 
50–59 
years 
Unweighted 
N 
Ages 
>60 
years 
Unweighted 
N 
P value 
(HIV 
comparisona)
P value (age 
comparisonb) 
Hypertension 2148 Positive 33.3% 25/53 76.0% 65/96 69.3% 36/51 0.167 0.0003 
  Negative 53.0% 125/238 67.2% 754/1128 70.3% 1144/1595   
Depression 141 Positive 5.9% 3/49 9.3% 9/93 2.6% 2/49 0.194 0.849 
  Negative 6.7% 11/233 5.1% 66/1089 4.5% 50/1535   
Arthritis 509 Positive 6.5% 2/49 5.1% 9/89 9.5% 5/44 <0.0001 0.999 
  Negative 3.2% 15/221 17.4% 175/1042 20.1% 303/1457   
Angina 188 Positive 5.0% 3/51 7.2% 7/92 13.7% 6/45 0.147 0.425 
  Negative 2.2% 8/229 7.4% 71/1048 5.8% 93/1428   
Asthma 171 Positive 2.0% 2/51 4.9% 7/93 5.5% 2/49 0.401 0.383 
  Negative 2.8% 10/232 6.6% 62/1092 6.8% 88/1532   
Stroke 119 Positive 0.0% 0/51 3.6% 3/94 3.6% 2/49 0.476 0.012 
  Negative 1.2% 4/233 3.8% 41/1092 5.6% 69/1536   
Diabetes 288 Positive 3.1% 1/51 10.1% 6/94 10.6% 1/49 0.780 0.118 
  Negative 1.8% 8/233 8.4% 93/1094 10.7% 179/1537 
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(b) Mean measurements by HIV status by age group, 2007–08 (weighted to be representative of South Africa) 
Measure Unweighted HIV status Ages N Ages N Ages N P value P value (age 
bBMI 3044 Positive 28.3 53 27.7 93 27.0 50 <0.0001 0.746 
  Negative 28.5 233 31.0 1084 30.4 1513   
WHR 2952 Positive 0.86 52 0.85 90 0.89 50 0.028 0.867 
  Negative 0.88 221 0.89 1050 0.89 1475   
WHODAS 3161 Positive 6.2 53 21.9 96 25.2 51 0.179 <0.0001 
  Negative 8.7 238 15.9 1128 25.6 1595   
Grip strength 2836 Positive 45.4 48 34.1 90 32.4 43 0.004 0.029 
  Negative 46.7 226 41.1 1024 35.7 1405   
Grip strength: grip strength is measured in mean maximum hand grip strength (kilograms). WHO Disability Assessment Schedule 
(WHODAS): the composite score -is scaled from 0 (no disability) to 100 (high disability). Note: weights were poststratified by 
province, sex and age-groups according to 2009 data from Statistics South Africa.  
WHR: waist to hip ratio 
aHIV comparison compares prevalence (Table 2a) or means (Table 2b) of people aged 50 and older who are HIV-positive and those 
who are HIV-negative. 
bAge comparison compares prevalence (Table 2a) or means (Table 2b) of HIV-positive individuals aged 18–49 and 50 and older. 
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Table 3. Associations between chronic conditions and HIV status, age and sex by 
logistic regression models among those aged 50 years and oldera. 
Condition N Variable Odds ratio 95% confidence 
intervals 
P value 
Hypertension 2869 HIV 1.27 0.78–2.07 0.346 
  Sex 1.28 0.98–1.68 0.070 
  Age 1.01 0.99–1.02 0.290 
Arthritis 2632 HIV 0.30 0.14–0.65 0.002 
  Sex 1.17 0.82–1.68 0.388 
  Age 1.00 0.99–1.02 0.583 
Stroke 2771 HIV 0.80 0.24–2.64 0.714 
  Sex 0.92 0.48–1.78 0.806 
  Age 1.02 0.99–1.04 0.157 
Angina 2613 HIV 1.29 0.57–2.92 0.537 
  Sex 2.09 1.28–3.44 0.004 
  Age 0.98 0.96–1.01 0.215 
Diabetes 2774 HIV 1.06 0.36–3.06 0.922 
  Sex 1.66 1.05–2.62 0.029 
  Age 1.01 0.99–1.03 0.307 
Asthma 2766 HIV 0.78 0.31–1.95 0.599 
  Sex 0.73 0.43–1.23 0.238 
  Age 1.00 0.98–1.03 0.833 
Depression 2766 HIV 1.47 0.65–3.29 0.354 
  Sex 1.02 0.55–1.87 0.963 
  Age 1.00 0.96–1.04 0.873 
aA model containing HIV status, age (continuous) and sex was run for each condition. 
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Table 4. Associations between various measures and HIV status, age and sex by linear 
regression models among those aged 50 years and oldera. 
Condition N Variable b (95% CI) t/F P value 
WHO 
disability 
assessment 
2869 HIV 
(positive) 
3.79 (0.35 
to 7.93) 
1.79 0.073 
 Sex (female) 5.00 (2.54–
7.45) 
3.99 <0.0001 
  Age 0.64 (0.52–
0.78) 
9.82 <0.0001 
BMI 2739 HIV 
(positive) 
3.86 (5.55 
to 2.17) 
4.48 <0.0001 
  Sex (female) 3.26 (2.11–
4.41) 
5.57 <0.0001 
  Age 0.11 (0.17 
to 0.05)
3.58 <0.001 
Waist-to-hip 
ratio 
2664 HIV 
(positive) 
0.02 (0.06 
to 0.02) 
1.08 0.282 
  Sex (female) 0.03 (0.05 
to 0.01)
2.47 0.013 
  Age 0.00 (0.00) 1.35 0.176 
Hand grip 
strength 
2561 HIV 
(positive) 
4.73 (8.70 
to 0.77)
2.34 0.019 
  Sex (female) 7.78 (9.38 
to 6.18)
6.50 <0.0001 
  Age 0.30 (0.43 
to 0.18)
4.75 <0.0001 
B: beta co-efficient 
t: t-test 
F: F-test 
CI: confidence interval 
aA model containing HIV status, age (continuous) and sex was run for each condition. 
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Chapter Five  
Supplementary Information 
 
 
 
 
The World Health Organization Study on Global Ageing and Adult 
Health (SAGE) Individual Questionnaire that was used as the basis for 
Chapter Five is available from:  
http://www.who.int/healthinfo/systems/GenericIndividualQ.pdf .  It is not 
reproduced here as the survey is 80 pages. 
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Summary of findings 
 
The research conducted for this thesis has provided new evidence for a neglected area 
of the global HIV response.  While the ageing of the HIV cohort in developed 
countries has been well documented – even if the targeted responses have been 
limited – the fact that many older adults are living with HIV in Africa has been 
largely ignored.  The chapters of this thesis provide information from a number of 
perspectives that contribute to the understanding of this emerging issue.  The chapters 
cover AIDS-related mortality, continent-wide epidemiological data, HIV-related 
knowledge, treatment outcomes and a study of national HIV prevalence among older 
adults and links to non-communicable diseases.   
 
In Chapter One, a community health worker–administered verbal autopsy system in a 
rural Kenyan village found that AIDS-related causes were the largest single cause of 
death among people aged 50 years and older.  For people aged 50-59 years, 34% of 
deaths were attributable to AIDS and, among those aged 60-69, 23% of deaths were 
due to AIDS.  These data confirm that HIV and AIDS are prevalent among older 
adults and that any suggestion that HIV is a disease of the young only is untrue. 
 
Following on from the reality of mortality from AIDS, the question of HIV 
prevalence among those aged 50 years and older was examined in Chapter Two using 
UNAIDS data.  UNAIDS does not report on prevalence in that age group: their 
regular reporting is only for those aged 15-49.  Chapter Two reveals that there are just 
under 3 million people living with HIV in sub-Saharan Africa aged 50 years and older 
as of 2007.  The prevalence of HIV infection in the older age group was 4.0%, 
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compared with 5.0% among those aged 15–49 years. Of the approximately 21 million 
people in sub-Saharan Africa aged ≥ 15 years that were HIV+, 14.3% were ≥ 50 years 
old.  The data suggest that in some high prevalence countries that have had HIV 
infection for over two decades, HIV prevalence among those aged 50 and older is 
actually higher than among younger age groups. 
 
In Chapter Three, an examination of HIV awareness, knowledge and testing across 
nine rural Millennium Village sites in Africa found that HIV-related knowledge 
among older adults was significantly lower than among adults aged 25-49.  Older 
women in particular had low levels of knowledge.  Older adults were also less likely 
to be tested for HIV.  The high prevalence rates and high mortality coupled with low 
levels of awareness and knowledge signify the difficulties faced by this group and the 
damage of the neglect shown to date towards older adults in the HIV response. 
 
The imperative to ensure that older adults are tested and commenced on anti-retroviral 
treatment (ART) at appropriate times is highlighted by the treatment outcome data 
from Zomba District in Malawi presented in Chapter Four.  Those aged 50-59 
survived while on treatment at similar rates as those aged 25-49 demonstrating that 
older adults respond well to treatment.  Those aged 60 years and older however were 
significantly more likely to die – which is not surprising due to higher rates of all-
cause mortality among older people. 
 
Even though the evidence presented here suggests that older adults generally do well 
on ART, there are some challenges that disproportionately affect older adults that 
have a direct bearing on the type of care and treatment they should receive.  The Fifth 
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Chapter reveals high rates of non-communicable diseases among HIV-positive older 
adults (as well as HIV-negative older adults) in South Africa.  The rates of co-
morbidities have considerable implications for questions of medications, adherence, 
social support and quality of life.  This highlights that efforts are needed to better 
understand the specific vulnerabilities and challenges faced by this group. 
 
The rest of this Conclusion Chapter will compare the findings presented in this thesis 
with other literature on the subject and, given that more on the topic of HIV among 
older adults in Africa has been published since the commencement of this thesis, the 
section will review the recently published literature.  Taking the accumulated 
knowledge from this thesis and the published literature, the conclusion will then pull 
together recommendations for improving HIV services specifically for older adults.  
Lastly, areas of future research will be outlined to further strengthen this emerging 
field of policy and practice.  
 
Comparison of findings with recently published literature 
 
Since commencement of the thesis, there has been a considerable increase in research 
evidence available on HIV among older adults in Africa.  In part, the published papers 
included in this thesis have galvanised the wider research community as evidenced by 
a considerable number of references to the published work.  A few of the published 
pieces have been advocacy articles [1-3] but most have provided substantive new 
evidence in the field. 
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One important change that has occurred since the commencement of this PhD has 
been that a some Demographic and Health Surveys (DHSs) conducted in sub-Saharan 
Africa have begun to include or expand HIV testing among those aged 50 and older.  
Whereas no DHSs previously surveyed women beyond the age of 49 years, national 
DHSs from countries such as Mozambique and Rwanda published in 2011 and 2012, 
do include older women as well as an expanded age range of older men.  More on the 
results of these surveys are provided below but the inclusion of these older adults in 
the surveys represents a significant expansion of how the research community views 
older adults and the importance of understanding their health status. 
 
Some of the work included in this thesis has, since publication, been validated by 
other studies conducted on related topics.  A study by Byass and colleagues tracking 
HIV-related mortality in South Africa found that adult mortality from AIDS had 
shifted to older ages as the epidemic progressed with a noticeable number of deaths in 
the over-65 year age group in recent years [4].  Similarly, Birnbaum and colleagues 
found high levels of misattribution of AIDS deaths in South Africa and their revised 
calculations found large increases in AIDS deaths among those aged 45-59 and 
60+[5].  A Zimbabwean study found an increase in mortality rates among those aged 
45 and older over time that the authors partially attributed to the ageing of the HIV 
epidemic[6].  These studies largely confirm the findings in Chapter One from rural 
Kenya of high levels of AIDS mortality among older adults [7]. 
 
Research from specific countries or treatment sites has also confirmed some of the 
data from the continent-wide epidemiologic study published in Chapter Two [8].  
Analysis of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) 
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Central Africa region cohort data revealed that 15% of those in treatment are aged 50 
years and older [9]– similar to the 14% found in Chapter Two.  A rural South African 
treatment site revealed that 10.4% of their cohort was aged 50 and older [10].  But 
both these studies are among those accessing treatment that might under-represent 
older people.  Other studies from South Africa [11] and Taiwan [12] found 
considerable numbers of people living with HIV among those aged 50 years and 
older. 
 
DHS reports from a number of sub-Saharan African countries also provide up to date 
data on HIV prevalence among older adults.  The Mozambique 2009 DHS in 
particular is notable for its inclusion of both men and women up to the age of 64.  
Women aged 50-64 had an HIV prevalence of 9.0% and men 8.0% compared to 
11.5% among those aged 15-49 [13].  The Malawi DHS 2010 found prevalence of 
13.1% among men aged 50-54 compared to 8.1% for men 15-49 [14] and the Lesotho 
2009 DHS also found higher rates of HIV among men aged 50-59 than those aged 15-
49 [15].  Chapter Two also noted higher HIV prevalence rates among those aged 50 
and older compared to those aged 15-49 signifying the ageing of the epidemic.  
Another study examined HIV prevalence among the elderly in a high prevalence rural 
site in KwaZulu-Natal, South Africa [16] demonstrating relatively high rates of HIV 
that concurs with that found in the analysis of South African prevalence found in this 
thesis. 
 
A recent study by Hontelez and colleagues took a longer-term view of the ageing 
trend highlighted in this thesis.  In it the authors modelled the impact of HIV over the 
next 30 years to 2040 in South Africa finding that HIV prevalence in people aged 50+ 
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will nearly double from 2010 to 2040 from 9% to 17% while the fraction of all HIV 
infected people who are aged 50 and older will go from 1 in 12 now to 1 in 4 [17].  
These projections reinforce the importance of understanding HIV among older adults 
as it will be central to the response over the coming years. 
 
Several studies have been published recently that assess treatment outcomes among 
older adults in sub-Saharan Africa.  These results can be compared to that of Chapter 
Four of this thesis using data from Zomba District in Malawi [18].  Mutevedzi and 
colleagues found 32% higher mortality among those aged 50 and older in their rural 
South African treatment site compared to those aged 25-49 [10].  They found that 
CD4 count reconstitution was lower among older adults but that virological response 
was stronger.  They did not consider those aged 50-59 separately so direct 
comparability to Chapter Four is difficult as excess mortality among older adults 
(especially beyond 60 years) is expected.  The South African study did confirm 
Chapter Four results that HIV-positive older adults are more likely to be male and do 
not present with more advanced disease than younger adults.  The higher percentage 
of males among HIV-positive older adults was confirmed by the IeDEA Central 
Africa cohort [9].   
 
The emerging African consensus is that older adults’ treatment outcomes are worse 
with regard to one year mortality on ART compared to younger age groups [19, 20] 
and is coupled with slower CD4 count recovery [10, 19, 21].  However, after the first 
year, outcomes among older adults are quite similar to those of younger age groups.  
This is perhaps due to higher levels of adherence as shown in the IeDEA Central 
Africa cohort [9] and lower levels of loss to follow-up [19]. 
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An important study recently released provides emerging evidence on the impact of 
ART services on the health of older adults in rural South Africa [22].  In the study, 
HIV-infected older adults actually have better health status than HIV-negative 
counterparts suggesting that the increased access to general healthcare provided by 
enrolment in ART programs is having a considerable impact on overall health status.  
This highlights the poor health access and status of older adults in parts of Africa.   
 
In the area of understanding older adults’ knowledge of HIV and sexual behaviour in 
general, not much new evidence has been forthcoming.  Peltzer and colleagues use 
data from the 2005 South African HIV prevalence and behavioural survey to describe 
sexual behaviour of older adults but little else has emerged [11].  The South African 
study found that of the people aged 50 and older, 41.1% had been sexually active in 
the past 12 months and 35.9% in the past month with men being significantly more 
sexually active than women. The study also found that 9.1% of men and 2.7% of 
women were still sexually active after the age of 70.  The authors found that HIV risk 
perception was low among older adults and that older age and being female were 
associated with risk behaviour. 
 
A forthcoming paper from Malawi [23] goes into substantial detail on the sexual 
activity of older adults using the Malawi Longitudinal Study of Families and Health.  
Levels of sexual activity among those aged 65+ remained considerable with 26.7% 
and 73.8% of women and men having had sex in the last year and men’s average 
number of sexual partners per year remained above one.  The study also found that 
HIV prevalence among men aged 50 years and older was higher than among men 
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aged 15-49, which matches the results found in the study presented in this thesis [8].  
A Zimbabwean ethnographic study found a number of elderly adults who had never 
used a condom in their lives and who felt alienated from current HIV programming 
[24]. 
 
The question of co-morbidities in Africa remains a significant gap in HIV knowledge 
not just for older adults though comorbidity will affect those aged 50 years and older 
more than other groups of people living with HIV.  Recent research in two sites in 
Uganda found that of HIV-positive people aged 50 years and older, 15% had 
depression and over 30% of both men and women had hypertension [25].  Overall, 
however, the study found that HIV infected older people had a similar health status as 
older people not living with HIV.  This represents an important finding that warrants 
further examination.  There have been suggestions – not yet confirmed by published 
evidence – that older adults living with HIV actually have better health status than 
their same-age HIV-negative counterparts due to higher levels of access to general 
health care (not just HIV-specific services) to help address their problems of ageing.  
In this context, due to high rates of poverty, isolation and stigma, being HIV-positive 
provides critical access to HIV and other services that are not available to those who 
are HIV-negative. 
 
Recommendations for Improving Services for Older Adults 
 
The increase in evidence regarding, and interest in, HIV among older adults in Africa 
demonstrates the beginnings of what is hoped to be an important shift in the global 
HIV response.  As the evidence accumulates, it is hoped that the larger global HIV 
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agencies including UNAIDS, WHO, the Global Fund for AIDS Tuberculosis and 
Malaria, and the U.S. President's Emergency Plan for AIDS Relief (PEPFAR) will 
start to include older adults in their policy documents and funding streams. 
 
In order to do so, however, more guidance will be needed on what approaches will be 
most effective to improve prevention, testing and treatment among older adults in 
Africa.  The lost opportunities to start providing this guidance – encapsulated by the 
failure of the aids2031 initiative to acknowledge the ageing of the epidemic [26] – 
must be overcome in a new era of planning for the long-term strength of the HIV 
response. 
 
One of the overarching and primary challenges to addressing HIV among older adults 
is ageist stigma not just in the African context but in the development industry more 
generally.  Studies conducted by WHO and HelpAge International in Africa reveal 
age discrimination in the health sector that includes denial of medication, neglect and 
negative attitudes [27].  Nhongo’s review cites cases where older people were turned 
away from care and told that they were not sick but were just old [27].  A Malawi 
newspaper article revealed that older adults were told that drugs should be saved for 
younger people [28].  As long as older adults remain neglected by development 
programs, they will remain the most vulnerable members of society and among the 
poorest of the poor. 
 
Focusing on treatment, at present there are no HIV treatment guidelines specifically 
for older adults in low and middle income settings.  In March 2012, for the first time, 
the United States Department of Health and Human Services’ Guidelines for the Use 
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of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents included specific 
content on “HIV and the Older Patient”[29].  Notably, the US guidelines recommend 
that patients aged 50 years and above are commenced on ART regardless of CD4 cell 
count “because the risk of non-AIDS related complications may increase and the 
immunologic response to ART may be reduced in older HIV-infected patients.”  
Additionally, the guidelines counsel that due to adverse events, the bone, kidney, 
metabolic, cardiovascular, and liver health of older HIV-infected adults should be 
monitored closely along with drug-drug interactions.  Such guidelines are needed for 
the African context as well especially given other health system challenges. 
 
In light of recent evidence of the positive impact of ART initiation at higher CD4 
counts [30], WHO has recommended putting pregnant women on treatment 
irrespective of CD4 count [31] and is exploring doing so for other vulnerable groups 
such as sex workers and men who have sex with men [32].  Given that advanced age 
has been associated with suboptimal CD4 restoration [33], perhaps the global 
community should consider adding older adults to the high priority category for early 
ART initiation.  Even if this is not deemed appropriate, there remains a strong 
imperative to test older adults early and initiate treatment before CD4 count has 
dropped significantly.  Similarly, older adults need to be actively included in 
emerging initiatives such as circumcision and pre-exposure prophylaxis among sero-
discordant couples [34]. 
 
Adherence is another challenge for older adults on treatment.  As rates of NCDs 
increase among older adults living with HIV, there is the potential for an increased 
daily pill burden and medication fatigue [35].  Coupled with cognitive impairment 
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linked to HIV infection [36], risks for suboptimal treatment outcomes are elevated.  
More adherence support targeted to older adults will be needed to address these 
specific challenges. 
 
A recently completed and submitted systematic review that I conducted (attached as 
an appendix), searched for published evidence on HIV interventions specifically 
targeted to older adults.  Despite the many urgent calls for prevention messaging and 
specific HIV programs targeted to older people [37-40] rather than simply the 
application of strategies designed for younger people [41], only 12 relevant articles 
were identified that actually presented results of such interventions.  None of the 12 
were from developing countries and the vast majority were American studies.  Orel 
and colleagues stated in 2005 that “more effective HIV/AIDS prevention educational 
materials for older adults need to be developed, and their effectiveness in reducing 
HIV infection must be explored”[42] yet the available evidence is paltry.  Authors of 
some of the studies identified needs for specific research projects conducted among 
older adults with regard to HIV prevention [43], testing, adherence [44] and other 
social and behavioural areas [45].  There are many hypotheses of what would help 
adherence or the effectiveness of prevention education among older adults including 
nutrition, mental stimulation, physical activity and better training among physicians 
[46] but proof of these approaches has not been compiled and provided to the affected 
community.  
 
The studies that did emerge in the systematic review highlighted a few areas of 
possible action in developing prevention and adherence interventions specifically for 
older adults.  
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Rose demonstrated that delivery of an age-specific AIDS education program was 
effective in improving HIV knowledge and perceptions of susceptibility among older 
Americans [47].  One of the most successful of the few interventions specifically 
targeting older adults was group educational sessions developed to reduce high-risk 
sexual behaviours run by a project called ROADMAP (Reeducating Older Adult in 
Maintaining AIDS Prevention)[48].  After sessions that included practicing condom 
use skills and role playing condom negotiation, participants in the intervention group 
decreased unprotected sexual acts compared with the control group. 
 
Heckman and colleagues report that group sessions with trained facilitators that 
include a focus on coping mechanisms and how to deal with stress are effective in 
reducing depressive symptoms in HIV-positive older adults [49].  Two studies used 
telephone-based interventions to reduce risky sexual behaviour [50, 51].   
 
Weekly resistance exercise training sessions trialled in Sao Paulo, Brazil, among 
HIV-positive older adults, produced increased strength and functional gains superior 
to those seen in age-matched HIV- controls [52, 53]. 
 
All twelve of the studies however were from the Americas with none focused on 
Africa.  Therefore, the critical question of the applicability of the lessons learned from 
the Americas to the African context remains.  African studies have called for more 
research on prevention evidence for older adults but, as yet, no studies exist [54, 55].  
Some of the interventions identified in the systematic review were delivered in old-
age homes – a delivery channel less available in the African context.  And two studies 
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used telephones to deliver messages: an intervention that might have applicability in 
sub-Saharan Africa due to the increasing ubiquity of mobile phones. 
 
From various studies, however, some lessons emerge on appropriate interventions that 
are relevant for Africa.  In many African countries, older adults are regarded as 
custodians of culture and societal memories and are therefore afforded social status 
[56].  This element needs to be built into prevention messaging and testing promotion 
efforts to portray HIV as a threat that requires a response from the senior members of 
the community.  A sense of duty as community leaders and elders might be an 
appropriate avenue for prevention messaging.  This would potentially have impacts 
not just among older adults but, in their role as grandparents and care-givers, among 
the younger generation as well [54].  
 
Using older adults as peer educators has been proposed in developed countries [56] 
and would be very applicable to African settings as well.  It is likely that older adults 
would be less likely to visit voluntary counselling and testing centres if the 
counsellors were in their early 20s than if some of the counsellors shared their 
characteristics in terms of age.  Training a small number of older counsellors and 
making it clear to the community which days of the week they would be working 
would be a possibly low-cost and simple way to increase HIV testing among older 
adults.  Anecdotal evidence from Dr Janet Seeley in Uganda noted that this had been 
trialled in one site in Uganda in 2010 and had led to increased uptake of testing by 
older adults. 
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Furthermore, older adults in Africa are predominantly found in rural areas which 
generally have lower levels of information access [56].  More concerted efforts to 
reach people in rural areas and to use messaging designed for those with limited 
literacy skills will be required.  Due to specific stigma associated with HIV and older 
adults, it might perhaps be more appropriate to label the information sessions as 
general health forums rather than as HIV-specific sessions.  This might lead to higher 
attendance and will open to doors to wider discussions of sexual health.  
 
Success is possible in reaching older adults.  The South African national HIV survey 
of 2008 found a considerable increase in condom use among men aged 50 and older 
[57].  In 2005, only 8.6% of men aged 50 and older used a condom during last sex 
but, by 2008, 39.9% had used a condom.  Such progress is likely to have been at least 
partially a result of the increased reach of HIV communication among over 50s where 
62.2% had been reached by HIV messages in 2008 compared to 47.2% in 2005 [57].  
 
Other research I conducted during the course of the PhD on the health of older adults 
in rural Africa (attached in the appendix) revealed that alcohol consumption among 
women aged 50 and older (45.0%) was more common (P=0.005) than among women 
under 50 (27.6%) across three rural sites in Malawi, Tanzania and Rwanda [58].  
Given these high rates of alcohol consumption and even higher rates among older 
men and the links between alcohol and risky sexual behaviour [59], there might be 
scope for alcohol-related interventions to curb HIV transmission among people aged 
50 and older.  
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Another important avenue to explore is educating health workers.  Due to presumed 
ageist stigma on the part of nurses, doctors and community health workers, informing 
those groups on the levels of HIV prevalence among older adults might lead to more 
appropriate diagnoses and faster transitions onto treatment for those in need.  This 
intervention has been called for in developed countries [60, 61] and is equally 
applicable in African settings. 
 
Fundamentally, there is an erroneous ageist assumption that older people are not able 
to make behaviour change changes [62] and so few people have even tried.  Given the 
trends outlined in this thesis, it is imperative that efforts be undertaken to support 
prevention, testing and adherence among those aged 50 and older in sub-Saharan 
Africa. 
 
Integration has been a key term used in discussions about the future of the HIV 
response.  While most of the focus has been on integration with reproductive health 
services or tuberculosis care, the integration challenge in the future with more people 
on ART will be with non-communicable disease (NCD) services [63].  Maher and 
colleagues have called for “integrated management of chronic NCDs with that of 
chronic communicable diseases”[64, 65].  This re-characterisation of HIV as a 
chronic disease fits well with Setel et al’s model of classifying diseases as acute 
versus chronic emphasising the response model rather than the transmission model. 
Setel et al asserted that in low-income countries, the “majority of the population 
clearly need a health system that can provide long-term care and management” [66].  
Maher and colleagues proposed “multidisciplinary chronic disease clinics” that could 
treat HIV, tuberculosis and NCDs in an integrated manner with the added feature of 
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reducing the stigma associated with visiting HIV clinics for care [64].  Such a model 
has been piloted in Cambodia across HIV, diabetes and hypertension with initial 
positive results and synergies being realised [67].  This is a clear area of need with 
regard to health systems research to establish the feasibility and cost-effectiveness of 
such an integrated approach [65]. 
 
The main features of such an integrated response to HIV and NCDs that would serve 
older adults living with HIV (as well as others on long-term ART) would include: 
screening for multiple conditions at health centre level; treatment initiation and 
continuation at health centre level; ongoing procurement of necessary medication and 
testing components; lab testing transportation to nearest testing facility; referral 
mechanism to district hospital; community adherence support; health information 
systems; and policy stewardship. The health system response model needed for each 
of these areas would be essentially identical between HIV and NCDs making 
integration not just feasible but necessary. 
 
The big advantage of integration in the African context is that billions of dollars have 
been invested in a strong chronic disease diagnosis, care and treatment model through 
the HIV response.  Adapting such a response to include non-HIV NCDs is not a case 
of starting from scratch but rather building on existing systems [68-70].  Rabkin and 
el Sadr correctly asked “why reinvent the wheel”[71]?  The challenge comes down to 
developing a strong health system that can provide both acute episodic care as well as 
longer-term chronic care to populations in developing countries. 
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The United Nations High-level Summit on Non-communicable Diseases, held in 
September 2011, might herald a new era of funding and attention to addressing NCDs 
in developing countries.  If so, the development community should not repeat the 
mistakes of the HIV scale-up which emphasised vertical programs but should rather 
emphasise integration and strengthening of systems.  Such an approach would provide 
for better quality of care not only for older adults but for all who access healthcare.  
Integrated HIV and NCDs services would likely be a cost-effective and appropriate 
health system intervention for older adults in Africa. 
 
Areas of Future Research 
 
Over the past thirty years, the response to the HIV epidemic has changed often and 
dramatically.  The response to HIV has swung from a focus on prevention, to an 
almost complete emphasis on treatment, to the current treatment-as-prevention 
paradigm [72].  Specific high-risk groups have been the focus for some elements of 
the global response and UNAIDS is currently seeking to eliminate mother-to-child 
transmission. 
 
As the epidemic moves into its fourth decade, one of the emerging trends will be the 
ageing of HIV patients in developed and developing countries.  As has occurred with 
programs that centred on men who have sex with men or injecting drug users or 
children, the global HIV community has explored and learned what works and what 
does not.  The coming years will see those interested in HIV and ageing go through 
the same process of exploration and learning. 
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These areas of future research are particularly relevant for sub-Saharan Africa due to 
the high number of people living with HIV but will also likely be pertinent for other 
developing regions of the world that experience similarities with regard to health 
systems and poverty.  Developing Asia and the Caribbean, which both have countries 
with relatively high HIV prevalence rates and increasing ART coverage, will also host 
an ageing HIV cohort and will therefore benefit from increased research and 
information gathering in this area. 
 
One of the first components that will be needed over the coming years is improved 
data collection.  Those aged 50 years and older must be included in routine HIV 
surveillance including Demographic and Health Surveys and national HIV surveys.  If 
HIV prevalence goes down amongst those aged 15-49, many will assume victory 
unless the prevalence among older adults is known as millions of older adults will 
remain infected and affected.  The annual UNAIDS epidemic update must begin to 
include these data routinely.  From personal communication, there have been some 
initial suggestions that UNAIDS is considering doing so. 
 
Of course, making such data available is not only about obtaining a picture of 
accurate prevalence but the inclusion of older adults in such surveys and reports will 
signify to the wider HIV community including national AIDS agencies, physicians 
and policymakers that older adults are part of their remit and that they will be judged 
on how they address the challenges of HIV among them.  
 
As noted above, one of the primary research needs in this area is to track the efficacy 
of various HIV-related interventions specifically targeted to older adults.  Whether 
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this is done through training peer educators and counsellors or educating health 
workers or implementing prevention messaging appropriate for older adults, these 
will need to be evaluated in rigorous studies to deepen the evidence base for the 
global community to use.  Using control groups (ideally in randomised trials) would 
be most appropriate for most of these studies as the HIV response is dynamic and 
ever-changing and thus, without controls, effects of programs would be hard to 
isolate. 
 
An additional requirement will be operational research to examine the implementation 
of integration of care [73-75].  The growing emphasis on developing a coherent model 
of chronic care delivery systems requires research into the ‘how’ of integration, the 
cost-effectiveness, the training implications and the impacts of such an approach on 
patient care, health worker satisfaction, health worker burden and ultimately on health 
outcomes.  With possible additional funding emerging as a consequence of the High 
Level Meeting on Non-Communicable Diseases held in September 2011, such 
operational research might become better funded and the opportunities to explore 
integration with HIV services – especially in Africa – cannot be missed. 
 
There remain considerable gaps in the knowledge base regarding the interactions and 
associations between various non-communicable diseases, HIV infection and ART 
both among older people and in the wider population.  The research included in this 
thesis represents one of the only studies that examines these linkages.  Datasets that 
include information on HIV status, ART status and are able to report on various 
NCDs not only relying on self-reported symptoms would be very valuable in this 
regard.  Some of the higher rates of NCDs seen among HIV-positive people in 
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developed countries are thought to be due to ART and therefore that information is 
required to develop a robust understanding of the associations between treatment and 
onset of some NCDs. 
 
As a result of the suspected higher rates of various NCDs among HIV-positive people 
– especially older adults, there might be scope for investigation into the feasibility and 
appropriateness of a polypill that would include antiretroviral medication along with 
treatments for cardiovascular or other chronic conditions.  Such possibilities will 
likely be discussed in greater detail once such epidemiologic associations are better 
understood. 
 
Other areas of HIV and ageing in Africa that require further investigation are the 
sexual activity of older adults including condom access and use, intergenerational 
relationships, widowhood, and practices such as wife inheritance whereby a widow 
marries a kinsman of her late husband to ensure ongoing social support.  Qualitative 
and quantitative research is needed to examine these issues more deeply and will be 
critical to developing appropriate programming relevant to older people.   
 
The road forward in the area of HIV and older adults in Africa is one full of 
possibility and potential for additional learning.  This thesis serves as one of the 
bricks in the foundation of this emerging research and practice area.  The research 
presented here has relevance throughout Africa and into other developing regions of 
the world. 
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Summary objective To expand the evidence base on the prevalence of non-communicable disease (NCD) risk
factors in rural Africa, in particular among older adults aged 50 and older.
methods Cross-sectional study in three rural sites in Malawi, Rwanda and Tanzania. One person was
interviewed from each of 665 households selected through a stratified random sampling procedure
across the three sites. The questionnaire included socio-demographic characteristics, smoking and
alcohol intake as well as a food frequency questionnaire.
results Smoking rates among older men and women were higher than among adults under 50. While
only 2.3% of women under 50 were current smokers, 21.0% of older women smoked (P < 0.0001).
Among men, 19.0% of men under 50 smoked versus 36.6% of older men (P = 0.001). Alcohol con-
sumption among older women aged 50 and older (45.0%) was more common (P = 0.005) than among
women under 50 (27.6%). Examining a set of five risk factors, more men aged 50 and older (49.5%) had
two or more risk factors than men under 50 (25.5%) (P < 0.0001). Similarly, 52.0% of women aged 50
and older had two or more risk factors, versus 24.1% of women under 50 (P < 0.0001).
conclusion Contrary to what is seen in developed country settings, this study reveals high rates of
smoking and alcohol consumption among men and women aged 50 years and older in rural Africa that
puts them at risk of NCDs. The health of older adults in rural Africa has been neglected, and these
findings highlight the importance of reaching out to older adults with messaging regarding diet, smoking,
alcohol use and general health.
keywords Africa, alcohol, non-communicable disease, risk factors, smoking
Introduction
The health of older people in sub-Saharan Africa (SSA) has
largely been neglected (Cohen &Menken 2006; Ferreira &
Kowal 2006; Kimokoti & Hamer 2008). This is despite the
fact that the percentage growth in the number of those
aged 50 and over in SSA from 2005 to 2030 will be the
highest of any region of the world with an expected
increase of 108% (76–157 million) (United Nations 2009).
Part of this neglect is because of the major global emphasis
given to addressing pressing priorities among the young
including undernutrition and preventable child deaths, the
recent focus on maternal mortality, and the scale-up of
interventions to address HIV and AIDS. There are major
gaps in data on the health of Africa’s elderly (Zimmer &
Dayton 2005). For example, Demographic and Health
Surveys do not include female participants over the age of
49 and often only include men up to age 54 or 59 (Negin &
Cumming 2010).
There has been increasing recognition of the burden of
non-communicable diseases (NCDs) in SSA which dispro-
portionately affect people over 50 (Kengne & Anderson
2006; Holmes et al. 2010; Mbanya et al. 2010). Globally,
more than 70% of cardiovascular mortality, 40% of
chronic respiratory disease deaths, 34% of cancer mortal-
ity and about 50% of all chronic disease deaths are
attributable to a small number of known modifiable risk
factors (Ezzati et al. 2003).
Data on the prevalence of some NCD risk factors –
including tobacco use, alcohol consumption, overweight,
low fruit ⁄ vegetable intake, and physical inactivity – are
lacking for some parts of SSA despite the availability of
some World Health Organization’s STEPwise approach to
surveillance (STEPS) surveys (World Health Organization
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2010a). In particular, the NCD evidence from rural parts
of sub-Saharan Africa is limited with more detailed
research, including some STEPS surveys, having been
conducted only in urban areas (Bovet et al. 2002; Ministry
of Health [Zambia] and World Health Organization 2008;
Tesfaye et al. 2008; Njelekela et al. 2009). The risk factor
evidence for many countries is lacking. Surprisingly, some
of the chronic disease risk factor research that has been
conducted in SSA has focused on adolescents rather than
those at higher risk of NCDs (Kitange et al. 1993; Muula
et al. 2008).
The aim of this paper is to expand the evidence base on
the prevalence of NCD risk factors in rural SSA, in
particular among older adults aged 50 and over. The
objective is to examine NCD risk factors by drawing from
cross-sectional data collected from rural sites in three
African countries.
Methods
This cross-sectional study was conducted in three Mil-
lennium Villages Project (MVP) sites in East Africa. The
MVP is a multi-sectoral health and development initiative
launched in 2004 that aims to demonstrate that
achievement of Millennium Development Goals in rural
Africa is possible through community-based, coordinated
delivery of science-based interventions at the village level
in agriculture, health, education and infrastructure
(Sanchez et al. 2007). The project is implemented in 14
rural sites in ten sub-Saharan African countries and
operated under a strict costing model consistent with the
internationally accepted target of 0.7% of rich world’s
gross national income. This study was conducted in the
project’s sites in Malawi (Mwandama), Rwanda (May-
ange) and Tanzania (Mbola) from January to March
2007.
The detailed methods employed in this sub-study have
been described elsewhere in a study on the prevalence of
hypertension and its correlates in the study population (de
Ramirez et al. 2010). Briefly, three hundred households
were selected in each project site using a stratified random
sampling procedure taking into account household income
and gender of the head of household to ensure accurate
representation of the larger village population. Of 2091
eligible adults aged 18 and older, 1485 (71%), representing
665 households, were available at home when the enu-
merators arrived and completed the survey. Enumerators
visited homes three times before removing the individual
from the survey list. One adult from each household was
selected to respond to a food frequency questionnaire
including dietary and alcohol intake that is reported in this
paper. Those who completed the food questionnaire were
similar to those who did not in terms of sex, age and type
of dwelling. Informed consent was obtained from each
study participant, and ethical approval was obtained from
Malawi’s National Health Sciences Research Committee,
the Institut National de la Statistique du Rwanda, Tanza-
nia’s National Institute for Medical Research and the
institutional review board of Columbia University, New
York, USA.
Data on socio-demographic characteristics and smoking
habits were collected using standardized questionnaires.
Physical activity was measured using the World Health
Organization’s Global Physical Activity Questionnaire
(World Health Organization 2006). Health professionals
with additional training measured height and weight for
body mass index calculations.
Statistical analysis was conducted using SPSS 17.0
(Chicago, IL, USA) and SAS 9.2 (Cary, NC, USA).
Continuous variables such as alcohol, fat, dairy and meat
consumption that were heavily skewed were re-categorized
as ‘no consumption’ for those who did not consume any
and ‘consumption’ for those that did. Heterogeneity across
study sites was assessed using the Breslow-Day tests for
categorical variables and using regression procedures for
continuous variables. A P-value of 0.05 was used to
indicate statistical significance.
Results
Of the 654 respondents for whom age was recorded, 193
(29.5%) were aged 50 years and older with the oldest
respondent being 97 years of age. In total, 361 respondents
were women (55.2%) including 100 (51.8%) of those aged
50 years and older (Table 1). Respondents in the
Mwandama, Malawi site comprised 286 (43.7%) of the
total study sample, with 194 (29.7%) coming from the
Mbola, Tanzania site and 174 (26.6%) from the Mayange,
Rwanda community. Of those aged 50 years and older, 72
(37.3%) were from the Malawian village, 65 (33.7%) from
the Rwandan village and 56 (29.0%) from the Tanzanian
community.
Using the Breslow-Day test and logistic regression
models, there was no strong evidence of heterogeneity
(P < 0.05) across the three countries for differences in risk
factors between those aged 50 and older and those aged
under 50 thus suggesting appropriateness of pooling the
data across the three sites. Doing so, alcohol consumption
among older women (45.0%) was significantly (P = 0.005)
more common than among women under 50 (27.6%).
Drinking of alcohol among men aged 50 and older
(36.6%) was higher than among men under 50 (27.0%);
though, this difference was not statistically significant
(P = 0.25) (Table 2).
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Smoking rates among older men and women were higher
than among adults under 50. While only 2.3% of women
under 50 were current smokers, 21.0% of older women
smoked (P < 0.0001). Among men, 19.0% of men under
50 smoked compared to 36.6% of older men (P = 0.001)
(Table 2).
Men aged 50 and older were less physically active than
men under 50 (P = 0.039) but there was no difference in
physical activity between older and younger women
(Table 2). Hypertension rates were significantly higher in
older men than men under 50 and in older than younger
women, as reported in more detail elsewhere (de Ramirez
et al. 2010). There were no statistically significant differ-
ences in the prevalence of overweight (BMI ‡25) between
younger men and older men and between younger women
and older women (Table 2). The prevalence of overweight
in women aged 50 and older (14.9%) was almost double
that among men aged 50 and older (7.7%) (P = 0.123).
This was particularly pronounced in the Malawi and
Tanzanian sites.
Examining these five risk factors further, those aged 50
and above were more likely to have multiple risk factors
than those aged under 50. Of the men aged 50 and older,
49.5% had two or more risk factors compared to 25.5% of
men under 50 (P < 0.0001). Similarly, 52.0% of women
aged 50 and older had two or more risk factors compared
to 24.1% of women under 50 (P < 0.0001). One-quarter
of women aged 50 and older had three or more risk factors.
Further breakdown of age groups into 10-year bands
revealed additional insights (Figures 1 and 2).While alcohol
consumption among men peaked at the age of 50–59,
drinking among women increased with age, with the highest
prevalence of alcohol drinking (50%) being among women
aged 70 years and older. The highest prevalences of smoking
were seen among men aged 70 years and older (41.4%) and
amongwomen aged 60–69 years (24.2%). BMI amongmen
gradually decreasedwith age;men aged 70 and older had the
lowest mean BMI of any age group (18.87).
Analysis of data from the food frequency questionnaire
(Table 3) showed that a large number of respondents did
not consume any dairy (73% of women over 50) and quite
a few (up to 43% of women over 50) did not consume any
meat. Consumption of meat was lower among older adults,
both men and women, than among adults under 50
(P = 0.0014 for women and P = 0.0305 for men). Addi-
tionally, women aged 50 and over consumed fewer fruits
Table 2 Distribution of NCD risk factors by age and gender
Female Male
<50 ‡50 P-value <50 ‡50 P-value
N 261 100 200 93
Alcohol intake No alcohol consumption 189 (72.4) 55 (55.0) 0.005 146 (73.0) 59 (63.4) 0.25
One or fewer drinks per day 65 (24.9) 39 (39.0) 48 (24.0) 30 (32.3)
More than one drink per day 7 (2.7) 6 (6.0) 6 (3.0) 4 (4.3)
Smoking Yes, current smoker 6 (2.3) 21 (21.0) <0.0001 38 (19.0) 34 (36.6) 0.001
Vigorous physical activity Yes 164 (62.8) 61 (61.0) 0.72 144 (72.0) 50 (64.5) 0.04
Hypertension Yes 28 (10.7) 41 (41.0) <0.0001 29 (14.5) 34 (36.6) <0.0001
Overweight N 248 94 189 91
Yes 30 (12.1) 14 (14.9) 0.49 14 (7.4) 7 (7.7) 0.93
NCD, non-communicable disease.
Table 1 Study population characteristics
Age
17–29 30–39 40–49 50–59 60–69 70+ Total
Mwandama, Malawi Female 61 42 20 17 14 10 164
Male 32 38 21 12 11 8 122
Mayange, Rwanda Female 34 20 23 17 14 11 119
Male 21 6 5 7 5 11 55
Mbola, Tanzania Female 31 18 12 7 5 5 78
Male 32 30 15 17 12 10 116
Total 211 154 96 77 61 55 654
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and vegetables than women under 50 and fewer than men
of any age. Dairy consumption among older adults was
also lower than among younger adults. These differences in
dietary intake were not statistically significant.
The only evidence of cross-site difference (heterogeneity
of P < 0.05) was for vigorous physical activity among men
(P for heterogeneity = 0.08). Whereas older men in
Malawi were less physically active than those aged under
50, older men in Rwanda were considerably more active
than men under 50 and there was almost no difference in
Tanzania.
Discussion
The study reveals that men and women aged 50 years and
older in rural Africa engage in a number of behaviours that
put them at high risk of NCDs. While it is well known that
hypertension rates generally increase with age, smoking
rates and alcohol consumption among older adults were
significantly higher than among those aged under 50
contrary to the pattern seen in a number of developed
countries (Scollo & Winstanley 2008; Robinson & Bugler
2010; United States Department of Health and Human
Services 2010). More than half of those aged 50 and older
had two or more NCD risk factors, suggesting that there is
need for urgent action to address NCDs.
While no STEPS surveys have been conducted for
Rwanda and Tanzania, the 2009 Malawi STEPS Survey
provides some similar data to that presented here (Ministry
of Health [Malawi] and World Health Organization
2010). The STEPS survey revealed that more men and
women aged 55–64 smoked than younger age brackets,
confirming the data found in our study. The rates of
smoking among Malawian women aged 50 and older in
our study were considerably higher than the national
figures found in the STEPS survey – some of which might
be accounted for by the higher rates of smoking in rural
compared to urban areas found in the STEPS report. The
Malawi STEPS study confirmed that current drinking was
more frequent among older than younger women. Rates of
overweight in the Malawian respondents in our study were
lower than in the national STEPS data but this can likely be
explained by the lower rates of overweight in rural areas
confirmed by STEPS.
African studies in younger age groups generally confirm
the findings presented in this paper. The large disparity in
smoking rates between men and women has been found in
Table 3 Food consumption by age and gender
Female Male
<50 ‡50 P-value <50 ‡50 P-value
N 261 100 200 93
Fruit and vegetables Median daily intake, number of times consumed 11.65 10.49 0.10 11.32 11.66 0.66
Fat consumption Yes – percentage who consumed fat that day 88.0% 87.1% 0.44 80.5% 84.0% 0.83
Dairy consumption Yes – percentage who consumed diary that day 35.2% 27.0% 0.14 45.0% 37.6% 0.24
Meat consumption Yes – percentage who consumed meat that day 74.3% 57.0% 0.001 83.0% 72.0% 0.03
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Figure 1 Percentage of respondents who are current smokers by
gender and age band.
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Figure 2 Percentage of respondents who consume alcohol by
gender and age band.
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various studies including Demographic and Health Surveys
(DHS). The Tanzania DHS of 2004–05 shows that 0.5% of
rural women and 22% of rural men aged 15–49 currently
smoke cigarettes (National Bureau of Statistics [Tanzania]
and ORC Macro 2005), which matches quite closely to the
data presented here from Mbola. Rwanda’s 2005 DHS
revealed that while only 3% of women 20–34 smoked,
11% of those 35–49 did (Institut National de la Statistique
du Rwanda and ORCMacro 2006). Smoking in Rwanda is
also more common in rural areas. The 2000 Malawi DHS
showed that only 2% of women aged 15–49 smoked
compared to 25% of men aged 15–54 (National Statistical
Office [Malawi] and ORC Macro 2001).
The percentage of current alcohol drinkers in our study
was at the high end of that seen in a recent cross-Africa
study among those aged 18 and older in 20 countries
(Clausen et al. 2009). In that study, those who had had a
drink in the previous week did not exceed 33% in any
country with abstention rates as high as 80% for women.
Contrary to our findings, some African studies have found
that younger women are more likely to drink than older
women (Mamman et al. 2002).
Our study found lower rates of obesity than in studies
with data from urban areas. A Tanzania study found
obesity rates of 13% in men and 35% in women in urban
areas with correspondingly high rates of NCDs (Njelekela
et al. 2009). In another urban Tanzania study, levels of
BMI increased up to the age of 45–54 years and dropped
slightly thereafter in both men and women (Bovet et al.
2002). Another study also found low rates of obesity in
rural areas of Tanzania but higher rates in women than
men (Njelekela et al. 2001).
The majority of work conducted on NCD risk factors in
Africa has not been conducted among older people. Across
SSA, the health of older adults has by and large been
neglected. At the same time, NCDs have not received
sufficient attention by the global community. Older adults
in SSA, who are more likely to have higher rates of NCDs,
play a significant role as productive labour, as carers and as
community leaders and therefore need to be included in
health interventions.
The findings reported here highlight the importance of
reaching out to older adults with messaging regarding diet,
smoking, alcohol use and general health. The higher rates
of smoking and alcohol use revealed in these sites have
important implications for the health of older people.
Beyond putting older Africans at higher risk of NCDs,
alcohol consumption is also associated with HIV trans-
mission (Fritz et al. 2010), tuberculosis (Rehm et al. 2009)
and intimate partner violence (Ntaganira et al. 2009).
Prevention of NCDs as well as treatment needs to be
integrated into rural primary care (Maher et al. 2009,
2010a). Rather than developing vertical NCD programs,
policymakers and governments should focus on developing
chronic care delivery systems that can leverage the invest-
ment in management of chronic HIV and tuberculosis
(Setel et al. 2004; Janssens et al. 2007; Bischoff et al.
2009).
This paper fills a gap in the data by focusing on NCD
risk factors in remote, impoverished communities in SSA
including in two countries where STEPS surveys have not
been conducted. The survey covers multiple risk factors
and uses validated tools across countries. Despite this, the
measures of dietary intake using the food frequency
questionnaire are likely to be crude and might misrepresent
true consumption. Recent studies have suggested that the
internationally established BMI cut-offs for overweight and
obesity may not be appropriate indicators of NCD risk in
some African populations with waist circumference per-
haps being a more sensitive measure (Steyn et al. 2005;
Maher et al. 2010b).
More information on NCDs and risk factors will
increasingly become available as STEPS surveys are com-
pleted but STEPS generally only interview individuals aged
up to 64 years of age. More recently, WHO studies on
global ageing and adult health (SAGE) have been con-
ducted in countries including Ghana and South Africa and
will provide robust data on the health of older people
including on NCD risk factors (World Health Organiza-
tion 2010b). The United Nations General Assembly has
agreed to hold a special session on NCDs in September
2011, marking global recognition of the emerging health
crisis. It is important that the meeting does not ignore older
people in developing countries. In advance of that meeting
and the global action that must ensue, it is hoped that the
findings of this study will help put NCDs in older adults in
SSA in greater focus and help contribute to the required
development of appropriate health planning and imple-
mentation strategies (Beaglehole et al. 2007).
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Abstract  
 
The increasing number of people living with HIV aged 50 years and older has been 
recognised around the world yet non-pharmacologic HIV behavioural interventions 
specifically targeted to older adults are limited.  We conducted a systematic review of the 
available literature.  The majority of articles identify and describe behaviours of older 
adults rather than evaluate an intervention.  Twelve articles were identified of which all 
originated from the Americas.  Eight of the interventions were conducted among older 
adults living with HIV and four for HIV-negative older adults.  Five studies included 
control groups.  Of the included studies, four focused on general knowledge of HIV, 
three emphasised mental health and coping, two on sexual behaviour, two on physical 
status and one on testing/screening.  More evidence is needed on what interventions work 
among older adults to support prevention, adherence and testing. 
 
 
 
Key words: older adults, HIV, interventions, systematic review, effectiveness 
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Introduction 
 
HIV prevalence among those aged 50 years of age and older has been rising over the past 
few years.  In the US, in 2005, 25% of those infected with HIV were older than 50 years 
of age [1] and recent estimates have noted that around 50% of people living with HIV 
will be older than 50 by 2015 [2].  The number of adults aged 50 years and older living 
with HIV in the US grew by 14% a year between 2004 and 2007 [3].  The increase has 
been seen partly due to widespread treatment access [3]. Articles have highlighted the 
HIV and ageing phenomenon in New York [4], London [5], Italy [6] and Australia [7]. 
 
The increasing trend of ageing is not only the results of longer survival due to treatment; 
older adults accounted for 15% of new cases of HIV in the US in 2005 [8].  Western 
European data reveals that 12.9% of newly reported cases of HIV infection in 2007 were 
among peopled aged 50 and older compared to 10.4% in 2003 [9].  The percentage of 
older adults among new infections in Eastern Europe has doubled over the same time 
frame [9] and the ageing trend has been increasingly recognised in sub-Saharan Africa as 
well [10-12]. 
 
The term “older adults” is used to describe those aged 50 years and older.  It is 
acknowledged that in many countries, people in this age group would not be considered 
old or elderly.  In Australia for example, most studies on the elderly focus on those aged 
65 years and above or even 70 [13].  The reason the 50 years cut off point is used here is 
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because the majority of HIV surveillance and reporting over the first two decades of the 
HIV response has only covered those aged 15-49 [14-16].   
 
Older adults are engaged in high risk behaviour with Stall and Catania noting that older 
adults were one-sixth as likely to use condoms during sex and one-fifth as likely to have 
been tested for HIV compared to a control group of at-risk people in their 20s [17].  
Testing rates among older adults are also lower: fewer than 15% of Americans aged over 
45 years have been tested for HIV compared to 44% of all adults [18].  Older adults – 
particularly older women – are at greater physiological risk for HIV transmission [19, 
20].  Those aged 50 and older might also enter into new relationships in which 
unprotected sex is more likely given the absence of pregnancy concerns [19]. 
 
When examined, HIV knowledge amongst older adults has been variable; while some 
exhibit adequate knowledge many do not considers themselves to be at risk as HIV is 
considered an illness of younger people [21].  Surveys of HIV positive older women have 
suggested that insufficient HIV prevention information contributes to risk taking 
behaviours [22].  Because of this, there have been many urgent calls for prevention 
messaging and specific HIV programs targeted to older people [19, 23-26] rather than 
simply the application of strategies designed for younger people [27].  This call has 
extended beyond developed countries to a number of countries in Africa [28, 29]. 
 
Strengthening the argument for research focussed on HIV positive older adults are the 
specific problems faced by this cohort [30].  Older HIV positive adults face the additional 
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burden of physical and psychological comorbidities [31] and accelerated senescence [32]. 
Concurrently, HIV positive older adults experience the double stigma of illness and 
ageism while having fewer support mechanisms from family, friends and community 
[33]. 
 
Given this situation, a number of academics have lamented the paucity of specific studies 
conducted among older adults with regard to HIV prevention [34], testing, adherence [35] 
and other social and behavioural areas [36] for older adults with HIV.  There are 
hypotheses of what would help adherence or the effectiveness of prevention education 
among older adults including nutrition, mental stimulation, physical activity and better 
training among physicians [37] but evidence regarding these approaches is patchy and 
few translated into programmatic use. Orel and colleagues [38] found that in 2004, 15 US 
States had HIV-related publications that were specifically targeted to older adults yet 
limited evidence is available on their impact on raising awareness and preventing new 
infections. 
 
The literature provides reviews of the available evidence on HIV behavioural 
interventions targeted to a range of other affected groups including sex workers [39, 40], 
children [41], men who have sex with men [42], drug users [43] and in occupational 
settings [44].  Yet no compilation of evidence exists for older adults despite the 
recognised trend of an ageing HIV cohort globally.  This paper systematically reviews the 
available published evidence on non-pharmacologic HIV behavioural interventions 
specifically targeted to older adults. 
157
  
Methods  
 
Searches were conducted on 6 February 2012 and again on 4 June 2012 in MEDLINE, 
Embase and the Education Resources Information Center (ERIC).  A search strategy was 
defined with high sensitivity but low specificity. The search strategy consisted of free-
text and Medical Subject Headings (MeSH) terms.  Search terms for older adults included 
“elderly," "older adults," “aged,” “geriatric” and “senior citizen” as well as HIV, AIDS 
and HIV/AIDS.  Additional search terms to identify interventions or trials included 
“intervention,” “trial,” “evaluation,” “intervention studies,” “randomized controlled 
trials,” “evaluation studies,” “program evaluation” and “prevention”, “testing” and 
“adherence” to ensure capture of relevant articles.  Additionally, references of identified 
publications and published reviews were hand searched for potential additional relevant 
articles.   
 
There were no restrictions on language or year of publication or country.  We included 
studies that included those aged 50 years and older or which reported specifically on that 
age group.  Studies that included participants aged, for example, 25-52 were excluded if 
there was no specific sub-group reporting on those aged 50 and older.  The focus of our 
work was non-pharmacologic, non-biological, behavioural interventions.  We did not 
search for studies that evaluated treatment efficacy among older adults but rather focused 
on interventions in the areas of prevention, adherence, testing, care and support. 
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 In the first review round, two reviewers (JN, AR) independently scrutinised the list of 
article titles to narrow the list of inclusions.  Another round of exclusions using abstracts 
of those articles deemed potentially relevant based on titles was conducted and the final 
selection was based on the full text of potentially relevant articles. In cases of 
disagreement, a third reviewer (AM) examined the articles. Results and inclusion were 
discussed until consensus was reached among all three reviewers.  Figure 1 outlines the 
number of studies included at each stage of the review process. 
 
Figure 1. Selection of manuscripts for systematic review of behavioural HIV 
interventions targeted to older adults 
 
Data were then extracted from each relevant study into an excel spreadsheet.  Extracted 
information included year, location of study, brief description, study type, sample size, 
study population, review of methods, primary outcome measure and focus topic of the 
study. 
 
Results 
 
After removing duplicates, the search revealed 1229 articles.  After a review of titles and 
then abstracts, 12 articles met study criteria and were included in the review. 
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The majority of articles  identify and describe behaviours of older adults rather than 
evaluating an intervention [30].  For example, there were articles that described specific 
intervention projects targeted to older adults – for example the Florida Senior HIV 
Intervention Project – but which did not provide any evidence of success or evaluation of 
the program [45].  Other papers did not report on those aged 50 and older.  For example, 
one paper provided data for the age group 30-59 but was not included in the review 
because it did not report on older adults specifically [46]. 
 
All twelve of the included studies originated from the Americas: two from Brazil and the 
rest from the United States.  Eight of the interventions were conducted among older 
adults living with HIV and four for HIV-negative older adults.  Five studies included 
control groups.  Of the included studies, four focused on general knowledge of HIV, 
three emphasised mental health and coping, two on sexual behaviour, two on physical 
status and one on testing/screening. 
 
The included studies do highlight areas for action in developing prevention and 
adherence interventions specifically for older adults.  Rose demonstrated that delivery of 
an age-specific AIDS education program was effective in improving HIV knowledge 
(p<0.001) and perceptions of susceptibility (p<0.01) among older HIV-negative 
Americans compared to a control group not receiving the education program [47].   
 
Other interventions targeted HIV-infected older adults.  One of the most successful 
interventions was group educational sessions developed to reduce high-risk sexual 
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behaviours run by a project called ROADMAP (Reeducating Older Adult in Maintaining 
AIDS Prevention) [48].  After sessions that included practicing condom use skills and 
role playing condom negotiation, participants in the intervention group (N=149) reported 
reduced inconsistent condom use (9% at baseline to 1% at 6 month follow-up; p=0.003) 
compared with the control group (N=92) (4% to 3%; p=.0999). 
 
Heckman and colleagues reported that group sessions with trained facilitators that 
included a focus on coping mechanisms and how to deal with stress are effective in 
reducing depressive symptoms in HIV-positive older adults (p values ranging from 0.01 
to 0.1 for variety of measures; see table 1) [49].  A study used telephone-based 
interventions to reduce risky sexual behaviour with controls reporting on average 3.24 
times (95% CI 1.79-5.85) as many occasions of unprotected sex at 3 follow-up [50].   
 
Weekly resistance exercise training sessions trialed in Sao Paulo, Brazil [32, 51], among 
HIV-positive older adults, produced increased strength and functional gains superior to 
those seen in age-matched HIV-negative controls.  Those receiving the intervention 
(N=11) increased weight lifted compared to controls (N=21) (p<0.01) and were faster at 
sit-to-stand after training (p=0.005) [32]. 
 
Table 1. Summary of included articles  
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Discussion 
 
This systematic review of behavioural HIV interventions specifically targeted to older 
adults reveals the paucity of published literature on this topic despite the increases in the 
number of people living with HIV aged 50 years and older and the increasing prevalence 
in this group globally.  Though there have been many calls for more evidence that 
specifically address the vulnerabilities and characteristics of older adults, only twelve 
articles were found that included some evaluation of an intervention for this population. 
 
Only four of the studies were randomised control trials and seven – including all of the 
studies among HIV-negative older adults – did not include controls at all.  A few of the 
studies conducted statistical testing on samples of 16 or 11 older adults making inference 
based on the results difficult.  A number of the studies – especially those among HIV-
negative individuals focused on general HIV awareness and interest as opposed to 
behaviour change.  More methodological rigour is needed in the studies targeting older 
adults.    
 
Despite the limited number of papers providing evidence on this topic, some lessons do 
emerge from the review.  Due to concerns over stigma and the perception of being low 
risk, researchers have suggested approaches for older adults through the lens of sexuality 
and sexual health rather than HIV directly [27].  Providing information on, for example, 
the impact of medications on sexuality may provide an appropriate time to discuss safe 
sex and HIV. 
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 Though there is an erroneous ageist assumption that older people are not able to make 
behaviour changes [52], a number of ideas were expressed as possible avenues to reach 
older adults with HIV services including using older adults as peer educators [38] and 
providing training in sexuality counselling to social workers working with this age group 
[36].  Others advocate for the increased use of internet and mobile phone based HIV 
programs to reach the elderly who might be uncomfortable discussing HIV in more 
public settings [53].  A number of authors called for more education of physicians on the 
topic to ensure that HIV counselling and also testing are carried out among older adults 
[54, 55]. 
 
This systematic review has a number of limitations.  The review focused specifically on 
interventions reporting outcomes among older adults and therefore might have missed 
interventions designed for adults of all ages that are effective among older adults.  The 
review only included published papers documenting interventions that had been 
evaluated thus eliminating a large set of publications that only describe interventions.   
 
The review only searched for studies specifically on HIV.  There are a number of other 
studies on medication adherence generally among older adults [56-58] or on sexual health 
interventions that might be relevant to HIV that were not included here.   
 
Given the trends within the HIV community, much more rigorous evidence is needed on 
how best to provide services for those aged 50 years and older.  A number of 
163
interventions were mentioned in articles, but without evidence of impact, suggesting that 
there are opportunities for evaluations to add to the base of knowledge in this area [45]. 
Through which channels to reach older adults most effectively, and how to message to 
them most appropriately, are critical to effective programming.  In particular, 
encouraging testing, supporting adherence, reducing risky sexual behaviours are all areas 
where the evidence base is currently insufficient.  More operational research is needed to 
scrutinise the “how” of service delivery for older adults [59] and how to provide it at 
scale.  The other major research challenge will be building an evidence base for older 
adults living in low and middle income countries where very little currently exists.  The 
applicability of American studies to other parts of the world is likely to be limited and 
such new research will be critical as the HIV cohort in Africa and Asia ages into the 
future. 
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Figure 1. Selection of manuscripts for systematic review of behavioural HIV 
interventions targeted to older adults 
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Table 1. Summary of included articles 
Article Participants Study Design Intervention Control 
Group 
(Y/N) 
Measure Results Summary 
AMONG HIV-NEGATIVE OLDER ADULTS 
Small 2010 Individuals 
aged 50 years 
and older 
 
N=50 
 
Purposive 
sampling 
 
 
Both 
quantitative 
and qualitative 
data were 
gathered 
during each 
session and 
included a pre-
survey and 
immediate 
post-37-item-
survey, a focus 
group, 
and an HIV 
educational 
curriculum. 
Four HIV education 
training sessions each 
lasting three hours 
covering the following 
topics:  
(a) Introduction and 
Overview, (b) Identifying 
Myths and Stereotypes, 
(c) HIV Facts, and (d) 
Provision of Resources. 
 
No Interest in 
HIV prevention 
and education 
(composite of 
two questions) 
 
Substantive HIV 
knowledge 
(composite of 
15 questions) 
HIV 
knowledge was 
not 
significantly 
(p=.273) 
higher in the 
posttest 
(mean=10.92) 
than in the 
pretest 
(mean=10.32) 
 
Substantive 
knowledge about 
HIV and AIDS 
remained low 
among 
respondents, and 
there was no 
significant change in 
knowledge after 
the administration of 
the modified 
curriculum 
Orel 2010 89 people aged 
60 and older 
 
N=11  
Before and 
after 
questionnaires 
“No One is Immune 
Project” – six-hour 
education and prevention 
workshop held at senior 
centre 
No 45-item 
HIV/AIDS 
Knowledge 
Questionnaire  
Increase in % 
answering 
correct 
 HIV can be 
spread by 
mosquitoes 
(48 to 98) 
 you cannot 
get HIV 
when getting 
a tattoo (25 
to 78) 
Workshop increased 
knowledge of HIV 
among older adults 
and 25% of 36 
registered 
participants received 
HIV test results that 
day 
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 women are 
always tested 
for HIV 
during their 
pap smears 
(12 to 100) 
 No data 
provided on 
overall 
changes in 
scores 
Altschuler 
2004 
 
 
Adults aged 50 
years and older 
in California 
 
Curriculum 
pilot tested 
with additional 
40 older adults 
 
N=249 
Purposive 
sample 
 
Verbal 
feedback from 
pilot test 
participants 
Interest in participating in 
HIV education 
prevention program 
surveyed and then 
specialised curriculum 
targeting older adults 
developed and presented 
 
Curriculum includes 
overview, myths and 
stereotypes, facts and 
resources. 
No Survey with 10 
questions 
concerning 
interest in 
prevention and 
education 
Pilot test 
participants 
identified 
learning that 
HIV was 
relevant to 
their lives; 
feeling 
empowered to 
speak up to 
their health 
care providers; 
positive 
impression 
being able to 
discuss a taboo 
topic. 
 
Women 
were more 
likely than men 
(p=.028) to 
A majority 
of participants 
reported interest in 
an HIV 
prevention program 
for older people.  
Presentations at 
centers serving older 
adults and from 
physicians are most 
appropriate. 
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attend an HIV/ 
AIDS 
educational 
program 
Rose 1996 Individuals 
aged >60 
recruited at 
senior citizen 
meal sites in 
USA 
 
Pre-
intervention 
N=458 
 
Post-
intervention 
N=318 
Pre and post-test 
cross-sectional 
survey 
20-30 minute age-
specific AIDS education 
program delivered at 
meal site and educational 
pamphlet. Consisted of 
statistics and facts about 
HIV, prevention 
measures and case 
studies of elderly people 
with HIV 
No Questionnaire 
measured HIV 
knowledge and 
perceptions of 
susceptibility to 
HIV (Likert 
scales) 
Significant 
increase in 
total 
knowledge 
about AIDS 
(p<0.001), 
perceived 
susceptibility 
(p<0.01) and 
perceived 
severity 
(p<0.001) 
 
Age specific 
education program 
significantly 
increased HIV-
related knowledge at 
senior citizen meal 
sites 
AMONG HIV-NEGATIVE OLDER ADULTS 
Lovejoy 2011 HIV-infected 
adults 45-plus 
years old who 
reported 
engaging in at 
least one 
occasion of 
unprotected sex 
in the 3 months 
prior to 
enrolment 
 
N=100 
Randomised 
control trial 
 
3 arms – 4-
sessions, 1 
session or 
nothing. 
Telephone delivered 
motivational interviewing 
(MI) (client-focused and 
directive form of 
counselling) to reduce 
risky sexual behaviour 
Yes Episodes of 
unprotected sex 
in past 3 months 
Participants in 
the 4-session 
MI arm 
engaged in the 
fewest 
occasions of 
unprotected 
sex at 3 and 6 
month follow-
up.  Controls 
had on average 
3.24 times as 
many 
occasions of 
Four sessions of 
telephone-delivered 
MI reduces sexual 
risk behaviour 
among HIV-positive 
older adults 
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unprotected 
sex (95% CI 
1.79-5.85). 
Ruiz 2010 
 
 
HIV-positive 
patients aged 
>60 years 
 
N=57 
Descriptive Functional screening for 
detection of 
comorbidities and 
referral for further care if 
failed in 3 or more 
domains 
No Referrals for 
comorbid 
conditions 
17 patients 
were referred 
due to 
problems in 
multiple 
domains 
including 
cognitive 
dysfunction  
(10), problems 
in daily living 
(8), nutritional 
issues (6), 
depression (5), 
and mobility 
(5) 
Screening for 
comorbidities 
among HIV-positive 
older adults can 
facilitate referral for 
further care likely to 
improve quality of 
care and outcomes 
Illa 2010 HIV –positive, 
45 or older, 
sexually active 
in last 12 
months 
 
N=241 (149 
intervention 
group and 92 in 
control group) 
Randomised 
control trial 
 
Follow-up at 6 
and 12 months 
Project ROADMAP (re-
educating older adult in 
maintaining AIDS 
prevention).  
 
Intervention group: 
educational brochure and 
four psycho-educational 
group sessions designed 
for HIV-positive older 
adults.  Sessions focused 
on information, 
motivation, behavioural 
skills and risk reduction 
behaviours. 
Yes Sexual risk 
(number of 
partners, partner 
HIV status, 
sexual acts, 
condom use) 
HIV knowledge 
(33 item 
measure) 
Sexual self-
efficacy 
Inconsistent 
condom use 
with partners 
of negative or 
unknown 
serostatus 
reduced from 
9% at baseline 
to 1.3% at 6 
month follow-
up among 
intervention 
group 
(p=.003); 4% 
to 3% with 
Group psyscho-
educational sessions 
reduced unprotected 
sexual acts with 
partners of unknown 
or negative 
serostatus 
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Control: educational 
brochure only.   
control 
(p=.999) 
 
Heckman et 
al 2001 
HIV-positive 
individuals 
aged 50 years 
and older 
attending AIDS 
service 
organizations 
 
N=16 
Pilot pre- and 
post-test cohort 
study 
Coping improvement 
group intervention 
 
10 face-face group 
sessions, each ~75min. 
Homogenous for 
sexuality and gender. 
No Severity of 
HIV-related Life 
Problem Scale 
 
Ways of coping 
Questionnaire 
 
Functional 
assessment of 
HIV Infection 
Scale 
 
Provision of 
Social relations 
 
Increased 
social 
wellbeing (2.20 
to 2.41, 
p<0.05) 
 
Marginal non -
significant 
change in 
coping 
(p<0.10)  
 
Marginal non-
significant 
decrease in 
stress 
associated with 
AIDS-related 
loss and health 
concerns (p 
<0.10) 
 
Marginal non-
significant 
increase in 
support from 
friends 
(p<0.10)  
Group sessions 
focusing on coping 
strategies had 
limited impact on 
coping and stress 
but increased social 
wellbeing among 
HIV-positive older 
adults 
Heckman et 
al 2006 
HIV-positive 
individuals 
aged 50 years 
Randomised 
control trial with 
delayed 
12, 90 minute sessions, 
telephone delivered 
weekly coping 
Yes, 
delayed 
treatment, 
Geriatric 
depression scale 
(GDS)  
Intervention 
group reported 
fewer 
Telephone delivered 
coping group 
sessions among 
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and older 
recruited from 
AIDS service 
organizations 
with diagnosis 
of depression 
or dysthymia 
 
N=90 
 
 
treatment 
control 
Embedded 
cohort study  
Assessed pre, 
post (within 1 
week of 
completion) and 
at 
3 months  
improvement group 
intervention to reduce 
psychological distress 
1) Immediate treatment 
(n=44) 
2) Delayed treatment 
(control) (n=46)  
 
 
 
control 
group  
 
 
 
Symptom 
checklist 90-
revised (SCL-
90-R) 
 
HIV-related life-
stressor burden 
scale  
 
UCLA  
Loneliness Scale 
(10-item) 
 
The Ways of 
Coping 
Checklist 
(WOCC) 
 
Coping self-
efficacy Scale  
psychological 
symptoms 
(p=0.05), less 
life stressor 
burden 
(p=0.058), less 
use of avoidant 
coping 
strategies 
(p=0.05) and 
marginally 
higher levels of 
coping self-
efficacy 
(p=0.10) 
compared to 
controls with 
no effect on 
depressive 
symptoms, 
loneliness or 
use of 
engagement 
coping 
 
Within 
cohorts  
IG:  significant 
decrease in 
depressive 
symptoms 
(p<0.003) 
psychological 
symptoms 
HIV-positive people 
with depression 
were effective in 
reducing 
psychological 
symptoms and stress 
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(p<0.001), life-
stressor burden 
(p<0.03) and 
avoidance 
coping (p<0.04) 
at 3 months  
 
Delayed group: 
significant 
decrease in 
psychological 
symptoms 
(p<0.03), life 
stressor 
burdens 
(p<0.001), 
loneliness 
(p<0.03) and 
greater coping 
self-efficacy 
(p<0.04) 
following 
intervention 
Heckman et 
al 2011 
HIV-positive 
individuals 
aged 50 years 
or older with 
Beck 
Depression 
Inventory-II 
score 10 or 
more and 
Modified mini-
mental state 
Randomised 
control trial 
3 arms 
1) 12 90 minute sessions 
face-to-face coping 
improvement (FFCI) 
group intervention 
(n=104) 
 
2) 12 session 
interpersonal support 
group (IPSG) 
intervention 
(n=105) 
Yes Geriatric 
Depression 
Screening Scale  
 
Completed 
using audio-
computer 
assisted self 
interviews (A-
CASI) 
Both FFCI and 
IPSG 
participants 
reported fewer 
depressive 
symptoms than 
controls post-
intervention, 4- 
and 8-month 
follow-up. This 
effect was not 
An age-appropriate 
coping improvement 
group intervention 
was effective in 
reducing depressive 
symptoms in HIV+ 
older adults. The 
effect was more 
pronounced amongst 
subjects suffering 
greater levels of 
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examination 
score of 75 or 
greater.  
 
N=295 
 
 
 
3) Individual therapy 
upon request (ITUR) 
control (n=86). Subjects 
had access to standard 
psychosocial services 
available in the 
community.  
 
always 
statistically 
significant 
(p’s<0.01-0.1) 
 
Effect size 
greater for 
subset of 
participants 
with mild, mod 
and severe 
depression at 
baseline 
depressive 
symptoms. 
Souza et al 
2008 
Subjects HIV+, 
older than 60 
(Mean 65.6+/- 
2.9), sedentary 
at baseline. 3 
subsequently 
excluded due to 
>3/12 absence 
from training 
program.  
 
N=11 
 
All subjects 
medical able to 
complete 
training and not 
using cortico- 
or anabolic 
steroids 
 
Prospective Case 
series study 
1 year resistance training 
program  
4 exercises targeting 
major muscle groups 
3 sets 8-12 reps at light, 
mod and heavy resistance 
respectively  
2 sessions/week, one year 
 
No Immunological 
and virological 
markers: 
T-CD4+  
T-CD8+,  
HIV-RNA PCR  
Anthropometric 
indices: 
Body mass, 
circumferences 
and skin folds 
Body 
composition 
(DEXA) 
Strength and 
functional tests: 
Sub-maximum 
weight lifted  
Two functional 
tests performed 
every 4 months 
Significant 
increase in 
CD4+ (388 pre 
to 539 post, 
p=0.008) and 
in CD4+/CD8+ 
ratio (0.63 to 
0.81, p=0.009)  
 
No significant 
change in 
weight 
 
Strength 
improvements 
of between 74-
97% 
(p’s=0.003-
0.021);  
 
Functional 
Following one year 
of progressive 
resistance training 
HIV positive older 
adults showed 
significant 
improvements in 
strength and 
functional capacity, 
no changes in body 
composition and 
improved 
immunological 
indices. 
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 assessing 
walking speed, 
and sit-to-stand 
performance. 
tests: decreased 
times for sit-
stand (2.00 to 
1.57s, 
p=0.003) and 
walking 2.4m 
(9.25 to 6.58s, 
p=0.003) 
Souza et al 
2011 
Subjects HIV+, 
age >= 60 (M= 
64.4 +/- 3.0) 
Ave. 9 year 
history of HIV, 
recruited at 
Hospital in Sao  
Paulo 
 
N=11 
 
All subjects 
medically able 
to complete 
training and not 
using cortico- 
or anabolic 
steroids 
Control trial Progressive resistance 
exercise 2 sessions per 
week for 1 year.  
 
Five exercises utilised 
major muscle groups 
 
3 sets 12/10/8 repetitions 
at sub-maximum load 
 
Yes, age, 
activity 
and 
gender 
matched 
HIV–
controls 
(N=21) 
Strength and 
functional tests: 
Sub-maximum 
load monitored 
bi-monthly  
 
Functional test 
of walk and sit-
stand speeds. 
 
 
Anthropometric 
and metabolic 
indices: 
Weight; BMI 
Lipid and 
glycaemic 
profiles (values 
registered in 
clinical record 
immediately 
before and after 
training 
program) 
 
 
Although 
weaker at 
baseline, HIV+ 
subjects 
increased 
weight lifted 
from 1.52 to 
2.33 times 
baseline, a 
significantly 
greater 
improvement 
than controls 
(1.21-1.48, 
p<0.01) 
 
HIV+ lighter, 
significantly 
lower BMI 
(p=0.007 pre 
and p=0.004 
post) 
Faster at 
walking tests 
(significant, 
p=0.036 pre-, 
Progressive 
resistance exercise 
training produced 
increased strength 
and functional gains 
in older adults living 
with HIV, with 
gains superior to 
those seen in age-
matched HIV- 
controls. An effect 
was also seen on 
metabolic indices. 
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not significant 
post-training). 
HIV+ 
significantly 
faster at sit-to-
stand after 
training than 
controls 
(p=0.005) 
 
Fasting BSL 
significantly 
improved in 
both groups 
(p’s=0.027-
0.037). 
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clinical care, a group of more 
than 200 clinicians and research-
ers who specialize in HIV care or 
investigation formally protested 
the bill, which is expected to un-
dergo further revision.
Remarkably, HIV infection has 
made the transition from death 
sentence to chronic condition in 
relatively short order. Laws that 
restrict the ability to collect, ana-
lyze, and appropriately share data 
on HIV-infected patients put them 
at risk for suboptimal care. HIV-
positive patients should be treat-
ed in patient-centered, coordinated 
systems that ensure they receive all 
needed elements of care, for all 
their conditions. We believe it 
is time to remove special provi-
sions for privacy that are based 
exclusively on HIV testing and di-
agnosis.
Disclosure forms provided by the authors 
are available with the full text of this arti-
cle at NEJM.org.
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legal Barriers to Care for HIV-Infected Patients
HIV and Aging — Preparing for the Challenges Ahead
Edward J. Mills, Ph.D., Till Bärnighausen, M.D., Sc.D., and Joel Negin, M.I.A.
By 2015, half the U.S. popula-tion living with human im-
munodeficiency virus (HIV) infec-
tion will be older than 50 years 
of age. As antiretroviral therapy 
(ART) coverage continues to ex-
pand worldwide, this aging of the 
HIV epidemic will be mirrored 
in developing countries. In sub-
Saharan Africa, ART has already 
reduced mortality rates, with 
320,000 (or 20%) fewer people 
dying of HIV-related causes in 
2009 than in 2004.1 Currently, 
HIV-infected Ugandans in their 
40s who are receiving ART can 
expect to live well into their 60s.2 
The increased life expectancy of 
HIV-infected persons will lead to 
increases in HIV prevalence among 
older adults. Approximately 1 in 
8 HIV-infected adults and 1 in 
10 patients receiving ART in sub-
Saharan Africa are older than 
50 years of age,3 and these ratios 
are likely to increase manyfold in 
the coming decades (see maps).
Yet the world is unprepared to 
deal with an aging population 
with HIV. We are still learning 
about what determines the success 
of ART in older age groups, and 
our understanding of the future 
needs with regard to treatment 
for chronic noncommunicable dis-
eases, such as cardiovascular dis-
ease and diabetes, in older HIV-
infected adults in developing 
countries is very limited. To date, 
the focus of the global response 
to HIV has been on providing 
care to mothers, children, and the 
most severely immunocompro-
mised patients. The June 2011 
United Nations High-Level Meet-
ing on AIDS emphasized the in-
tegration of HIV services with 
maternal and child health services 
but neglected the emerging evi-
dence on the aging of the HIV 
epidemic. Similarly, the September 
2011 United Nations High-Level 
Meeting on Non-Communicable 
Diseases did not consider the ef-
fect of the large-scale provision of 
ART in developing countries on 
the age distribution of the popu-
lation and the future global need 
for the treatment of noncommu-
nicable diseases. The failure of 
both meetings to consider the is-
sue of HIV and aging underscores 
how little attention is being paid 
to this coming challenge.
Effectively addressing the needs 
of aging HIV-infected populations 
will require political will, strength-
ened health systems, a greater 
commitment of human resources, 
and improved clinical infrastruc-
ture and expertise.
Political will is needed to put 
the aging of the epidemic on po-
litical agendas worldwide, just as 
it was necessary before 2004 to 
mobilize governments and donors 
to commit to improving access 
to ART. Political pressure helped 
drive down the price of ART from 
more than $10,000 to less than 
$100 per person per year. Similar 
action could help address the cur-
rent high cost of drugs for dis-
eases occurring late in life, includ-
ing many cancers and end-stage 
organ diseases such as congestive 
heart failure and renal failure.
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The second major challenge 
relates to the way in which health 
systems in developing countries 
respond to the need for treatment 
of chronic noncommunicable dis-
eases in HIV-infected patients. 
Both HIV infection and ART ex-
acerbate a range of diseases that 
occur in older people, including 
cardiovascular disease, diabetes, 
and osteoporosis. In Africa, pro-
viders of HIV-related services are 
unable to meet the health systems 
challenges of caring for HIV- 
infected patients with other chron-
ic diseases. Clinics that provide 
ART are typically minimally 
stocked with drugs other than 
antiretrovirals and rarely offer 
drugs that reduce modifiable dis-
ease risk factors (most notably, 
antiplatelet, antihypertensive, and 
lipid-lowering medications). Health 
maintenance through routine as-
sessment of blood pressure, blood 
glucose levels, and cardiac func-
tion through clinical examination, 
as well as counseling and screen-
ing for common cancers, is often 
overlooked. Clinical visits for HIV 
care may be the only medical ac-
cess that a patient has in many 
African countries. ART programs 
therefore ought to begin screening 
for coexisting chronic conditions 
and ensuring that patients have 
access to appropriate treatments. 
Yet few ART clinics can offer lab-
oratory tests to detect risk factors 
for noncommunicable diseases 
and to diagnose cardiovascular 
disease, diabetes, and cancers; and 
treatments for common chronic 
diseases of old age are either not 
integrated into ART services or 
not available at all.
The third challenge — the need 
for adequate human resources — 
HIV and Aging — Preparing for the Challenges Ahead
15–49 Yr of Age
≥50 Yr of Age
HIV prevalence <1% 1–1.9% 2–4.9% 5–9.9% 10–14.9% ≥15%
2011 2025 2040
HIV Prevalence in Sub-Saharan Africa in 2011, 2025, and 2040.
Shown are the prevalence of HIV in the population 15 to 49 years of age and in the population 50 years of age or older in sub-
Saharan Africa for the year 2011 and projections of HIV prevalence in those populations in the years 2025 and 2040 with continuous 
scale-up of antiretroviral therapy programs. Maps courtesy of Jan Hontelez, Erasmus University, Rotterdam.
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has been largely ignored. There 
are fewer than 25 geriatric clini-
cians in all of sub-Saharan Africa, 
and in most of the region’s coun-
tries there are none. In many sub-
Saharan African countries, medi-
cal schools do not offer courses 
in geriatrics. Clinicians in HIV 
service organizations typically do 
not receive ongoing education 
about the complexity of HIV in 
older patients.
One of the great achievements 
in the organization of the HIV re-
sponse has been the definition of, 
training for, and large-scale im-
plementation of appropriate ways 
of shifting clinical tasks from 
medical experts to nonphysician 
clinicians and even lay health 
workers and patients. Given cur-
rent shortages in the health work-
force in many developing coun-
tries, it seems likely that managing 
chronic diseases in HIV-infected 
patients will require similar ap-
proaches. Task shifting in the pro-
vision of clinical services such as 
hypertension screening, monitor-
ing of adherence to cardiovascular 
drugs, tobacco cessation pro-
grams, and cancer support groups 
can be a first step while infra-
structure is built. However, task 
shifting is not a long-term solu-
tion to aging-related care. Train-
ing and recruiting specialist non-
physician clinicians with expertise 
in geriatrics will be necessary and 
require the involvement of medi-
cal colleges and support from in-
ternational funding bodies.
Rehabilitation services, includ-
ing physical therapy, occupational 
therapy, and mobility aids, will 
also present an important chal-
lenge for HIV service providers. 
Building rehabilitation infrastruc-
ture will require innovative strat-
egies such as turning to resources 
and talent in the affected com-
munities. For example, makeshift 
mobility or rehabilitative aids con-
structed from locally sourced ma-
terials could benefit patients when 
standard equipment is unavail-
able or in short supply. Even such 
small advances can have a large 
positive impact on communities.
Finally, older adults with HIV 
face a number of distinct clinical 
challenges, including slower im-
munologic recovery with ART than 
is observed in younger popula-
tions. According to emerging evi-
dence on survival, patients 50 
years of age or older who are re-
ceiving ART are 30% (95% confi-
dence interval, 19 to 40) more 
likely than younger adults to die 
prematurely within 4 years after 
beginning treatment.4
The reasons for poor survival 
in this population are not well 
understood. Insufficient attention 
has been given to clinical chal-
lenges of adherence, drug inter-
actions, and toxicities when older 
HIV-infected patients are receiv-
ing multiple treatments for various 
conditions such as tuberculosis. 
These challenges are exacerbated 
by poor nutrition, high rates of 
poverty, and the social demands 
on older adults in many commu-
nities in developing countries.
Yet services for HIV-infected 
patients cannot be provided with-
out also considering the needs of 
HIV-negative patients with aging-
associated diseases. Although 
there is currently international 
attention focused on noncommu-
nicable diseases, the level of com-
mitment for treating these con-
ditions is limited. The principles 
of the HIV–AIDS response — test, 
treat, retain, adhere, and simplify 
care — can be useful in address-
ing aging-associated diseases in 
Africa.
U.S. Secretary of State Hillary 
Clinton has called on the world 
to commit greater treatment and 
preventive resources in the hope 
of ushering in an “AIDS-free gen-
eration.” This is indeed a laud-
able goal, yet we must also care 
for the millions of already-infected 
people struggling to obtain and 
cope with long-term ART while 
dealing with coexisting condi-
tions. Recent modeling using 
South African data suggests that 
HIV prevalence among people 
older than 50 years of age will 
nearly double in the next 30 years, 
and the absolute number of simi-
larly aged HIV-infected patients 
will triple in the same period.5 
The development of programs for 
aging HIV-infected populations 
in developing countries will thus 
be a critical medical and public 
health challenge in the near fu-
ture. How it is addressed may 
well decide the long-term success 
of the global ART scale-up, one 
of the largest public health inter-
ventions in history.
Disclosure forms provided by the au-
thors are available with the full text of this 
article at NEJM.org.
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Both HIV infection and antiretroviral therapy 
exacerbate a range of diseases that occur in 
older people, including cardiovascular disease, 
diabetes, and osteoporosis.
184
n engl j med 366;14 nejm.org april 5, 2012
PERSPECTIVE
1273
and the Sydney School of Public Health, 
University of Sydney, Sydney, NSW, Austra-
lia ( J.N.).
1. UNAIDS report on the global AIDS epi-
demic 2010. Geneva: Joint United Nations 
Programme on HIV/AIDS, 2010 (http://
www.unaids.org/globalreport/global_report 
.htm).
2. Mills EJ, Bakanda C, Birungi J, et al. Life 
expectancy of persons receiving combina-
tion antiretroviral therapy in low-income 
countries: a cohort analysis from Uganda. 
Ann Intern Med 2011;155:209-16.
3. Negin J, Cumming RG. HIV infection in 
older adults in sub-Saharan Africa: extrapo-
lating prevalence from existing data. Bull 
World Health Organ 2010;88:847-53.
4. Bakanda C, Birungi J, Mwesigwa R, et al. 
Association of aging and survival in a large 
HIV-infected cohort on antiretroviral thera-
py. AIDS 2011;25:701-5.
5. Hontelez JAC, Lurie MN, Newell ML, et al. 
Ageing with HIV in South Africa. AIDS 
2011;25:1665-7.
Copyright © 2012 Massachusetts Medical Society.
HIV and Aging — Preparing for the Challenges Ahead
185
Correspondence
768 www.thelancet.com   Vol 378   August 27, 2011
Further analyses of the 
Myeloma IX Study
Athanassios Kyrgidis and 
Thrasivoulos-George Tzellos (June 25, 
p 2177)1 and Tetsuya Tanimoto and 
colleagues (June 25, p 2178)2 make 
important comments on our paper3 
reporting the results of the Medical 
Research Council (MRC) Myeloma IX 
Study.
In response to Kyrgidis and Tzellos, 
the statistical analyses were done as 
prospectively planned for the MRC 
Myeloma IX Study. The additional 
exploratory analyses were done to verify 
that the overall survival model was valid 
despite a model violation detected for 
one treatment centre (model omitting 
stratiﬁ cation by treatment centre) and 
to test a hypothesis that the eﬀ ect of 
zoledronic acid on survival was simply 
due to prevention of skeletal-related 
events, which was found not to be 
the case. The outcome from this latter 
model was consistent when treatment-
centre stratiﬁ cation was omitted, 
although the comparison then fell just 
short of signiﬁ cance (p=0·0515). The 
overall survival beneﬁ t with zoledronic 
acid versus clodronic acid seen in the 
overall population in Myeloma IX was 
also consistent (though statistically 
underpowered) when the intensive and 
non-intensive pathways were analysed 
separately.
The intention of the diﬀ erent curves 
presented in ﬁ gure 2 was not, as implied, 
to present a favourable impression 
for zoledronic acid. The overall and 
progression-free survival curves were 
initially generated for the entire time 
course (ﬁ gures 2A and 2C) per the 
study protocol. Given the lower rates 
of early death and generally favourable 
response proﬁ les in patients treated 
with zoledronic acid, the ﬁ rst 4 months 
on study (ie, during chemotherapy) 
were analysed separately and revealed 
striking diﬀ erences.
The cumulative incidence of 
osteonecrosis of the jaw in patients 
treated with zoledronic acid was 3–4% 
across a median follow-up of 3·7 years. 
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with HIV aged 50 years and older, 
representing more than 13% of the 
region’s HIV cases.3
With the ageing of the epidemic, 
HIV/AIDS has become a complex 
chronic disease characterised 
by increasing rates of comorbid 
conditions including liver and renal 
disease, cancers, osteoporosis, and 
neurocognitive and cardiovascular 
diseases.4 The vertical AIDS funding 
approach has meant that AIDS clinics 
have training and resources to deal 
with AIDS-speciﬁ c conditions, but 
lack access to eﬀ ective diagnostics 
and treatments for these comorbid 
disorders.
The UN meeting was tasked with 
charting the future course of the 
global HIV response, yet failed to 
mention the ageing of the pandemic. 
It acknowledged the need for a more 
integrated approach, but centred 
mainly on infectious diseases and 
reproductive and child health. The 
call for integration is appropriate, 
but should focus on strengthening 
the response to non-communicable 
diseases in developing countries, 
building on existing eﬀ orts to develop 
HIV chronic-care models.5
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Continued neglect of 
ageing of HIV epidemic 
at UN meeting
On June 10, 2011, the UN HIV/AIDS 
meeting in New York, USA, concluded 
with a set of commitments including 
to redouble eﬀ orts to achieve 
universal access to prevention, 
treatment, and care. As you report 
(June 18, p 2055),1 integration was 
highlighted as the way forward for the 
epidemic’s response. The declaration, 
however, missed an opportunity to 
acknowledge the integration needed 
to address the reality that, as more 
people are put on treatment and as 
survival on treatment is enhanced 
around the world, a growing 
proportion of people living with HIV 
will be classiﬁ ed as elderly.2
UN data have focused on those aged 
15–49 years but, across the world, 
the epidemic is aﬀ ecting those aged 
50 years and older more than ever 
before. By 2015, at least half of those 
living with HIV in the USA will be aged 
50 years and older. In sub-Saharan 
Africa, there are 3 million people living 
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